• Aarsetoy H, Brugger-Andersen T, Hetland O, Grundt H, Nilsen DW. Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-associated plasma protein A and matrix metalloproteinase-9 following acute myocardial infarction. Thromb. Haemost. 95: 329-336 (2006).

• Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, Mandel SJ, Stagnaro-Green A. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 92: S1-S47 (2007).

• Abbott BD, Wolf CJ, Schmid JE, Das KP, Zehr RD, Helfant L, Nakayama S, Lindstrom AB, Strynar MJ, Lau CS. Perfluorooctanoic acid (PFOA)-induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha (PPARalpha). Toxicol. Sci. 98: 571-581 (2007). *

• Abdel-Naser MB, Zouboulis C. Clindamycin phosphate/tretinoin gel formulation in the treatment of acne vulgaris. Expert Opin. Pharmacother. 9: 2931-2937 (2008).

• Abergel A. Liver and pregnancy. Literature review. Gastroenterol. Clin. Biol. 25: 802-805 (2001).

• Aberra FN. To be or not to be: infliximab during pregnancy? Inflamm. Bowel Dis. 12: 76-78 (2006). *

• Abroms L, Maibach E, Lyon-Daniel K, Feldman SR. What is the best approach to reducing birth defects associated with isotretinoin? PLoS Med. 3: e483 (2006). *

• Achterbergh R, Lakeman P, Stemerding D, Moors EH, Cornel MC. Implementation of preconceptional carrier screening for cystic fibrosis and haemoglobinopathies: a sociotechnical analysis. Health Policy 83: 277-286 (2007).

• Adams KM, Nelson JL. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA 291: 1127-1131 (2004). *

• Adams KM, Yan Z, Stevens AM, Nelson JL. The changing maternal "self" hypothesis: a mechanism for maternal tolerance of the fetus. Placenta 28: 378-382 (2007).

• Aflatoonian R, Fazeli A. Toll-like receptors in female reproductive tract and their menstrual cycle dependent expression. J. Reprod. Immunol. 77: 7-13 (2008).

• Afzali B, Lechler RI, Hernandez-Fuentes MP. Allorecognition and the alloresponse: clinical implications. Tissue Antigens 69: 545-556 (2007). *

• Agale S, Kulkarni A, Ranjekar P, Joshi S. Maternal caloric restriction spares fetal brain polyunsaturated fatty acids in Wistar rats. Brain Dev. Jan 5 [Epub ahead of print] (2009).

• Agostoni C, Riva E, Giovannini M, Pinto F, Colombo C, Risé P, Galli C, Marangoni F. Maternal smoking habits are associated with differences in infants' long-chain polyunsaturated fatty acids in whole blood: a case-control study. Arch. Dis. Child. 93: 414-418 (2008).

• Agret F, Cosnes J, Hassani Z, Gornet JM, Gendre JP, Lemann M, Beaugerie L. Impact of pregnancy on the clinical activity of Crohn's disease. Aliment. Pharmacol. Ther. 21: 509-513 (2005). *

• Ahmed S, Bryant L, Hewison J. 'Balance' is in the eye of the beholder: providing information to support informed choices in antenatal screening via Antenatal Screening Web Resource. Health Expect. 10: 309-320 (2007).

• Ai Y, Liu SY, Yao Q. Clinical characteristics of 1241 cases of intrahepatic cholestasis of pregnancy. Zhonghua Fu Chan Ke Za Zhi 39: 217-220 (2004).

• Aikawa J, Moretto KD, Denes F, Yamazaki RK, Freitas FA, Hirabara SM, Tchaikovski O Jr, Kaelher MD, Brito GA, Curi R, Fernandes LC. Glucose metabolism by lymphocytes, macrophages, and tumor cells from Walker 256 tumor-bearing rats supplemented with fish oil for one generation. Cell. Biochem. Funct. 26: 874-880 (2008). *

• Airas L, Nikula T, Huang YH, Lahesmaa R, Wiendl H. Postpartum-activation of multiple sclerosis is associated with down-regulation of tolerogenic HLA-G. J. Neuroimmunol. 187: 205-211 (2007).

• Airas L, Saraste M, Rinta S, Elovaara I, Huang YH, Wiendl H; The Finnish Multiple Sclerosis and Pregnancy Study Group. Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells. Clin. Exp. Immunol. 151: 235-243 (2008). *

• Ajonuma LC, Chan PK, Ng EH, Fok KL, Wong CH, Tsang LL, Tang XX, Ho LS, Lau MC, Chung CM, He Q, Huang HY, Yang DZ, Rowlands DK, Chung YW, Chan HC. Involvement of cystic fibrosis transmembrane conductance regulator (CFTR) in the pathogenesis of hydrosalpinx induced by Chlamydia trachomatis infection. J. Obstet. Gynaecol. Res. 34: 923-930 (2008).

• Akamizu T. Genetic and environmental factors of autoimmune thyroid diseases. Nippon Rinsho 57: 1697-1702 (1999).

• Alallam A, Barth D, Heathcote EJ. Role of plasmapheresis in the treatment of severe pruritus in pregnant patients with primary biliary cirrhosis: case reports. Can. J. Gastroenterol. 22: 505-507 (2008).

• Albaar MT, Adam JM. Gestational transient thyrotoxicosis. Acta Med. Indones. 41: 99-104 (2009).

• Alberti A, Venti M, Biagini S. Headache and cerebral vein and sinus thrombosis. Front. Neurol. Neurosci. 23: 89-95 (2008).

• Alcalay J, Landau M, Zucker A. Analysis of laboratory data in acne patients treated with isotretinoin: is there really a need to perform routine laboratory tests? J. Dermatolog. Treat. 12: 9-12 (2001).

• Alef K. Clostridium difficile-associated disease. Implications for midwifery practice. J. Nurse Midwifery 44: 19-29 (1999).

• Alessio AM, Hoehr NF, Siqueira LH, Ozelo MC, de Padua Mansur A, Annichino-Bizzacchi JM. Association between estrogen receptor alpha and beta gene polymorphisms and deep vein thrombosis. Thromb. Res. 120: 639-645 (2007). *

• Ali T, Srinivasan N, Le V, Rizvi S. Alpha-methyldopa hepatotoxicity in pregnancy. J. Coll. Physicians Surg. Pak. 19: 125-126 (2009).

• Alijotas-Reig J, Casellas-Caro M, Ferrer-Oliveras R, Cabero-Roura L, Vilardell-Tarres M. Recurrent Kikuchi-Fujimoto disease during pregnancy: report of case evolving into systemic lupus erythematosus and review of published work. J. Obstet. Gynaecol. Res. 34: 595-598 (2008).

• Alijotas-Reig J, Casellas-Caro M, Ferrer-Oliveras R, Llurba-Olive E, Hermosilla E, Vilardell-Tarres M, Cabero-Roura L. Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women? Am. J. Reprod. Immunol. 60: 229-237 (2008). *

• Alijotas-Reig J, Ferrer-Oliveras R, Rodrigo-Anoro MJ, Farran-Codina I, Cabero-Roura L, Vilardell-Tarres M. Anti-beta(2)-glycoprotein-I and anti-phosphatidylserine antibodies in women with spontaneous pregnancy loss. Fertil. Steril. Mar 16 [Epub ahead of print] (2009).

• Alijotas-Reig J, Palacio-Garcia C, Vilardell-Tarres M. Circulating microparticles, lupus anticoagulant and recurrent miscarriages. Eur. J. Obstet. Gynecol. Reprod. Biol. May 1 [Epub ahead of print] (2009).

• Alijotas-Reig J, Suy-Franch A, Casellas-Caro M, Vilardell-Tarres M, Cabero-Roura L. Recurrent Kikuchi-Fujimoto necrotizing lymphadenitis during pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 140: 144-145 (2008).

• Almasio P, Bortolini M, Pagliaro L, Coltorti M. Role of S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis. Drugs 40 Suppl. 3: 111-123 (1990).

• Alonso L AG. Effect of pregnancy on pre-existing liver disease physiological changes during pregnancy. Ann. Hepatol. 5: 184-186 (2006). *

• Alstead EM. Inflammatory bowel disease in pregnancy. Postgrad. Med. J. 78: 23-26 (2002). *

• Alstead EM, Nelson-Piercy C. Inflammatory bowel disease in pregnancy. Gut 52: 159-161 (2003). *

• Aluvihare VR, Betz AG. The role of regulatory T cells in alloantigen tolerance. Immunol. Rev. 212: 330-343 (2006). *

• Ambros-Rudolph CM, Glatz M, Trauner M, Kerl H, Mullegger RR. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from Central Europe. Arch. Dermatol. 143: 757-762 (2007). *

• Amitrano L, Guardascione MA, Brancaccio V, Balzano A. Coagulation disorders in liver disease. Semin. Liver Dis. 22: 83-96 (2002).

• Amoudruz P, Minang JT, Sundstrom Y, Nilsson C, Lilja G, Troye-Blomberg M, Sverremark-Ekstrom E. Pregnancy, but not the allergic status, influences spontaneous and induced interleukin-1beta (IL-1beta), IL-6, IL-10 and IL-12 responses. Immunology 119: 18-26 (2006). *

• Andryushkova AA, Kuznetsova IA, Orlovskaya IA, Buneva VN, Nevinsky GA. Antibodies with amylase activity from the sera of autoimmune-prone MRL/MpJ-lpr mice. FEBS Lett. 580: 5089-5095 (2006). *

• Angelberger S, Reinisch W, Dejaco C. Prevention of abortion by ciclosporin treatment of fulminant ulcerative colitis during pregnancy. Gut 55: 1364-1365 (2006). *

• Angelo Ghezzi A, Zaffaroni M. Female-specific issues in multiple sclerosis. Expert Rev. Neurother. 8: 969-977 (2008).

• Angelucci E, Cocco A, Viscido A, Caprilli R. Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception. Inflamm. Bowel Dis. 14: 435-436 (2008). *

• Angulo P. Use of ursodeoxycholic acid in patients with liver disease. Curr. Gastroenterol. Rep. 4: 37-44 (2002).

• Anjum N, Baker PN, Robinson NJ, Aplin JD. Maternal celiac disease autoantibodies bind directly to syncytiotrophoblast and inhibit placental tissue transglutaminase activity. Reprod. Biol. Endocrinol. 7: 16 (2009). *

• Antolic B, Gersak K, Verdenik I, Novak-Antolic Z. Adverse effects of thyroid dysfunction on pregnancy and pregnancy outcome: epidemiologic study in Slovenia. J. Matern. Fetal Neonatal Med. 19: 651-654 (2006).

• Antonio M, Patrizia F, Ilaria I, Paolo F. A rational approach on the use of sex steroids in multiple sclerosis. Recent Patents CNS Drug Discov. 3: 34-39 (2008).

• Aouthmany A, Horattas MC. Ileal pouch perforation in pregnancy: report of a case and review of the literature. Dis. Colon Rectum 47: 243-245 (2004).

• Apps R, Gardner L, Sharkey AM, Holmes N, Moffett A. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur. J. Immunol. 37: 1924-1937 (2007). *

• Apps R, Murphy SP, Fernando R, Gardner L, Ahad T, Moffett A. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 127: 26-39 (2009). *

• Arakaki O, Yamamoto Y, Awazawa R, Nonaka K, Taira K, Asato Y, Hagiwara K, Oyama B, Ishii N, Hashimoto T, Uezato H. Case of linear immunoglobulin A bullous dermatosis associated with acquired hemophilia. J. Dermatol. 35: 437-446 (2008).

• Ardaillou R, Le Gall JY. Mass neonatal screening using biological testing. Gynecol. Obstet. Fertil. 35: 367-374 (2007).

• Armenti VT, Herrine SK, Moritz MJ. Reproductive function after liver transplantation. Clin. Liver Dis. 1: 471-485 (1997).

• Armony S, Elyashar-Earon H, Sciaky-Tamir Y, Wilschanski M. Prolonged TPN during pregnancy in a cystic fibrosis patient with chronic pancreatitis. Eur. J. Obstet. Gynecol. Reprod. Biol. 143: 62-63 (2009).

• Arora M, Ettinger AS, Peterson KE, Schwartz J, Hu H, Hernandez-Avila M, Tellez-Rojo MM, Wright RO. Maternal dietary intake of polyunsaturated fatty acids modifies the relationship between lead levels in bone and breast milk. J. Nutr. 138: 73-79 (2008). *

• Arrese M. Cholestasis during pregnancy: rare hepatic diseases unmasked by pregnancy. Ann. Hepatol. 5: 216-218 (2006). *

• Arrese M, Accatino L. Ursodeoxycholic acid in the treatment of cholestatic liver diseases. Rev. Med. Chil. 121: 439-446 (1993).

• Arrese M, Accatino L. Is intrahepatic cholestasis of pregnancy an MDR3-related disease? Gastroenterology 125: 1922-1923 (2003). *

• Arrese M, Macias RI, Briz O, Perez MJ, Marin JJ. Molecular pathogenesis of intrahepatic cholestasis of pregnancy. Expert Rev. Mol. Med. 10: e9 (2008).

• Arrese M, Reyes H. Intrahepatic cholestasis of pregnancy: a past and present riddle. Ann. Hepatol. 5: 202-205 (2006). *

• Arrese M, Trauner M, Ananthanarayanan M, Pizarro M, Solis N, Accatino L, Soroka C, Boyer JL, Karpen SJ, Miquel JF, Suchy FJ. Down-regulation of the Na+/taurocholate cotransporting polypeptide during pregnancy in the rat. J. Hepatol. 38: 148-155 (2003). *

• Artlett CM. Microchimerism in health and disease. Curr. Mol. Med. 2: 525-535 (2002).

• Arundel C, Lewis JH. Drug-induced liver disease in 2006. Curr. Opin. Gastroenterol. 23: 244-254 (2007).

• Asherson RA, Frances C, Iaccarino L, Khamashta MA, Malacarne F, Piette JC, Tincani A, Doria A. The antiphospholipid antibody syndrome: diagnosis, skin. Clin. Exp. Rheumatol. 24: S46-S51 (2006).

• Asimakopoulos G. Pregnancy and inflammatory bowel disease. Rev. Med. Chir. Soc. Med. Nat. Iasi. 108: 46-50 (2004).

• Asimuakopoulos G. Pregnancy and liver disease. Rev. Med. Chir. Soc. Med. Nat. Iasi. 110: 326-333 (2006).

• Aslan E, Tarim E, Kilicdag E, Simsek E. Sjogren's syndrome diagnosed in pregnancy: a case report. J. Reprod. Med. 50: 67-70 (2005).

• Aspberg S, Dahlquist G, Kahan T, Kallen B. Fetal and perinatal risk factors for inflammatory bowel disease. Acta Paediatr. 95: 1001-1004 (2006). *

• Assisi A, Banzi R, Buonocore C, Capasso F, Muzio VD, Michelacci F, Renzo D, Tafuri G, Trotta F, Vitocolonna M, Garattini S. Fish oil and mental health: the role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disorders. Int. Clin. Psychopharmacol. 21: 319-336 (2006).

• Atabey S, Duvan CI, Eren U, Turhan NO. Intrahepatic cholestasis and eclampsia: a case report. Hypertens. Pregnancy 26: 363-369 (2007).

• Atanassova PA. Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview. Yonsei Med. J. 48: 901-926 (2007). *

• Ates Y, Aslan M, Tuzun A, Bagci S, Dagalp K. Ulcerative colitis case beginning during pregnancy in a patient with antiphospholipid antibody syndrome. Turk. J. Gastroenterol. 15: 263-265 (2004). *

• Avagliano L, Grillo C, Prioli MA. Congenital heart disease: a retrospective study of their frequency. Minerva Ginecol. 57: 171-178 (2005).

• Avalos P, Camacho FM. Practical management of adalimumab. Actas. Dermosifiliogr. 99 Suppl. 3: 25-27 (2008).

• Ayed K, Gorgi Y, Sfar I, Khrouf M. Congenital heart block associated with maternal anti SSA/SSB antibodies: a report of four cases. Pathol. Biol. (Paris) 52: 138-147 (2004).

• Aytac S, Kargili A, Turkay C. A prolonged gestational intrahepatic cholestasis: a case report. Turk. J. Gastroenterol. 17: 206-208 (2006). *

• Azoulay L, Oraichi D, Berard A. Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern? Eur. J. Clin. Pharmacol. 62: 667-674 (2006). *

• Azzaroli F, Mennone A, Feletti V, Simoni P, Baglivo E, Montagnani M, Rizzo N, Pelusi G, DE Aloysio D, Lodato F, Festi D, Colecchia A, Roda E, Boyer JL, Mazzella G. Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. Aliment. Pharmacol. Ther. 26: 1139-1146 (2007). *

• Bacq Y, Myara A, Brechot MC, Hamon C, Studer E, Trivin F, Metman EH. Serum conjugated bile acid profile during intrahepatic cholestasis of pregnancy. J. Hepatol. 22: 66-70 (1995). *

• Bai A, Guo Y, Shen Y, Xie Y, Zhu X, Lu N. Seasonality in flares and months of births of patients with ulcerative colitis in a Chinese population. Dig. Dis. Sci. 54: 1094-1098 (2009). *

• Bakker EC, Hornstra G, Blanco CE, Vles JS. Relationship between long-chain polyunsaturated fatty acids at birth and motor function at 7 years of age. Eur. J. Clin. Nutr. 63: 499-504 (2009). *

• Bal J, Sobczynska-Tomaszewska A, Czerska K, Obersztyn E, Sands D, Mazurczak T. Prenatal diagnostics of cystic fibrosis in risk families in Poland - results of the molecular analyses. Med. Wieku. Rozwoj. VIII: 871-883 (2004).

• Balascakova M, Holubova A, Skalicka V, Zemkova D, Kracmar P, Gonsorcíkova L, Camajova J, Piskackova T, Lebl J, Drevínek P, Gregor V, Vavrova V, Votava F, Macek M Jr. Pilot newborn screening project for cystic fibrosis in the Czech Republic: defining role of the delay in its symptomatic diagnosis and influence of ultrasound-based prenatal diagnosis on the incidence of the disease. J. Cyst. Fibros. 8: 224-227 (2009).

• Baldassarre M, Laneve AM, Grosso R, Laforgia N. Celiac disease: pathogenesis and novel therapeutic strategies. Endocr. Metab. Immune Disord. Drug Targets 8: 152-158 (2008).

• Balistreri WF. Bile acid therapy in pediatric hepatobiliary disease: the role of ursodeoxycholic acid. J. Pediatr. Gastroenterol. Nutr. 24: 573-589 (1997). *

• Balistreri WF. Genetic liver disease. 54th Annual Meeting of the American Association for the Study of Liver Diseases (2003).

• Barlow C. Ulcerative colitis, pregnancy, prenatal expression and breastfeeding. Breastfeed. Rev. 14: 17-19 (2006).

• Barnes DS. Intrahepatic cholestatic liver disease. http://www.clevelandclinicmeded.com/diseasemanagement/gastro/intrahepatic/intrahepatic1.htm (2002). *

• Baron S, Turck D, Leplat C, Merle V, Gower-Rousseau C, Marti R, Yzet T, Lerebours E, Dupas JL, Debeugny S, Salomez JL, Cortot A, Colombel JF. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut 54: 357-363 (2005). *

• Barth A, Rost M, Kindt A, Peiker G. Serum bile acid profile in women during pregnancy and childbed. Exp. Clin. Endocrinol. Diabetes 113: 372-375 (2005).

• Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet. Gynecol. 112: 359-372 (2008).

• Bartosik-Psujek H, Stelmasiak Z. Multiple sclerosis - difficult answers to easy questions. Neurol. Neurochir. Pol. 40: 441-445 (2006).

• Basch E, Bent S, Collins J, Dacey C, Hammerness P, Harrison M, Smith M, Szapary P, Ulbricht C, Vora M, Weissner W. Flax and flaxseed oil (Linum usitatissimum): a review by the Natural Standard Research Collaboration. J. Soc. Integr. Oncol. 5: 92-105 (2007).

• Basille C, Frydman R, Aly AE, Hesters L, Fanchin R, Tachdjian G, Steffann J, Lelorc'h M, Achour-Frydman N. Preimplantation genetic diagnosis: state of the art. Eur. J. Obstet. Gynecol. Reprod. Biol. May 1 [Epub ahead of print] (2009).

• Basu D, Thornton JG. Abdominal dystocia in a case of undetected intrauterine meconium peritonitis due to cystic fibrosis. Congenit. Anom. (Kyoto) 47: 72-73 (2007).

• Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin. Liver Dis. 21: 437-451 (2001).

• Baumgart DC, Sturm A, Wiedenmann B, Dignass AU. Uneventful pregnancy and neonatal outcome with tacrolimus in refractory ulcerative colitis. Gut 54: 1822-1823 (2005). *

• Beaulieu DB, Ananthakrishnan AN, Issa M, Rosenbaum L, Skaros S, Newcomer JR, Kuhlmann RS, Otterson MF, Emmons J, Knox J, Binion DG. Budesonide induction and maintenance therapy for Crohn's disease during pregnancy. Inflamm. Bowel Dis. 15: 25-28 (2009).

• Bebo BF Jr, Dehghani B, Foster S, Kurniawan A, Lopez FJ, Sherman LS. Treatment with selective estrogen receptor modulators regulates myelin specific T-cells and suppresses experimental autoimmune encephalomyelitis. Glia 57: 777-790 (2008).

• Bebo BF Jr, Dveksler GS. Evidence that pregnancy specific glycoproteins regulate T-cell function and inflammatory autoimmune disease during pregnancy. Curr. Drug Targets Inflamm. Allergy 4: 231-237 (2005).

• Bedocs PM, Kumar V, Mahon MJ. Pemphigoid gestationis: a rare case and review. Arch. Gynecol. Obstet. 279: 235-238 (2009).

• Belloni G, Talamazzini A, Soldati PM, Bernini L, Di Gennaro F, Bergamaschi P. Primary biliary cirrhosis with onset in pregnancy: a case report. Medicina (Firenze) 10: 31-32 (1990).

• Ben-David G, Sheiner E, Hallak M, Levy A. Pregnancy outcome in women with psoriasis. J. Reprod. Med. 53: 183-187 (2008).

• Beniada A, Benoist G, Maurel J, Dreyfus M. Inflammatory bowel disease and pregnancy: report of 76 cases and review of the literature. J. Gynecol. Obstet. Biol. Reprod. (Paris) 34: 581-588 (2005).

• Benjaminov FS, Heathcote J. Liver disease in pregnancy. Am. J. Gastroenterol. 99: 2479-2488 (2004). *

• Berard A, Azoulay L, Koren G, Blais L, Perreault S, Oraichi D. Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective. Br. J. Clin. Pharmacol. 63: 196-205 (2007). *

• Bergasa NV. The pruritus of cholestasis. J. Hepatol. 43: 1078-1088 (2005). *

• Bergasa NV, Mason A, Floreani A, Heathcote J, Swain MG, Jones DE, Lindor KM, Bassendine MF, Worman HJ. Primary biliary cirrhosis: report of a focus study group. Hepatology 40: 1013-1020 (2004). *

• Bergquist A, Montgomery SM, Lund U, Ekbom A, Olsson R, Lindgren S, Prytz H, Hultcrantz R, Broome U. Perinatal events and the risk of developing primary sclerosing cholangitis. World J. Gastroenterol. 12: 6037-6040 (2006). *

• Berkane N, Cocheton JJ, Brehier D, Merviel P, Wolf C, Lefevre G, Uzan S. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. A retrospective study of 19 cases. Acta Obstet. Gynecol. Scand. 79: 941-946 (2000).

• Berkley EM, Leslie KK, Arora S, Qualls C, Dunkelberg JC. Chronic hepatitis C in pregnancy. Obstet. Gynecol. 112: 304-310 (2008).

• Bernuau J. Hepatic complications of pregnancy. Rev. Prat. 53: 1889-1893 (2003).

• Berthelot JM, De Bandt M, Goupille P, Solau-Gervais E, Liote F, Goeb V, Azais I, Martin A, Pallot-Prades B, Maugars Y, Mariette X; on behalf of CRI (Club Rhumatismes et Inflammation). Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature. Joint Bone Spine 76: 28-34 (2009). *

• Berti PR, Soueida R, Kuhnlein HV. Dietary assessment of indigenous Canadian Arctic women with a focus on pregnancy and lactation. Int. J. Circumpolar Health 67: 349-362 (2008).

• Berti S, Amato L, Chiarini C, Fabbri P. Case study: an itching and excoriated dermatosis during intrahepatic cholestasis of pregnancy. Skinmed. 4: 248-249 (2005).

• Bertolaccini ML, Khamashta MA. Laboratory diagnosis and management challenges in the antiphospholipid syndrome. Lupus 15: 172-178 (2006).

• Bertolaccini ML, Khamashta MA, Hughes GR. Diagnosis of antiphospholipid syndrome. Nat. Clin. Pract. Rheumatol. 1: 40-46 (2005). *

• Beuers U. Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 318-328 (2006). *

• Beuers U, Oswald M. Cholestasis: therapeutic options. Ther. Umsch. 55: 97-103 (1998).

• Beuers U, Pusl T. Intrahepatic cholestasis of pregnancy - a heterogeneous group of pregnancy-related disorders? Hepatology 43: 647-649 (2006). *

• Bhat PV, Manolescu DC. Role of vitamin A in determining nephron mass and possible relationship to hypertension. J. Nutr. 138: 1407-1410 (2008). *

• Bhutta ZA, Ahmed T, Black RE, Cousens S, Dewey K, Giugliani E, Haider BA, Kirkwood B, Morris SS, Sachdev H, Shekar M; for the Maternal and Child Undernutrition Study Group. What works? Interventions for maternal and child undernutrition and survival. Lancet 371: 417-440 (2008). *

• Bianchi DW. Fetomaternal cell traffic, pregnancy-associated progenitor cells, and autoimmune disease. Best Pract. Res. Clin. Obstet. Gynaecol. 18: 959-975 (2004).

• Biczysko M, Kosciniski T, Biczysko R. Unusual complication after caesarean section in a pregnant women with undiagnosed Crohn's disease. Ginekol. Pol. 79: 635-637 (2008).

• Biesiada L, Pietrzak Z, Brocka U, Oszukowski P, Krasomski G. Markers of oxidative stress in pregnancies complicated by pregnancy induced hypertension and intrahepatic cholestasis. Ginekol. Pol. 78: 956-960 (2007).

• Biggioggero M, Borghi M, Gerosa M, Trespidi L, Cimaz R, Meroni P. Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants. Lupus 16: 651-656 (2007).

• Binder T, Salaj P, Zima T. Intrahepatic cholestasis in pregnancy - guidelines of treatment. Ceska. Gynekol. 72: 94-98 (2007).

• Binder T, Salaj P, Zima T, Vitek L. Ursodeoxycholic acid, S-adenosyl-L-methionine and their combinations in the treatment of gestational intrahepatic cholestasis (ICP). Ceska. Gynekol. 71: 92-98 (2006).

• Binder T, Salaj P, Zima T, Vitek L. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy. J. Perinat. Med. 34: 383-391 (2006).

• Binder T, Zima T, Vítek L. Biochemical parameters of the intrahepatic cholestasis of pregnancy. Ceska. Gynekol. 72: 90-94 (2007).

• Bismuth M, Aguilar-Martinez P, Michel H. Hereditary haemochromatosis. Presse. Med. 32: 1716-1723 (2003).

• Bladt V, Steengaard-Pedersen K, Poulsen LH, Petersen OB, Laursen B, d'Amore F. Late puerperal thrombohemorrhagic complications in a patient with antiphospholipid syndrome. Eur. J. Haematol. 73: 437-440 (2004). *

• Blank M, Anafi L, Zandman-Goddard G, Krause I, Goldman S, Shalev E, Cervera R, Font J, Fridkin M, Thiesen HJ, Shoenfeld Y. The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model. Int. Immunol. 19: 857-865 (2007). *

• Bodamer OA, Mitterer G, Maurer W, Pollak A, Mueller MW, Schmidt WM. Evidence for an association between mannose-binding lectin 2 (MBL2) gene polymorphisms and pre-term birth. Genet. Med. 8: 518-524 (2006).

• Boehm T, Zufall F. MHC peptides and the sensory evaluation of genotype. Trends Neurosci. 29: 100-107 (2006). *

• Boomsma CM, Kavelaars A, Eijkemans MJ, Amarouchi K, Teklenburg G, Gutknecht D, Fauser BJ, Heijnen CJ, Macklon NS. Cytokine profiling in endometrial secretions: a non-invasive window on endometrial receptivity. Reprod. Biomed. Online 18: 85-94 (2009).

• Boomsma CM, Kavelaars A, Eijkemans MJ, Lentjes EG, Fauser BC, Heijnen CJ, Macklon NS. Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF. Hum. Reprod. 24: 1427-1435 (2009).

• Bopp T, Jonuleit H, Schmitt E. Regulatory T cells - the renaissance of the suppressor T cells. Ann. Med. 39: 322-334 (2007).

• Borrelli I. Endocrine disruptors: literature review on toxicology and application field in occupational medicine. G. Ital. Med. Lav. Ergon. 29: 526-528 (2007).

• Bortoli A, Saibeni S, Tatarella M, Prada A, Beretta L, Rivolta R, Politi P, Ravelli P, Imperiali G, Colombo E, Pera A, Daperno M, Carnovali M, de Franchis R, Vecchi M; the Study Group for Inflammatory Bowel Diseases (GSMII). Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case-control study. J. Gastroenterol. Hepatol. 22: 542-549 (2007). *

• Borum ML. Hepatobiliary diseases in women. Med. Clin. North Am. 82: 51-75 (1998).

• Boucher BJ. Comment on "Vitamin D discovery outpaces FDA decision making". Bioessays 30: 508-509 (2008). *

• Bourre JM. Dietary omega-3 fatty acids for women. Biomed. Pharmacother. 61: 105-112 (2007).

• Bourre JM. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J. Nutr. Health Aging 8: 163-174 (2004).

• Bourre JM. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J. Nutr. Health Aging 10: 377-385 (2006).

• Bradley RJ, Rosen MP. Subfertility and gastrointestinal disease: 'Unexplained' is often undiagnosed. Obstet. Gynecol. Surv. 59: 108-117 (2004).

• Braillon A, Nguyen-Khac E. Pregnancy and hepatitis B in Europe. Liver Int. Jun 6 [Epub ahead of print] (2009).

• Branche J, Cortot A, Bourreille A, Coffin B, de Vos M, de Saussure P, Seksik P, Marteau P, Lemann M, Colombel JF. Cyclosporine treatment of steroid-refractory ulcerative colitis during pregnancy. Inflamm. Bowel Dis. 15: 1044-1048 (2009).

• Brant SR. Exposed: the genetic underpinnings of ulcerative colitis relative to Crohn's disease. Gastroenterology 136: 396-399 (2009). *

• Brantsaeter AL, Haugen M, Samuelsen SO, Torjusen H, Trogstad L, Alexander J, Magnus P, Meltzer HM. A dietary pattern characterized by high intake of vegetables, fruits, and vegetable oils is associated with reduced risk of preeclampsia in nulliparous pregnant Norwegian women. J. Nutr. 139: 1162-1168 (2009).

• Brar H, Einarson A. Effects and treatment of inflammatory bowel disease during pregnancy. Can. Fam. Physician 54: 981-983 (2008). *

• Bray RA, Gebel HM, Ellis TM. Flow cytometric assessment of HLA alloantibodies. Curr. Protoc. Cytom. Chapter 6: Unit 6.16 (2004).

• Brazle AE, Johnson BJ, Webel SK, Rathbun TJ, Davis DL. Omega-3 fatty acids in the gravid pig uterus as affected by maternal supplementation with omega-3 fatty acids. J. Anim. Sci. 87: 994-1002 (2009).

• Brewster JA, Orsi NM, Gopichandran N, Ekbote UV, Cadogan E, Walker JJ. Host inflammatory response profiling in preeclampsia using an in vitro whole blood stimulation model. Hypertens. Pregnancy 27: 1-16 (2008).

• Briceno-Perez C, Briceno-Sanabria L, Vigil-De Gracia P. Prediction and prevention of preeclampsia. Hypertens. Pregnancy 28: 138-155 (2009).

• Briemberg HR. Neuromuscular diseases in pregnancy. Semin. Neurol. 27: 460-466 (2007).

• Brites D. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid. Ann. Hepatol. 1: 20-28 (2002). *

• Brites D, Rodrigues CM. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy. J. Hepatol. 29: 743-751 (1998). *

• Brites D, Rodrigues CM, Oliveira N, Cardoso M, Graca LM. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy. J. Hepatol. 28: 91-98 (1998). *

• Briz O, Macias RI, Perez MJ, Serrano MA, Marin JJ. Excretion of fetal biliverdin by the rat placenta-maternal liver tandem. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290: R749-R756 (2006). *

• Bronte V, Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 5: 641-654 (2005). *

• Brookes KJ, Chen W, Xu X, Taylor E, Asherson P. Association of fatty acid desaturase genes with attention-deficit/hyperactivity disorder. Biol. Psychiatry 60: 1053-1061 (2006). *

• Bruce K, Watson S. Management of intrahepatic cholestasis of pregnancy: a case report. J. Midwifery Womens Health 52: 67-72 (2007).

• Bruguera M, Barrera J, Corradi F, Mas A. Hypertransaminasemia greater than 400 U/l in adults attended. Gastroenterol. Hepatol. 28: 15-19 (2005).

• Bruining DH, Loftus EV. Current and future diagnostic approaches: from serologies to imaging. Curr. Gastroenterol. Rep. 9: 489-496 (2007).

• Brunner W. Pruritus - also a challenge in internal medicine. Schweiz. Med. Wochenschr. 125: 2244-2250 (1995).

• Bruno M. Irritable bowel syndrome and inflammatory bowel disease in pregnancy. J. Perinat. Neonatal Nurs. 18: 341-350 (2004).

• Bryce J, Coitinho D, Darnton-Hill I, Pelletier D, Pinstrup-Andersen P; for the Maternal and Child Undernutrition Study Group. Maternal and child undernutrition: effective action at national level. Lancet 371: 510-526 (2008). *

• Bu C, Zhang C, Li Z, Gao L, Xie Z, Cai G. Autoantibodies to plasminogen and tissue plasminogen activator in women with recurrent pregnancy loss. Clin. Exp. Immunol. 149: 31-39 (2007). *

• Buchel E, Van Steenbergen W, Nevens F, Fevery J. Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery. Am. J. Gastroenterol. 97: 3160-3165 (2002). *

• Buell C, Koo J. Long-term safety of mycophenolate mofetil and cyclosporine: a review. J. Drugs Dermatol. 7: 741-748 (2008).

• Burrows RF, Clavisi O, Burrows E. Interventions for treating cholestasis in pregnancy. Cochrane Database Syst. Rev. 4: CD000493 (2001). *

• Bush M, Patel S, Lapinski R, Stone J. Perinatal outcomes in inflammatory bowel disease. J. Matern. Fetal. Neonatal. Med. 15: 237-241 (2004).

• Bussel JB. Therapeutic approaches to secondary immune thrombocytopenic purpura. Semin. Hematol. 46: S44-S58 (2009).

• Bustos D, Moret A, Tambutti M, Gogorza S, Testa R, Ascione A, Prigoshin N. Autoantibodies in Argentine women with recurrent pregnancy loss. Am. J. Reprod. Immunol. 55: 201-207 (2006). *

• Byrnes V, Cardenas A, Afdhal N, Hanto D. Symptomatic focal nodular hyperplasia during pregnancy: a case report. Ann. Hepatol. 3: 35-37 (2004). *

• Caballeria L, Pares A, Rodes J. Treatment of primary biliary cirrhosis. Contributions to Science 1: 79-85 (1999). *

• Calcagni E, Elenkov I. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann. N. Y. Acad. Sci. 1069: 62-76 (2006). *

• Calcaterra V, Lanzarini L, Guerci B, Mancini L, Giovenale D, Scaglia F, Albanesi M, Larizza D. Pregnancy in a woman with Turner syndrome and celiac disease. J. Endocrinol. Invest. 30: 598-600 (2007).

• Calder PC, Krauss-Etschmann S, de Jong EC, Dupont C, Frick JS, Frokiaer H, Heinrich J, Garn H, Koletzko S, Lack G, Mattelio G, Renz H, Sangild PT, Schrezenmeir J, Stulnig TM, Thymann T, Wold AE, Koletzko B. Early nutrition and immunity - progress and perspectives. Br. J. Nutr. 96: 774-790 (2006). *

• Calmelet P, Coumaros D, Viville B, Raiga J, Favreau JJ, Treisser A. Ursodeoxycholic acid: prospect for treatment of gravidic cholestasis? Report of 3 cases. J. Gynecol. Obstet. Biol. Reprod. (Paris) 27: 617-621 (1998).

• Candia L, Marquez J, Espinoza LR. Autoimmune hepatitis and pregnancy: a rheumatologist's dilemma. Semin. Arthritis Rheum. 35: 49-56 (2005). *

• Canellada A, Alvarez I, Berod L, Gentile T. Estrogen and progesterone regulate the IL-6 signal transduction pathway in antibody secreting cells. J. Steroid Biochem. Mol. Biol. 111: 255-261 (2008).

• Capobianco E, White V, Higa R, Martínez N, Jawerbaum A. Effects of natural ligands of PPARgamma on lipid metabolism in placental tissues from healthy and diabetic rats. Mol. Hum. Reprod. 14: 491-499 (2008).

• Cappell MS. Hepatic disorders severely affected by pregnancy: medical and obstetric management. Med. Clin. North Am. 92: 739-760 (2008).

• Cappell MS. The fetal safety and clinical efficacy of gastrointestinal endoscopy during pregnancy. Gastroenterol. Clin. North Am. 32: 123-179 (2003). *

• Cappell MS. Colon cancer during pregnancy. Gastroenterol. Clin. North Am. 32: 341-383 (2003). *

• Cappell MS. Gastrointestinal disorders during pregnancy. Preface. Gastroenterol. Clin. North Am. 32: xi-xiii (2003). *

• Cappell MS. Gastric and duodenal ulcers during pregnancy. Gastroenterol. Clin. North Am. 32: 263-308 (2003). *

• Cappell MS, Friedel D. Abdominal pain during pregnancy. Gastroenterol. Clin. North Am. 32: 1-58 (2003). *

• Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Dig. Liver Dis. 37: 407-417 (2005).

• Caprilli R, Gassull MA, Escher JC, Moser G, Munkholm P, Forbes A, Hommes DW, Lochs H, Angelucci E, Cocco A, Vucelic B, Hildebrand H, Kolacek S, Riis L, Lukas M, de Franchis R, Hamilton M, Jantschek G, Michetti P, O'Morain C, Anwar MM, Freitas JL, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 55 Suppl. 1: i36-i58 (2006). *

• Carecchio M, Comi C, Varrasi C, Stecco A, Sainaghi PP, Bhatia K, Carriero A, Cantello R, Monaco F. Complex movement disorders in primary antiphospholipid syndrome: a case report. J. Neurol. Sci. 281: 101-103 (2009).

• Carlson SE. Docosahexaenoic acid supplementation in pregnancy and lactation. Am. J. Clin. Nutr. 89: 678S-684S (2009). *

• Carp HJ, Meroni PL, Shoenfeld Y. Autoantibodies as predictors of pregnancy complications. Rheumatology (Oxford) 47 Suppl. 3: iii6-iii8 (2008). *

• Carta G, Iovenitti P, Falciglia K. Recurrent miscarriage associated with antiphospholipid antibodies: prophylactic treatment with low-dose aspirin and fish oil derivates. Clin. Exp. Obstet. Gynecol. 32: 49-51 (2005).

• Carter JD, Ladhani A, Ricca LR, Valeriano J, Vasey FB. A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration Database. J. Rheumatol. 36: 635-641 (2009).

• Carter JD, Valeriano J, Vasey FB. Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship. J. Rheumatol. 33: 1014-1017 (2006).

• Casadio R, Santi V, Mirici-Cappa F, Magini G, Cacciari M, Bernardi M, Trevisani F. Telangiectasia as a presenting sign of Graves' disease. Horm. Res. 69: 189-192 (2008).

• Casais P, Meschengieser SS, Gennari LC, Alberto MF, Sanchez-Luceros A, Blanco AN, Lazzari MA. Antiphospholipid antibodies and hyperhomocysteinaemia in patients with vascular occlusive disease. Thromb. Haemost. 96: 19-23 (2006).

• Cashman KD. Homocysteine and osteoporotic fracture risk: a potential role for B vitamins. Nutr. Rev. 63: 29-36 (2005).

• Cassar CL. Nocardia sepsis in a multigravida with systemic lupus erythematosus and autoimmune hepatitis. Anaesth. Intensive Care 35: 601-604 (2007).

• Castelli EC, Mendes-Junior CT, Wiezel CE, Peres NT, Simoes AL, Rossi NM, Donadi EA. A novel HLA-G allele, HLA-G*010111, in the Brazilian population. Tissue Antigens 70: 349-350 (2007). *

• Castro-Parodi M, Levi L, Dietrich V, Zotta E, Damiano AE. CFTR may modulate AQP9 functionality in preeclamptic placentas. Placenta May 27 [Epub ahead of print] (2009).

• Caughey AB. Cholestasis of pregnancy: in need of a more rapid diagnosis. J. Perinatol. 26: 525-526 (2006). *

• Cerimagic D, Bilic E. Stiff-person syndrome first manifesting in pregnancy. Gynecol. Obstet. Invest. 67: 134-136 (2008).

• Cervera R, Balasch J. Bidirectional effects on autoimmunity and reproduction. Hum. Reprod. Update 14: 359-366 (2008).

• Cetin I, Alvino G, Cardellicchio M. Long chain fatty acids and dietary fats in fetal nutrition. J. Physiol. Jun 15 [Epub ahead of print] (2009).

• Cetin I, Koletzko B. Long-chain omega-3 fatty acid supply in pregnancy and lactation. Curr. Opin. Clin. Nutr. Metab. Care 11: 297-302 (2008).

• Ch'ng CL, Kingham JG, Morgan M. Acute fatty liver in pregnancy in the UK. Gut 58: 467 (2009).

• Chakravarty EF, Nelson L, Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 54: 899-907 (2006). *

• Chambers C, Koren G, Tutuncu ZN, Johnson D, Jones KL. Are new agents used to treat rheumatoid arthritis safe to take during pregnancy? Organization of Teratology Information Specialists (OTIS) study. Can. Fam. Physician 53: 409-412 (2007).

• Chan CC, Reed GF, Kim Y, Agron E, Buggage RR. A correlation of pregnancy term, disease activity, serum female hormones, and cytokines in uveitis. Br. J. Ophthalmol. 88: 1506-1509 (2004). *

• Chapman C, Morgan LM, Murphy MC. Maternal and early dietary fatty acid intake: changes in lipid metabolism and liver enzymes in adult rats. J. Nutr. 130: 146-151 (2000). *

• Charakida A, Mouser PE, Chu AC. Safety and side effects of the acne drug, oral isotretinoin. Expert Opin. Drug Saf. 3: 119-129 (2004). *

• Chaudhuri A. Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis. Med. Hypotheses 64: 608-618 (2005).

• Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. Dietary fatty acid intakes and the risk of ovulatory infertility. Am. J. Clin. Nutr. 85: 231-237 (2007). *

• Chechi K, Cheema SK. Maternal diet rich in saturated fats has deleterious effects on plasma lipids of mice. Exp. Clin. Cardol. 11: 129-135 (2006). *

• Cheetham TC, Wagner RA, Chiu G, Day JM, Yoshinaga MA, Wong L. A risk management program aimed at preventing fetal exposure to isotretinoin: retrospective cohort study. J. Am. Acad. Dermatol. 55: 442-448 (2006).

• Chen K, Zhang X, Wei XP, Qu P, Liu YX, Li TY. Antioxidant vitamin status during pregnancy in relation to cognitive development in the first two years of life. Early Hum. Dev. Mar 13 [Epub ahead of print] (2009).

• Chen ST, Chen HL, Su YN, Liu YJ, Ni YH, Hsu HY, Chu CS, Wang NY, Chang MH. Prenatal diagnosis of progressive familial intrahepatic cholestasis type 2. J. Gastroenterol. Hepatol. 23: 1390-1393 (2008). *

• Chen SU, Su YN, Fang MY, Chang LJ, Tsai YY, Lin LT, Lee CN, Yang YS. PGD of beta-thalassaemia and HLA haplotypes using OmniPlex whole genome amplification. Reprod. Biomed. Online 17: 699-705 (2008).

• Chen YP, Pfab T, Slowinski T, Richter CM, Godes M, Hocher B. Impact of genetic variation of tumor necrosis factor-alpha on gestational hypertension. Chin. Med. J. (Engl.) 119: 719-724 (2006). *

• Cheng CW, Yu JC, Huang CS, Shieh JC, Fu YP, Wang HW, Wu PE, Shen CY. Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan. Breast Cancer Res. Treat. 111: 145-155 (2008).

• Chermesh I, Eliakim R. Mesalazine-induced reversible infertility in a young male. Dig. Liver Dis. 36: 551-552 (2004).

• Cherry K. Ursodeoxycholic acid for treatment of intrahepatic cholestasis of pregnancy. Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 555 (2005). *

• Chiarenza L, Pignataro A, Lanza V. Refeeding syndrome in early pregnancy. Case report. Minerva Anestesiol. 71: 803-808 (2005).

• Chiovato L, Rotondi M, Pirali B, Lodigiani S, Bray S, Leporati P, Chytiris S, Balzano S, Magri F. The post partum period and the onset of Graves' disease: an overestimated risk factor. Eur. J. Endocrinol. 159: 161-165 (2008). *

• Chiu CC, Huang SY, Shen WW, Su KP. Omega-3 fatty acids for depression in pregnancy. Am. J. Psychiatry 160: 385 (2003). *

• Choi YH, Stamm C, Hammer PE, Kwaku KF, Marler JJ, Friehs I, Jones M, Rader CM, Roy N, Eddy MT, Triedman JK, Walsh EP, McGowan FX Jr, Del Nido PJ, Cowan DB. Cardiac conduction through engineered tissue. Am. J. Pathol. 169: 72-85 (2006). *

• Cholongitas E, Papatheodoridis GV, Zappoli P, Giannakopoulos A, Patch D, Marelli L, Shusang V, Kalambokis G, Shirling G, Rolando N, Burroughs AK. Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis. Liver Transpl. 13: 552-557 (2007). *

• Chopra S, Suri V, Bagga R, Thami MR, Sharma A, Bambery P. Autoimmune inflammatory myopathy in pregnancy. Medscape J. Med. 10: 17 (2008). *

• Christensen KL, Andersen BN, Vilstrup H. Primary sclerosing cholangitis with itching treated during pregnancy with ursodeoxycholic acid. Ugeskr. Laeger. 159: 7151-7153 (1997).

• Christensen LA, Dahlerup JF, Nielsen MJ, Fallingborg JF, Schmiegelow K. Azathioprine treatment during lactation. Aliment. Pharmacol. Ther. 28: 1209-1213 (2008). *

• Christian P, Darmstadt GL, Wu L, Khatry SK, Leclerq SC, Katz J, West KP Jr, Adhikari RK. The effect of maternal micronutrient supplementation on early neonatal morbidity in rural Nepal: a randomised, controlled, community trial. Arch. Dis. Child. 93: 660-664 (2008).

• Chung L, Flyckt RL, Colon I, Shah AA, Druzin M, Chakravarty EF. Outcome of pregnancies complicated by systemic sclerosis and mixed connective tissue disease. Lupus 15: 595-589 (2006).

• Church MW, Catherine Jen KL, Stafferton T, Hotra JW, Adams BR. Reduced auditory acuity in rat pups from excess and deficient omega-3 fatty acid consumption by the mother. Neurotoxicol. Teratol. 29: 203-210 (2007).

• Church MW, Jen KL, Dowhan LM, Adams BR, Hotra JW. Excess and deficient omega-3 fatty acid during pregnancy and lactation cause impaired neural transmission in rat pups. Neurotoxicol. Teratol. 30: 107-117 (2008). *

• Church MW, Jen KL, Jackson DA, Adams BR, Hotra JW. Abnormal neurological responses in young adult offspring caused by excess omega-3 fatty acid (fish oil) consumption by the mother during pregnancy and lactation. Neurotoxicol. Teratol. 31: 26-33 (2009).

• Ciacci C, Iovino P, Amoruso D, Siniscalchi M, Tortora R, Di Gilio A, Fusco M, Mazzacca G. Grown-up coeliac children: the effects of only a few years on a gluten-free diet in childhood. Aliment. Pharmacol. Ther. 21: 421-429 (2005). *

• Ciacci C, Tortora R, Scudiero O, Di Fiore R, Salvatore F, Castaldo G. Early pregnancy loss in celiac women: the role of genetic markers of thrombophilia. Dig. Liver Dis. Apr 21 [Epub ahead of print] (2009).

• Cicek D, Kandi B, Demir B, Turgut D. Intrahepatic cholestasis occurring with prurigo of pregnancy. Skinmed. 6: 298-301 (2007).

• Cimaz R, Meregalli E, Biggioggero M, Airo P, Danieli E, Antonioli CM, Motta M, Chirico G, Columbrita D, Frassi M, Meroni PL, Tincani A. Response to tetanus vaccination in infants exposed in utero to immunosuppressants for maternal autoimmune disorders. Lupus 16: 129-132 (2007).

• Cipollone D, Carsetti R, Tagliani A, Rosado MM, Borgiani P, Novelli G, D'Amati G, Fumagalli L, Marino B, Businaro R. Folic acid and methionine in the prevention of teratogen-induced congenital defects in mice. Cardiovasc. Pathol. 18: 100-109 (2009).

• Clancy RM, Buyon JP, Ikeda K, Nozawa K, Argyle DA, Friedman DM, Chan EK. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects. Arthritis Rheum. 52: 3079-3086 (2005). *

• Clark CA, Spitzer KA, Laskin CA. Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J. Rheumatol. 32: 1709-1712 (2005).

• Clark DA, Wong K, Banwatt D, Chen Z, Liu J, Lee L, Gorczynski RM, Blajchman MA. CD200-dependent and nonCD200-dependant pathways of NK cell suppression by human IVIG. J. Assist. Reprod. Genet. 25: 67-72 (2008).

• Clavien PA. Liver transplantation for pregnancy-related liver diseases, pregnancy and sexual function after liver transplantation: what do we know? J. Hepatol. 49: 505-506 (2008). *

• Clayton A, Ramamurthy S. The impact of physical illness on sexual dysfunction. Adv. Psychosom. Med. 29: 70-88 (2008).

• Cleary BJ, Kallen B. Early pregnancy azathioprine use and pregnancy outcomes. Birth Defects Res. A. Clin. Mol. Teratol. Apr 2 [Epub ahead of print] (2009).

• Cline AM, Kutteh WH. Is there a role of autoimmunity in implantation failure after in-vitro fertilization? Curr. Opin. Obstet. Gynecol. 21: 291-295 (2009).

• Coburn LA, Wise PE, Schwartz DA. The successful use of adalimumab to treat active Crohn's disease of an ileoanal pouch during pregnancy. Dig. Dis. Sci. 51: 2045-2047 (2006). *

• Coffey JC, Winter DC, Neary P, Murphy A, Redmond HP, Kirwan WO. Quality of life after ileal pouch-anal anastomosis: an evaluation of diet and other factors using the Cleveland Global Quality of Life instrument. Dis. Colon Rectum 45: 30-38 (2002).

• Cohen PR. Sweet's syndrome - a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J. Rare Dis. 2: 34 (2007). *

• Coluccia A, Borracci P, Belfiore D, Renna G, Giustino A, Carratů MR. Effects of early gestational all-trans retinoic acid treatment on motor skills: a longitudinal study in the offspring of Sprague-Dawley rats. Neurotoxicology 29: 1107-1113 (2008).

• Connell W, Miller A. Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy. Drug Saf. 21: 311-323 (1999).

• Connor KM, Sangiovanni JP, Lofqvist C, Aderman CM, Chen J, Higuchi A, Hong S, Pravda EA, Majchrzak S, Carper D, Hellstrom A, Kang JX, Chew EY, Salem N, Serhan CN, Smith LE. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat. Med. 13: 868-873 (2007). *

• Contini P, Ghio M, Poggi A, Filaci G, Indiveri F, Ferrone S, Puppo F. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur. J. Immunol. 33: 125-134 (2003). *

• Coolman M, de Maat M, Van Heerde WL, Felida L, Schoormans S, Steegers EA, Bertina RM, de Groot CJ. Matrix metalloproteinase-9 gene -1562C/T polymorphism mitigates preeclampsia. Placenta 28: 709-713 (2007).

• Cooper RM, Butler DF, Ghali F, Grimwood RE. Periorbital cutaneous neonatal lupus. Skinmed. 6: 145-146 (2007).

• Coppede F, Colognato R, Bonelli A, Astrea G, Bargagna S, Siciliano G, Migliore L. Polymorphisms in folate and homocysteine metabolizing genes and chromosome damage in mothers of Down syndrome children. Am. J. Med. Genet. A. 143: 2006-2015 (2007).

• Cornish JA, Tan E, Teare J, Teoh TG, Rai R, Darzi AW, Paraskevas P, Clark SK, Tekkis PP. The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review. Dis. Colon Rectum 50: 1128-1138 (2007). *

• Cornish JA, Tan EK, Teare J, Teoh TG, Rai R, Clark SK, Tekkis PP. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 56: 830-837 (2007). *

• Costa M, Colia D. Treating infertility in autoimmune patients. Rheumatology (Oxford) 47 Suppl. 3: iii38-iii41 (2008). *

• Costello J, Lynch J, Byrne P, Browne G. Pregnancy and cystic fibrosis. Ir. Med. J. 101: 254-255 (2008).

• Courville AB, Keplinger MR, Judge MP, Lammi-Keefe CJ. Plasma or red blood cell phospholipids can be used to assess docosahexaenoic acid status in women during pregnancy. Nutr. Res. 29: 151-155 (2009). *

• Craig D, Robins G, Howdle PD. Advances in celiac disease. Curr. Opin. Gastroenterol. 23: 142-148 (2007).

• Croen LA, Grether JK, Yoshida CK, Odouli R, Van de Water J. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch. Pediatr. Adolesc. Med. 159: 151-157 (2005). *

• Cruciat G, Stamatian F, Puscas M, Cruciat C, Ispasoiu F, Muresan D. Acute pancreatitis in a pregnant woman with acute fatty liver dystrophy. A case report. J. Gastrointestin. Liver Dis. 16: 193-196 (2007). *

• Cucnik S, Bozic B, Kveder T, Tomsic M, Rozman B. Avidity of anti-beta2-glycoprotein I and thrombosis or pregnancy loss in patients with antiphospholipid syndrome. Ann. N. Y. Acad. Sci. 1051: 141-147 (2005). *

• Curnow JL, Morel-Kopp MC, Roddie C, Aboud M, Ward CM. Reduced fibrinolysis and increased fibrin generation can be detected in hypercoagulable patients using the Overall Haemostatic Potential assay (OHP). J. Thromb. Haemost. 5: 528-534 (2007). *

• Currie C, Wax JR, Pinette MG, Blackstone J, Cartin A. Cogan's syndrome complicating pregnancy. J. Matern. Fetal Neonatal Med. Jun 1 [Epub ahead of print] (2009).

• Cutolo M, Capellino S, Sulli A, Serioli B, Secchi ME, Villaggio B, Straub RH. Estrogens and autoimmune diseases. Ann. N. Y. Acad. Sci. 1089: 538-547 (2006). *

• Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 23: 255-262 (2007).

• Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 18: 334-344 (2002).

• Czaja AJ. Autoimmune liver disease and rheumatic manifestations. Curr. Opin. Rheumatol. 19: 74-80 (2007).

• Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 20: 231-240 (2004).

• Czarneski J, Rassa JC, Ross SR. Mouse mammary tumor virus and the immune system. Immunol. Res. 27: 469-480 (2003).

• Czlonkowska A, Sliwinska A. Multiple sclerosis and antiphospholipid syndrome - difficulties in differential diagnostics. Pol. Arch. Med. Wewn. 117: S28-S32 (2007).

• Czymek R, Limmer S, Kleemann M, Hildebrand P, Schmidt A, Jungbluth T, Roblick U, Kujath P, Bruch HP. Crohn's disease - a chameleon during pregnancy. Langenbecks Arch. Surg. 394: 517-527 (2009). *

• D'Apice MR, Gambardella S, Russo S, Lucidi V, Nardone AM, Pietropolli A, Novelli G. Segregation analysis in cystic fibrosis at-risk family demonstrates that the M348K CFTR mutation is a rare innocuous polymorphism. Prenat. Diagn. 24: 981-983 (2004). *

• D'Cruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet 369: 587-596 (2007). *

• da Fonseca LM, Castro FV, Celani MF, da Silva RG, Lacerda-Filho A. Ileo-uterine fistula during pregnancy in a patient with Crohn disease: an uncommon complication. ANZ J. Surg. 78: 1142-1143 (2008).

• Dann AT, Kenyon AP, Seed PT, Poston L, Shennan AH, Tribe RM. Glutathione S-transferase and liver function in intrahepatic cholestasis of pregnancy and pruritus gravidarum. Hepatology 40: 1406-1414 (2004). *

• Dann AT, Kenyon AP, Wierzbicki AS, Seed PT, Shennan AH, Tribe RM. Plasma lipid profiles of women with intrahepatic cholestasis of pregnancy. Obstet. Gynecol. 107: 106-114 (2006).

• Danneskiold-Samsoe B, Bartels EM, Dreyer L. Gender differences in autoimmune diseases illustrated by rheumatoid arthritis. Ugeskr. Laeger. 169: 2440-2442 (2007).

• David AL, Peebles D. Gene therapy for the fetus: is there a future? Best Pract. Res. Clin. Obstet. Gynaecol. 22: 203-218 (2008).

• Davies CJ. Why is the fetal allograft not rejected? J. Anim. Sci. 85: E32-E35 (2007). *

• Davies MH, da Silva RC, Jones SR, Weaver JB, Elias E. Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid. Gut 37: 580-584 (1995). *

• Davies MH, Ngong JM, Yucesoy M, Acharya SK, Mills CO, Weaver JB, Waring RH, Elias E. The adverse influence of pregnancy upon sulphation: a clue to the pathogenesis of intrahepatic cholestasis of pregnancy? J. Hepatol. 21: 1127-1134 (1994).

• Davis PB, di Sant'Agnese PA. Diagnosis and treatment of cystic fibrosis. An update. Chest 85: 802-809 (1984). *

• Day C, Hewins P, Sheikh L, Kilby M, McPake D, Lipkin G. Cholestasis in pregnancy associated with ciclosporin therapy in renal transplant recipients. Transpl. Int. 19: 1026-1029 (2006). *

• de Almeida RC, Lima BO, Castro LC, Gandolfi L, Pratesi R. Maternal celiac disease: improbable risk factor for neural tube defect. Eur. J. Gastroenterol. Hepatol. Apr 4 [Epub ahead of print] (2009).

• de Boer NK, Jarbandhan SV, de Graaf P, Mulder CJ, van Elburg RM, van Bodegraven AA. Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. Am. J. Gastroenterol. 101: 1390-1392 (2006). *

• de Boer NK, Van Elburg RM, Wilhelm AJ, Remmink AJ, Van Vugt JM, Mulder CJ, Van Bodegraven AA. 6-Thioguanine for Crohn's disease during pregnancy: thiopurine metabolite measurements in both mother and child. Scand. J. Gastroenterol. 40: 1374-1377 (2005). *

• De Carolis S, Botta A, Fatigante G, Garofalo S, Ferrazzani S, Gasbarrini A,. Celiac disease and inflammatory bowel disease in pregnancy. Lupus 13: 653-658 (2004).

• de Groot CJ, Jansen MW, Bertina RM, Schonkeren JJ, Helmerhorst FM, Huizinga TW. Interleukin 10-2849AA genotype protects against pre-eclampsia. Genes Immun. 5: 313-314 (2004). *

• de la Torre E, Mulla MJ, Yu AG, Lee SJ, Kavathas PB, Abrahams VM. Chlamydia trachomatis infection modulates trophoblast cytokine/chemokine production. J. Immunol. 182: 3735-3745 (2009).

• de Laat B, Derksen RH, Mackie IJ, Roest M, Schoormans S, Woodhams BJ, de Groot PG, van Heerde WL. Annexin A5 polymorphism (-1C>T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome. Ann. Rheum. Dis. 65: 1468-1472 (2006). *

• De Leo V, Benedetto C, Cianci A. Is micronutrients supplementation useful in pregnancy? Minerva Ginecol. 60: 437-443 (2008).

• de Pagter AG, van Berge Henegouwen GP, ten Bokkel Huinink JA, Brandt KH. Familial benign recurrent intrahepatic cholestasis. Interrelation with intrahepatic cholestasis of pregnancy and from oral contraceptives? Gastroenterology 71: 202-207 (1976).

• Dealberto MJ. Why are immigrants at increased risk for psychosis? Vitamin D insufficiency, epigenetic mechanisms, or both? Med. Hypotheses 68: 259-267 (2007).

• Debieve F, Duliere S, Bernard P, Hubinont C, De Nayer P, Daumerie C. To treat or not to treat euthyroid autoimmune disorder during pregnancy? Gynecol. Obstet. Invest. 67: 178-182 (2008).

• Decsi T, Campoy C, Koletzko B. Effect of n-3 polyunsaturated fatty acid supplementation in pregnancy: the Nuheal trial. Adv. Exp. Med. Biol. 569: 109-113 (2005).

• Delatycki MB. Population screening for reproductive risk for single gene disorders in Australia: now and the future. Twin Res. Hum. Genet. 11: 422-430 (2008).

• Delpy L, Douin-Echinard V, Garidou L, Bruand C, Saoudi A, Guery JC. Estrogen enhances susceptibility to experimental autoimmune myasthenia gravis by promoting type 1-polarized immune responses. J. Immunol. 175: 5050-5057 (2005). *

• Deltenre P, Denninger MH, Hillaire S, Guillin MC, Casadevall N, Briere J, Erlinger S, Valla DC. Factor V Leiden related Budd-Chiari syndrome. Gut 48: 264-268 (2001). *

• Demarco P, Singh I, Weinstein A. Management of the antiphospholipid syndrome. Curr. Rheumatol. Rep. 8: 114-120 (2006).

• den Dulk M, Valentijn RM, Welten CA, Beyer GP. Intrahepatic cholestasis of pregnancy. Neth. J. Med. 60: 366-369 (2002). *

• Descamps D, Hardt K, Spiessens B, Izurieta P, Verstraeten T, Breuer T, Dubin G. Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials. Hum. Vaccin. May 20 [Epub ahead of print] (2009).

• Devarbhavi H, Kremers WK, Dierkhising R, Padmanabhan L. Pregnancy-associated acute liver disease and acute viral hepatitis: differentiation, course and outcome. J. Hepatol. 49: 930-935 (2008).

• Devereux G. The increase in the prevalence of asthma and allergy: food for thought. Nat. Rev. Immunol. 6: 869-874 (2006). *

• Devereux G. Early life events in asthma - diet. Pediatr. Pulmonol. 42: 663-673 (2007).

• Dhar JP, Sokol RJ. Lupus and pregnancy: complex yet manageable. Clin. Med. Res. 4: 310-321 (2006). *

• Diaferia A, Nicastri PL, Tartagni M, Loizzi P, Iacovizzi C, Di Leo A. Ursodeoxycholic acid therapy in pregnant women with cholestasis. Int. J. Gynaecol. Obstet. 52: 133-140 (1996).

• Diav-Citrin O, Shechtman S, Gotteiner T, Arnon J, Ornoy A. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study. Teratology 63: 186-192 (2001).

• Dietert RR, Piepenbrink MS. The managed immune system: protecting the womb to delay the tomb. Hum. Exp. Toxicol. 27: 129-134 (2008).

• Dietrich CS 3rd, Hill CC, Hueman M. Surgical diseases presenting in pregnancy. Surg. Clin. North Am. 88: 403-419 (2008).

• Dimarco CS, Dimarco DS, Klingele CJ, Gebhart JB. Vesicouterine fistula: a review of eight cases. Int. Urogynecol. J. Pelvic Floor Dysfunct. 17: 395-399 (2006).

• Dimitri D, Pagnoux C. Pregnancy and inflammatory myopathies. Presse. Med. 37: 1652-1656 (2008).

• Dimitrova V, Atanasova M, Tsankova M, Chernev T, Georgiev S. Autoimmune thrombocytopenia during pregnancy (case report and review of literature). Akush. Ginekol. (Sofiia) 46: 50-55 (2007).

• Ding Y, Shen H, Wang X, Fan X, Wu X, Yang X. The polymorphism of HLA-DR and -DQ allelic genes associated with intrahepatic cholestasis of pregnancy. Genet. Test. 12: 215-220 (2008).

• Ding YL, Tan LL, Deng W. Clinical analysis of intrahepatic cholestasis during pregnancy in 150 patients. Hunan Yi Ke Da Xue Xue Bao 28: 645-647 (2003).

• Dixit SP. Liver and the contraceptive pill. Can. J. Surg. 23: 222-227, 255 (1980).

• Dixon PH, van Mil S, Chambers J, Strautnieks S, Thompson R, Lammert F, Kubitz R, Keitel V, Glantz A, Mattsson LA, Marschall HU, Molokhia M, Moore G, Linton K, Williamson C. Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut 58: 537-544 (2009).

• Dixon PH, Weerasekera N, Linton KJ, Donaldson O, Chambers J, Egginton E, Weaver J, Nelson-Piercy C, de Swiet M, Warnes G, Elias E, Higgins CF, Johnston DG, McCarthy MI, Williamson C. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum. Mol. Genet. 9: 1209-1217 (2000). *

• Dobson JV, Bryce L, Glaeser PW, Losek JD. Age limits and transition of health care in pediatric emergency medicine. Pediatr. Emerg. Care 23: 294-297 (2007).

• Dominitz JA, Young JC, Boyko EJ. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am. J. Gastroenterol. 97: 641-648 (2002). *

• Donahue SM, Rifas-Shiman SL, Olsen SF, Gold DR, Gillman MW, Oken E. Associations of maternal prenatal dietary intake of n-3 and n-6 fatty acids with maternal and umbilical cord blood levels. Prostaglandins Leukot. Essent. Fatty Acids Apr 18 [Epub ahead of print] (2009). *

• Dong AM, Yin HF, Gao YM, Guo XH. Spontaneous pregnancy in a patient with lymphocytic hypophysitis. Beijing Da Xue Xue Bao 41: 242-244 (2009).

• Doornbos B, van Goor SA, Dijck-Brouwer DA, Schaafsma A, Korf J, Muskiet FA. Supplementation of a low dose of DHA and DHA+AA does not prevent peripartum depressive symptoms in a small population based sample. Prog. Neuropsychopharmacol. Biol. Psychiatry 33: 49-52 (2009).

• Doria A, Iaccarino L, Arienti S, Ghirardello A, Zampieri S, Rampudda ME, Cutolo M, Tincani A, Todesco S. Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod. Toxicol. 22: 234-241 (2006).

• Doria A, Iaccarino L, Ghirardello A, Briani C, Zampieri S, Tarricone E, Gambari PF. Pregnancy in rare autoimmune rheumatic diseases: UCTD, MCTD, myositis, systemic vasculitis and Bechet disease. Lupus 13: 690-695 (2004).

• Doria A, Iaccarino L, Sarzi-Puttini P, Ghirardello A, Zampieri S, Arienti S, Cutolo M, Todesco S. Estrogens in pregnancy and systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 1069: 247-256 (2006). *

• Dosiou C, Sanders GD, Araki SS, Crapo LM. Screening pregnant women for autoimmune thyroid disease: a cost-effectiveness analysis. Eur. J. Endocrinol. 158: 841-851 (2008).

• Dozois EJ, Wolff BG, Tremaine WJ, Watson WJ, Drelichman ER, Carne PW, Bakken JL. Maternal and fetal outcome after colectomy for fulminant ulcerative colitis during pregnancy: case series and literature review. Dis. Colon Rectum 49: 64-73 (2006). *

• Drouillet P, Forhan A, De Lauzon-Guillain B, Thiebaugeorges O, Goua V, Magnin G, Schweitzer M, Kaminski M, Ducimetiere P, Charles MA. Maternal fatty acid intake and fetal growth: evidence for an association in overweight women. The 'EDEN mother-child' cohort (study of pre- and early postnatal determinants of the child's development and health). Br. J. Nutr. 101: 575-583 (2009). *

• Dubinsky M, Abraham B, Mahadevan U. Management of the pregnant IBD patient. Inflamm. Bowel Dis. 14: 1736-1750 (2008).

• Dubinsky MC, Fleshner PP. Treatment of Crohn's disease of inflammatory, stenotic, and fistulizing phenotypes. Curr. Treat. Options Gastroenterol. 6: 183-200 (2003).

• Dubnov-Raz G, Finkelstein Y, Koren G. Omega-3 fatty acid supplementation during pregnancy: for mother, baby, or neither? Can. Fam. Physician 53: 817-818 (2007).

• Dudesek A, Zettl UK. Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis. J. Neurol. 253 Suppl. 5: v50-v58 (2006).

• Duffy A, Shia J, Klimstra D, Temple L, O'Reilly EM. Collision tumor of the large bowel in the context of advanced pregnancy and ulcerative colitis. Clin. Colorectal Cancer 7: 402-405 (2008).

• Dunn JM, McNair A. Prolonged cholestasis following successful removal of common bile duct stones: beware patients on estrogen therapy. World J. Gastroenterol. 13: 6277-6280 (2007). *

• Dunstan JA, Mitoulas LR, Dixon G, Doherty DA, Hartmann PE, Simmer K, Prescott SL. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized, controlled trial. Pediatr. Res. 62: 689-694 (2007). *

• Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG, Prescott SL. Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy. Clin. Exp. Allergy 33: 442-448 (2003). *

• Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG, Prescott SL. Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. J. Allergy Clin. Immunol. 112: 1178-1184 (2003). *

• Dunstan JA, Prescott SL. Does fish oil supplementation in pregnancy reduce the risk of allergic disease in infants? Curr. Opin. Allergy Clin. Immunol. 5: 215-221 (2005).

• Dunstan JA, Simmer K, Dixon G, Prescott SL. Cognitive assessment at 21/2 years following fish oil supplementation in pregnancy: a randomized controlled trial. Arch. Dis. Child. Fetal Neonatal Ed. 93: F45-F50 (2008).

• Duvnjak M, Lerotic I, Tomasic V, Pavic T, Virovic L. Inflammatory bowel disease and pregnancy. Lijec. Vjesn. 128: 48-55 (2006).

• Edenborough FP, Borgo G, Knoop C, Lannefors L, Mackenzie WE, Madge S, Morton AM, Oxley HC, Touw DJ, Benham M, Johannesson M. Guidelines for the management of pregnancy in women with cystic fibrosis. J. Cyst. Fibros. 7 Suppl. 1: S2-S32 (2008).

• Egan DJ, Bisanzo MC, Hutson HR. Emergency department evaluation and management of peripartum cardiomyopathy. J. Emerg. Med. 36: 141-147 (2009).

• Egerman RS, Riely CA. Predicting fetal outcome in intrahepatic cholestasis of pregnancy: is the bile acid level sufficient? Hepatology 40: 287-288 (2004). *

• Ehrlich S, Haas J, Zipp F, Infante-Duarte C. Serum levels of soluble CD95 are not associated with amelioration of multiple sclerosis during pregnancy. J. Neurol. Sci. 252: 83-87 (2007). *

• Eilander A, Hundscheid DC, Osendarp SJ, Transler C, Zock PL. Effects of n-3 long chain polyunsaturated fatty acid supplementation on visual and cognitive development throughout childhood: a review of human studies. Prostaglandins Leukot. Essent. Fatty Acids 76: 189-203 (2007). *

• Einarson A, Ho E, Koren G. Can we use metronidazole during pregnancy and breastfeeding? Putting an end to the controversy. Can. Fam. Physician 46: 1053-1054 (2000).

• Ekbom A, Daszak P, Kraaz W, Wakefield AJ. Crohn's disease after in-utero measles virus exposure. Lancet 348: 515-517 (1996). *

• El-Mir MY, Monte MJ, Morales AI, Arevalo M, Serrano MA, Marin JJ. Effect of maternal cholestasis on biliary lipid and bile acid secretion in the infant rat. Hepatology 26: 527-536 (1997). *

• Elbaz G, Fich A, Levy A, Holcberg G, Sheiner E. Inflammatory bowel disease and preterm delivery. Int. J. Gynaecol. Obstet. 90: 193-197 (2005).

• Elias E. Hepatology highlights. Hepatology 42: 1241-1242 (2005). *

• Elliott AM, Kizza M, Quigley MA, Ndibazza J, Nampijja M, Muhangi L, Morison L, Namujju PB, Muwanga M, Kabatereine N, Whitwortha JA. The impact of helminths on the response to immunization and on the incidence of infection and disease in childhood in Uganda: design of a randomized, double-blind, placebo-controlled, factorial trial of deworming interventions delivered in pregnancy … Clin. Trials 4: 42-57 (2007). *

• Eloranta ML, Hakli T, Hiltunen M, Helisalmi S, Punnonen K, Heinonen S. Association of single nucleotide polymorphisms of the bile salt export pump gene with intrahepatic cholestasis of pregnancy. Scand. J. Gastroenterol. 38: 648-652 (2003). *

• Eloranta ML, Heiskanen J, Hiltunen M, Helisalmi S, Mannermaa A, Heinonen S. Apolipoprotein E alleles in women with intrahepatic cholestasis of pregnancy. Scand. J. Gastroenterol. 35: 966-968 (2000). *

• Elsing C, Stremmel W, Herrmann T. Spontaneous remission of autoimmune hepatitis in pregnancy and postpartum flare. Indian J. Gastroenterol. 26: 104 (2007). *

• Enders M, Helbig S, Hunjet A, Pfister H, Reichhuber C, Motz M. Comparative evaluation of two commercial enzyme immunoassays for serodiagnosis of human parvovirus B19 infection. J. Virol. Methods 146: 409-413 (2007).

• Erez Y, Ben-Shushan A, Elchalal U, Ben-Meir A, Rojansky N. Maternal morbidity following routine second trimester genetic amniocentesis. Fetal Diagn. Ther. 22: 226-228 (2007).

• Erkan D, Harrison MJ, Levy R, Peterson M, Petri M, Sammaritano L, Unalp-Arida A, Vilela V, Yazici Y, Lockshin MD. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum. 56: 2382-2391 (2007). *

• Erkkola M, Kaila M, Nwaru BI, Kronberg-Kippila C, Ahonen S, Nevalainen J, Veijola R, Pekkanen J, Ilonen J, Simell O, Knip M, Virtanen SM. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin. Exp. Allergy 39: 875-882 (2009).

• Ernst L, Grossman A, Ruchelli E. Familial perinatal liver disease and fetal thrombotic vasculopathy. Pediatr. Dev. Pathol. 11: 160-163 (2008).

• Estes CM. Response to Surti et al.: 'Pregnancy and liver transplantation' Liver Int. 29: 475 (2009). *

• European Association for the Study of the Liver. EASL clinical practice guidelines: management of cholestatic liver diseases. J. Hepatol. Jun 5 [Epub ahead of print] (2009). *

• Evelyn CM, Kim JW, Wong AL. HELLP-like syndrome associated with hepatic necrosis in a patient with systemic lupus erythematosus. J. Clin. Rheumatol. 7: 179-183 (2001).

• Evereklioglu C. Current concepts in the etiology and treatment of Behcet disease. Surv. Ophthalmol. 50: 297-350 (2005).

• Everson GT. Gallbladder function in gallstone disease. Gastroenterol. Clin. North Am. 20: 85-110 (1991).

• Everson GT. Gastrointestinal motility in pregnancy. Gastroenterol. Clin. North Am. 21: 751-776 (1992).

• Everson GT. Liver problems in pregnancy: Part 2 - managing pre-existing and pregnancy-induced liver disease. Medscape Womens Health 3: 2 (1998).

• Everson GT, McKinley C, Lawson M, Johnson M, Kern F Jr. Gallbladder function in the human female: effect of the ovulatory cycle, pregnancy, and contraceptive steroids. Gastroenterology 82: 711-719 (1982).

• Everson GT, Taylor MR. Management of polycystic liver disease. Curr. Gastroenterol. Rep. 7: 19-25 (2005).

• Fagan EA. Intrahepatic cholestasis of pregnancy. Clin. Liver Dis. 3: 603-632 (1999).

• Faiz SA, Nainar SI, Addar MH. Herpes gestationis. Saudi Med. J. 25: 792-794 (2004).

• Fan P, Gao T, Li M, Liao W, Fu M, Liu Y, Ikeda S. A case of impetigo herpetiformis associated with intrahepatic cholestasis of pregnancy. J. Dermatol. 33: 563-566 (2006).

• Fautrel B, Benhamou M. Chronic inflammatory disorders and reproduction. Gynecol. Obstet. Fertil. 35: 848-852 (2007).

• Favaloro EJ. Diagnostic issues in thrombophilia: a laboratory scientist's view. Semin. Thromb. Hemost. 31: 11-16 (2005).

• Favaloro EJ, Wong RC. Laboratory testing and identification of antiphospholipid antibodies and the antiphospholipid syndrome: a potpourri of problems, a compilation of possible solutions. Semin. Thromb. Hemost. 34: 389-410 (2008).

• Fedorova I, Hussein N, Baumann MH, Di Martino C, Salem N. An n-3 fatty acid deficiency impairs rat spatial learning in the Barnes maze. Behav. Neurosci. 123: 196-205 (2009).

• Feher J, Lengyel G. A new approach to drug therapy in non-alcoholic steatohepatitis (NASH). J. Int. Med. Res. 31: 537-551 (2003).

• Ferenci P, Zollner G, Trauner M. Hepatic transport systems. J. Gastroenterol. Hepatol. 17: S105-S112 (2002). *

• Ferguson CB, Mahsud-Dornan S, Patterson RN. Inflammatory bowel disease in pregnancy. BMJ 337: a427 (2008).

• Fermo I, Vigano' D'Angelo S, Paroni R, Mazzola G, Calori G, D'Angelo A. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. Ann. Intern. Med. 123: 747-753 (1995).

• Ferraz AC, Kiss A, Araujo RL, Salles HM, Naliwaiko K, Pamplona J, Matheussi F. The antidepressant role of dietary long-chain polyunsaturated n-3 fatty acids in two phases in the developing brain. Prostaglandins Leukot. Essent. Fatty Acids 78: 183-188 (2008). *

• Ferrero S, Ragni N. Inflammatory bowel disease: management issues during pregnancy. Arch. Gynecol. Obstet. 270: 79-85 (2004).

• Feuer G, Di Fonzo CJ. Intrahepatic cholestasis: a review of biochemical-pathological mechanisms. Drug Metabol. Drug Interact. 10: 1-161 (1992).

• Feuz J, Wisser J, Heufelder A, Joba W, Zimmermann R, von Mandach U. Vitamin D receptor genotype BB is associated with higher serum osteocalcin in first pregnancy. J. Perinat. Med. Jun 3 [Epub ahead of print] (2009).

• Feys HB, Canciani MT, Peyvandi F, Deckmyn H, Vanhoorelbeke K, Mannucci PM. ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis. Br. J. Haematol. 138: 534-540 (2007). *

• Feys HB, Deckmyn H, Vanhoorelbeke K. ADAMTS13 in health and disease. Acta Haematol. 121: 183-185 (2009).

• Filippi U, Brizzolara R, Venuti D, Cesarone A, Maritati VA, Podesta M, Yung WF, Bottaro LC, Orselli A, Chiappori A, Schiavo M, Caputo M, Bonassi S, Bagnasco M. Prevalence of post-partumt hyroiditis in Liguria (Italy): an observational study. J. Endocrinol. Invest. 31: 1063-1068 (2008).

• Filteau SM, Rollins NC, Coutsoudis A, Sullivan KR, Willumsen JF, Tomkins AM. The effect of antenatal vitamin A and beta-carotene supplementation on gut integrity of infants of HIV-infected South African women. J. Pediatr. Gastroenterol. Nutr. 32: 464-470 (2001). *

• Finegold MJ, Carpenter RJ. Obliterative cholangitis due to cytomegalovirus: a possible precursor of paucity of intrahepatic bile ducts. Hum. Pathol. 13: 662-665 (1982).

• Finucane FM, O'Connell J, Kinsley BT. Propylthiouracil induced C-ANCA positive agranulocytosis complicating Graves' thyrotoxicosis in pregnancy. Ir. J. Med. Sci. 177: 69-71 (2008). *

• Firmin CJ, Kruger TF, Davids R. Proximal renal tubular acidosis in pregnancy. A case report and literature review. Gynecol. Obstet. Invest. 63: 39-44 (2006).

• Fleta Asin B, Gonzalvo Liarte MC, Cia Gomez P. Chimerism: origin and medical implications. Rev. Clin. Esp. 206: 340-342 (2006).

• Fliege H, Rose M, Arck P, Walter OB, Kocalevent RD, Weber C, Klapp BF. The perceived stress questionnaire (PSQ) reconsidered: validation and reference values from different clinical and healthy adult samples. Psychosom. Med. 67: 78-88 (2005).

• Floreani A, Carderi I, Paternoster D, Soardo G, Azzaroli F, Esposito W, Montagnani M, Marchesoni D, Variola A, Rosa Rizzotto E, Braghin C, Mazzella G. Hepatobiliary phospholipid transporter ABCB4, MDR3 gene variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancy. Dig. Liver Dis. 40: 366-370 (2008).

• Floreani A, Carderi I, Paternoster D, Soardo G, Azzaroli F, Esposito W, Variola A, Tommasi AM, Marchesoni D, Braghin C, Mazzella G. Intrahepatic cholestasis of pregnancy: three novel MDR3 gene mutations. Aliment. Pharmacol. Ther. 23: 1649-1653 (2006). *

• Floreani A, Niro G, Rosa Rizzotto E, Antoniazzi S, Ferrara F, Carderi I, Baldo V, Premoli A, Olivero F, Morello E, Durazzo M. Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study. Aliment. Pharmacol. Ther. 24: 1051-1057 (2006).

• Floreani A, Paternoster D, Melis A, Grella PV. S-Adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial. Eur. J. Obstet. Gynecol. Reprod. Biol. 67: 109-113 (1996).

• Folador A, Hirabara SM, Bonatto SJ, Aikawa J, Yamazaki RK, Curi R, Fernandes LC. Effect of fish oil supplementation for 2 generations on changes in macrophage function induced by Walker 256 cancer cachexia in rats. Int. J. Cancer 120: 344-350 (2007). *

• Fontana RJ. Side effects of long-term oral antiviral therapy for hepatitis B. Hepatology 49: S185-S195 (2009).

• Foocharoen C, Nanagara R, Salang L, Suwannaroj S, Mahakkanukrauh A. Pregnancy and disease outcome in patients with systemic lupus erythematosus (SLE): a study at Srinagarind Hospital. J. Med. Assoc. Thai. 92: 167-174 (2009).

• Forastiero R, Martinuzzo M. Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome. Lupus 17: 872-877 (2008).

• Forges T, Pellanda H, Diligent C, Monnier P, Gueant JL. Do folates have an impact on fertility? Gynecol. Obstet. Fertil. 36: 930-939 (2008).

• Forget S, Senesse P, Burlet G, Lacroix N, Boulot P. Total parenteral nutrition for recurrent episodes of acute pancreatitis during pregnancy. A case report and literature review. J. Gynecol. Obstet. Biol. Reprod. (Paris) 36: 817-820 (2007).

• Fournier T, Handschuh K, Tsatsaris V, Guibourdenche J, Evain-Brion D. Role of nuclear receptors and their ligands in human trophoblast invasion. J. Reprod. Immunol. 77: 161-170 (2008).

• Fournier T, Therond P, Handschuh K, Tsatsaris V, Evain-Brion D. PPARgamma and early human placental development. Curr. Med. Chem. 15: 3011-3024 (2008).

• Francella A, Dyan A, Bodian C, Rubin P, Chapman M, Present DH. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 124: 9-17 (2003). *

• Franchini M, Capra F, Nicolini N, Veneri D, Manzato F, Baudo F, Lippi G. Drug-induced anti-factor VIII antibodies: a systematic review. Med. Sci. Monit. 13: RA55-RA61 (2007). *

• Franchini M, Targher G, Manzato F, Lippi G. Acquired factor VIII inhibitors in oncohematology: a systematic review. Crit. Rev. Oncol. Hematol. 66: 194-199 (2008).

• Franco J, Saeian K. Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis. Curr. Gastroenterol. Rep. 1: 95-101 (1999).

• Franke C, Verwied-Jorky S, Campoy C, Trak-Fellermeier M, Decsi T, Dolz V, Koletzko B. Dietary intake of natural sources of docosahexaenoic acid and folate in pregnant women of three European cohorts. Ann. Nutr. Metab. 53: 167-174 (2008).

• Freathy RM, Ring SM, Shields B, Galobardes B, Knight B, Weedon MN, Smith GD, Frayling TM, Hattersley AT. A common genetic variant in the 15q24 nicotinic acetylcholine receptor gene cluster (CHRNA5-CHRNA3-CHRNB4) is associated with a reduced ability of women to quit smoking in pregnancy. Hum. Mol. Genet. May 9 [Epub ahead of print] (2009). *

• Freathy RM, Weedon MN, Bennett A, Hypponen E, Relton CL, Knight B, Shields B, Parnell KS, Groves CJ, Ring SM, Pembrey ME, Ben-Shlomo Y, Strachan DP, Power C, Jarvelin MR, McCarthy MI, Davey Smith G, Hattersley AT, Frayling TM. Type 2 diabetes TCF7L2 risk genotypes alter birth weight: a study of 24,053 individuals. Am. J. Hum. Genet. 80: 1150-1161 (2007). *

• Freeman MP. Omega-3 fatty acids in psychiatry: a review. Ann. Clin. Psychiatry 12: 159-165 (2000).

• Freeman MP. Omega-3 fatty acids and perinatal depression: a review of the literature and recommendations for future research. Prostaglandins Leukot. Essent. Fatty Acids 75: 291-297 (2006). *

• Freeman MP. Complementary and alternative medicine for perinatal depression. J. Affect. Disord. 112: 1-10 (2009).

• Freeman MP, Helgason C, Hill RA. Selected integrative medicine treatments for depression: considerations for women. J. Am. Med. Womens Assoc. 59: 216-224 (2004). *

• Frezza M. A meta-analysis of therapeutic trials with ademetionine in the treatment of intrahepatic cholestasis. Ann. Ital. Med. Int. 8 Suppl.: 48S-51S (1993).

• Frezza M, Pozzato G, Chiesa L, Stramentinoli G, di Padova C. Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration. Hepatology 4: 274-278 (1984).

• Friedman S. Medical therapy and birth outcomes in women with Crohn's disease: what should we tell our patients? Am. J. Gastroenterol. 102: 1414-1416 (2007). *

• Friedman S. Management of inflammatory bowel disease during pregnancy and nursing. Semin. Gastrointest. Dis. 12: 245-252 (2001).

• Friedrich N, Schwarz S, Thonack J, John U, Wallaschofski H, Völzke H. Association between parity and autoimmune thyroiditis in a general female population. Autoimmunity 41: 174-180 (2008).

• Fruntes V, Limosin F. Schizophrenia and viral infection during neurodevelopment: a pathogenesis model? Med. Sci. Monit. 14: RA71-RA77 (2008). *

• Fung TY, Li CY. Successful pregnancy in a woman with secondary biliary cirrhosis with portal hypertension from recurrent pyogenic cholangitis. A case report. J. Reprod. Med. 44: 475-477 (1999).

• Furenes EB, Seljeflot I, Solheim S, Hjerkinn EM, Arnesen H. Long-term influence of diet and/or omega-3 fatty acids on matrix metalloproteinase-9 and pregnancy-associated plasma protein-A in men at high risk of coronary heart disease. Scand. J. Clin. Lab. Invest. 68: 177-184 (2008). *

• Furuhjelm C, Warstedt K, Larsson J, Fredriksson M, Bottcher MF, Falth-Magnusson K, Duchen K. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatr. Jun 1 [Epub ahead of print] (2009).

• Fux Otta C, Szafryk de Mereshian P, Iraci GS, Ojeda de Pruneda MR. Pregnancies associated with primary adrenal insufficiency. Fertil. Steril. 90: 1199.e17-e20 (2008).

• Gaby AR. Natural approaches to epilepsy. Altern. Med. Rev. 12: 9-24 (2007). *

• Gadi VK. Fetal microchimerism and cancer. Cancer Lett. 276: 8-13 (2009).

• Gadi VK, Nelson JL. Fetal microchimerism in women with breast cancer. Cancer Res. 67: 9035-9038 (2007). *

• Galanti MR, Cnattingius S, Granath F, Ekbom-Schnell A, Ekbom A. Smoking and environmental iodine as risk factors for thyroiditis among parous women. Eur. J. Epidemiol. 22: 467-472 (2007). *

• Galhenage SP, Viiala CH, Olynyk JK. Screening for hemochromatosis: patients with liver disease, families, and populations. Curr. Gastroenterol. Rep. 6: 44-51 (2004).

• Gallagher S. Omega 3 oils and pregnancy. Midwifery Today Int. Midwife 69: 26-31 (2004).

• Gallant M, Lories R, Verbanck J. Polymyalgia rheumatica/arteritis temporalis and acquired factor VIII inhibitor. Clin. Rheumatol. 27 Suppl. 1: 19-21 (2008). *

• Gao XL, Yang HX, Zhao Y. Variations of tumor necrosis factor-alpha, leptin and adiponectin in mid-trimester of gestational diabetes mellitus. Chin. Med. J. (Engl.) 121: 701-705 (2008).

• Garay L, Gonzalez Deniselle MC, Gierman L, Meyer M, Lima A, Roig P, De Nicola AF. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Neuroimmunomodulation 15: 76-83 (2008).

• Garcia-Gonzalez E, Castro-Llamas J, Karchmer S, Zuniga J, de Oca DM, Ambaz M, Bolanos R, Granados J. Class II major histocompatibility complex typing across the ethnic barrier in pemphigoid gestationis. A study in Mexicans. Int. J. Dermatol. 38: 46-51 (1999). *

• Gargano JW, Holzman C, Senagore P, Thorsen P, Skogstrand K, Hougaard DM, Rahbar MH, Chung H. Mid-pregnancy circulating cytokine levels, histologic chorioamnionitis and spontaneous preterm birth. J. Reprod. Immunol. 79: 100-110 (2008).

• Geboes K. From inflammation to lesion. Acta Gastroenterol. Belg. 57: 273-284 (1994).

• Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J. Gastroenterol. 15: 2049-2066 (2009). *

• Geier A, Wagner M, Dietrich CG, Trauner M. Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochim. Biophys. Acta 1773: 283-308 (2007). *

• Gendrot C, Bacq Y, Brechot MC, Lansac J, Andres C. A second heterozygous MDR3 nonsense mutation associated with intrahepatic cholestasis of pregnancy. J. Med. Genet. 40: e32 (2003). *

• Genuis SJ. A fishy recommendation: omega-3 fatty acid intake in pregnancy. BJOG 115: 1-4 (2008). *

• Genuis SJ, Schwalfenberg GK. Time for an oil check: the role of essential omega-3 fatty acids in maternal and pediatric health. J. Perinatol. 26: 359-365 (2006).

• George JN. The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: overview of pathogenesis (experience of the Oklahoma TTP-HUS Registry, 1989-2007). Kidney Int. Suppl. 112: S8-S10 (2009).

• George JN, Sadler JE, Lammle B. Platelets: thrombotic thrombocytopenic purpura. Hematology (Am. Soc. Hematol. Educ. Program) 2002: 315-334 (2002). *

• Germain S, Nelson-Piercy C. Lupus nephritis and renal disease in pregnancy. Lupus 15: 148-155 (2006).

• Gerosa M, Cimaz R, Stramba-Badiale M, Goulene K, Meregalli E, Trespidi L, Acaia B, Cattaneo R, Tincani A, Motta M, Doria A, Zulian F, Milanesi O, Brucato A, Riboldi P, Meroni PL. Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases - a multicentre prospective study. Rheumatology (Oxford) 46: 1285-1289 (2007). *

• Gershwin ME, Incaudo G. Topics in allergy and immunology during pregnancy and early infancy. Clin. Rev. Allergy Immunol. 26: 127-128 (2004).

• Gezer S. Antiphospholipid syndrome. Dis. Mon. 49: 696-741 (2003).

• Ghafoor F, Mansoor M, Malik T, Malik MS, Khan AU, Edwards R, Akhtar W. Role of thyroid peroxidase antibodies in the outcome of pregnancy. J. Coll. Physicians Surg. Pak. 16: 468-471 (2006).

• Ghosh K, Shetty S. Immune response to FVIII in hemophilia A: an overview of risk factors. Clin. Rev. Allergy Immunol. Jan 17 [Epub ahead of print] (2009). *

• Giaginis C, Spanopoulou E, Theocharis S. PPAR-gamma signaling pathway in placental development and function: a potential therapeutic target in the treatment of gestational diseases. Expert Opin. Ther. Targets 12: 1049-1063 (2008).

• Gilat T, Hacohen D, Lilos P, Langman MJ. Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scand. J. Gastroenterol. 22: 1009-1024 (1987).

• Gillio-Meina C, Phang S, Mather J, Knight B, Kennedy T. Expression patterns and role of prostaglandin-endoperoxide synthases, prostaglandin E synthases, prostacyclin synthase, prostacyclin receptor, peroxisome proliferator-activated receptor delta (PPARD) and retinoid X receptor alpha (RXRA) in rat … Reproduction 137: 537-552 (2009).

• Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J. Exp. Med. 203: 2165-2175 (2006). *

• Gisondi P, Fantuzzi F, Malerba M, Girolomoni G. Folic acid in general medicine and dermatology. J. Dermatolog. Treat. 18: 138-146 (2007).

• Glantz A, Benthin L, Lammert F, Mattsson LA, Marschall HU. Disulfated progesterone metabolites in urine relate to pruritus in intrahepatic cholestasis of pregnancy treated with ursodeoxycholic acid. Falk Symposium 155. XIII FALK LIVER WEEK (Part I) XIX International Bile Acid Meeting. Bile Acids: Biological Actions and Clinical Relevance, October 6 - 7, 2006 Freiburg (Germany), p. 62 (2006). *

• Glantz A, Lammert FL, Mattsson L-A, Marschall H-U. Intrahepatic cholestasis of pregnancy: results from the Swedish observation and intervention trials. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 79. June 18-19 (2004). *

• Glantz A, Marschall HU, Lammert F, Mattsson LA. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 42: 1399-1405 (2005). *

• Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 40: 467-474 (2004). *

• Glantz A, Reilly SJ, Benthin L, Lammert F, Mattsson LA, Marschall HU. Intrahepatic cholestasis of pregnancy: amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine. Hepatology 47: 544-551 (2008). *

• Gleicher N. Why much of the pathophysiology of preeclampsia-eclampsia must be of an autoimmune nature. Am. J. Obstet. Gynecol. 196: 5.e1-7 (2007).

• Gleicher N, Elkayam U. Peripartum cardiomyopathy, an autoimmune manifestation of allograft rejection? Autoimmun. Rev. 8: 384-387 (2009).

• Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: II. Different genotype and phenotype for genetic and autoimmune etiologies. Fertil. Steril. 91: 1707-1711 (2009).

• Gleicher N, Weiner R, Vietzke M. The impact of abnormal autoimmune function on reproduction: maternal and fetal consequences. J. Autoimmun. 27: 161-165 (2006).

• Glenville M. Nutritional supplements in pregnancy: commercial push or evidence based? Curr. Opin. Obstet. Gynecol. 18: 642-647 (2006).

• Glinoer D. The systematic screening and management of hypothyroidism and hyperthyroidism during pregnancy. Trends Endocrinol. Metab. 9: 403-411 (1998). *

• Goh SK, Gull SE, Alexander GJ. Pregnancy in primary biliary cirrhosis complicated by portal hypertension: report of a case and review of the literature. BJOG 108: 760-762 (2001). *

• Goldberg DM, Spooner RJ, Ellis G, Ward AM. Biochemical features of intrahepatic cholestasis. Am. J. Clin. Pathol. 71: 557-563 (1979).

• Goldberg Green M, Bragg J, Rosenman KS, Keltz Pomeranz M. Pustular psoriasis of pregnancy in a patient whose dermatosis showed features of acute generalized exanthematous pustulosis. Int. J. Dermatol. 48: 299-303 (2009).

• Golding J, Steer C, Emmett P, Davis JM, Hibbeln JR. High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fish. Epidemiology Mar 10 [Epub ahead of print] (2009).

• Gomez-Puerta JA, Cervera R, Espinosa G, Bucciarelli S, Font J. Pregnancy and puerperium are high susceptibility periods for the development of catastrophic antiphospholipid syndrome. Autoimmun. Rev. 6: 85-88 (2006).

• Gomez-Puerta JA, Martin H, Amigo MC, Aguirre MA, Camps MT, Cuadrado MJ, Hughes GR, Khamashta MA. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus? Medicine (Baltimore) 84: 225-230 (2005).

• Gomollon F. Treatment safety in inflammatory bowel disease. Gastroenterol. Hepatol. 29 Suppl. 3: 45-51 (2006).

• Gonen-Gross T, Mandelboim O. HLA-G complexes are observed on the cell surface. Hum. Immunol. 68: 227-232 (2007).

• Gonzales E, Davit-Spraul A, Baussan C, Buffet C, Maurice M, Jacquemin E. Liver diseases related to MDR3 (ABCB4) gene deficiency. Front. Biosci. 14: 4242-4256 (2009).

• Gonzalez A, Varo N, Alegre E, Diaz A, Melero I. Immunosuppression routed via the kynurenine pathway: a biochemical and pathophysiologic approach. Adv. Clin. Chem. 45: 155-197 (2008).

• Gonzalez M, Ribalta J, Reyes H, Klinger J, Maggiolo P, Varleta P, Hernandez I, Delgado M, Donoso S. Primary biliary cirrhosis. The clinical experience in 31 patients. Rev. Med. Chil. 118: 1350-1354 (1990).

• Gordon C. Pregnancy and autoimmune diseases. Best Pract. Res. Clin. Rheumatol. 18: 359-379 (2004).

• Gorelik J, Patel P, Ng'andwe C, Vodyanoy I, Diakonov I, Lab M, Korchev Y, Williamson C. Genes encoding bile acid, phospholipid and anion transporters are expressed in a human fetal cardiomyocyte culture. BJOG 113: 552-558 (2006). *

• Gossard AA, Lindor KD. Pregnancy in a patient with primary sclerosing cholangitis. J. Clin. Gastroenterol. 35: 353-355 (2002).

• Gotthardt D, Runz H, Keitel V, Fischer C, Flechtenmacher C, Wirtenberger M, Weiss KH, Imparato S, Braun A, Hemminki K, Stremmel W, Ruschendorf F, Stiehl A, Kubitz R, Burwinkel B, Schirmacher P, Knisely AS, Zschocke J, Sauer P. A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults. Hepatology 48: 1157-1166 (2008).

• Gottrand F. Long-chain polyunsaturated fatty acids influence the immune system of infants. J. Nutr. 138: 1807S-1812S (2008). *

• Granath A, Hellgren M, Gunnarsson R. Lactose intolerance and long-standing pelvic pain after pregnancy: a case control study. Acta Obstet. Gynecol. Scand. Feb 19 [Epub ahead of print] (2007).

• Grandjean EM, Aubry JM. Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety. CNS Drugs 23: 397-418 (2009).

• Granell R, Heron J, Lewis S, Smith GD, Sterne JA, Henderson J. The association between mother and child MTHFR C677T polymorphisms, dietary folate intake and childhood atopy in a population-based, longitudinal birth cohort. Clin. Exp. Allergy 38: 320-328 (2008). *

• Greco L, Veneziano A, Di Donato L, Zampella C, Pecoraro M, Paladini D, Paparo F, Vollaro A, Martinelli P. Undiagnosed coeliac disease does not appear to be associated with unfavourable outcome of pregnancy. Gut 53: 149-151 (2004). *

• Greco M, Chiriaco F, Del Boccio P, Tagliaferro L, Acierno R, Menegazzi P, Pinca E, Pignatelli F, Storelli C, Federici G, Urbani A, Maffia M. A proteomic approach for the characterization of C677T mutation of the human gene methylenetetrahydrofolate reductase. Proteomics 6: 5350-5361 (2006). *

• Green AS, Schwartz A. Is universal screening for thyroid disease in pregnancy a cost-effective strategy? Nat. Clin. Pract. Endocrinol. Metab. 4: 598-599 (2008).

• Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 123: 1367-1384 (2002). *

• Greenberg JA, Bell SJ, Ausdal WV. Omega-3 fatty acid supplementation during pregnancy. Rev. Obstet. Gynecol. 1: 162-169 (2008).

• Grimaud JC, Bourliere M. Contraception and hepatogastroenterology. Fertil. Contracept. Sex 17: 407-413 (1989).

• Grogan PM, Katz JS. Inflammatory myopathies. Curr. Treat. Options Neurol. 6: 155-161 (2004).

• Groom KM. Pharmacological prevention of prematurity. Best Pract. Res. Clin. Obstet. Gynaecol. 21: 843-856 (2007).

• Gudjonsson JE, Karason A, Runarsdottir EH, Antons dottir AA, Hauksson VB, Jonsson HH, Gulcher J, Stefansson K, Valdimarsson H. Distinct clinical differences between HLA-Cw(*)0602 positive and negative psoriasis patients - an analysis of 1019 HLA-C- and HLA-B-typed patients. J. Invest. Dermatol. 126: 740-745 (2006). *

• Guerin LR, Prins JR, Robertson SA. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum. Reprod. Update Mar 11 [Epub ahead of print] (2009). *

• Guettier C, Sebagh M, Buard J, Feneux D, Ortin-Serrano M, Gigou M, Tricottet V, Reynes M, Samuel D, Feray C. Male cell microchimerism in normal and diseased female livers from fetal life to adulthood. Hepatology 42: 35-43 (2005). *

• Guntupalli SR, Steingrub J. Hepatic disease and pregnancy: an overview of diagnosis and management. Crit. Care Med. 33: S332-S339 (2005).

• Gurung V, Williamson C, Chappell L, Chambers J, Briley A, Broughton-Pipkin F, Thornton J. Pilot study for a trial of ursodeoxycholic acid (UDCA) and/or early delivery for obstetric cholestasis. BMC Pregnancy Childbirth 9: 19 (2009). *

• Gutenberg A, Hans V, Puchner MJ, Kreutzer J, Bruck W, Caturegli P, Buchfelder M. Primary hypophysitis: clinical-pathological correlations. Eur. J. Endocrinol. 155: 101-107 (2006). *

• Gutierrez Gutierrez HI, Carrillo Iniguez MJ, Pestana Mendoza S, Santamaria Ferreira M. Ofuji's diseases and pregnancy. A report of a case. Ginecol. Obstet. Mex. 74: 158-163 (2006).

• Gutierrez-Mateo C, Sanchez-García JF, Fischer J, Tormasi S, Cohen J, Munne S, Wells D. Preimplantation genetic diagnosis of single-gene disorders: experience with more than 200 cycles conducted by a reference laboratory in the United States. Fertil. Steril. Oct 18 [Epub ahead of print] (2008).

• Gutkowski K, Gutkowska D. Systemic lupus erythematosus (SLE). Ginekol. Pol. 77: 893-900 (2006).

• Habal FM, Hui G, Greenberg GR. Oral 5-aminosalicylic acid for inflammatory bowel disease in pregnancy: safety and clinical course. Gastroenterology 105: 1057-1060 (1993).

• Habal FM, Kapila V. Inflammatory bowel disease and pregnancy: evidence, uncertainty and patient decision-making. Can. J. Gastroenterol. 23: 49-53 (2009).

• Habal FM, Ravindran NC. Management of inflammatory bowel disease in the pregnant patient. World J. Gastroenterol. 14: 1326-1332 (2008). *

• Hadders-Algra M. Prenatal long-chain polyunsaturated fatty acid status: the importance of a balanced intake of docosahexaenoic acid and arachidonic acid. J. Perinat. Med. 36: 101-109 (2008).

• Hadj-Kacem H, Rebuffat S, Mnif-Feki M, Belguith-Maalej S, Ayadi H, Peraldi-Roux S. Autoimmune thyroid diseases: genetic susceptibility of thyroid-specific genes and thyroid autoantigens contributions. Int. J. Immunogenet. 36: 85-96 (2009). *

• Hadziselimovic F, Geneto R, Buser M. Celiac disease, pregnancy, small for gestational age: role of extravillous trophoblast. Fetal Pediatr. Pathol. 26: 125-134 (2007).

• Haga HJ, Gjesdal CG, Koksvik HS, Skomsvoll JF, Irgens LM, Ostensen M. Pregnancy outcome in patients with primary Sjogren's syndrome. A case-control study. J. Rheumatol. 32: 1734-1736 (2005).

• Hagedorn KA, Cooke CL, Falck JR, Mitchell BF, Davidge ST. Regulation of vascular tone during pregnancy: a novel role for the pregnane X receptor. Hypertension 49: 328-333 (2007).

• Hahnloser D, Pemberton JH, Wolff BG, Larson D, Harrington J, Farouk R, Dozois RR. Pregnancy and delivery before and after ileal pouch-anal anastomosis for inflammatory bowel disease: immediate and long-term consequences and outcomes. Dis. Colon Rectum 47: 1127-1135 (2004). *

• Hamaoui E, Hamaoui M. Nutritional assessment and support during pregnancy. Gastroenterol. Clin. North Am. 32: 59-121, v (2003). *

• Hanchard N, Rockett K, Udalova I, Wilson J, Keating B, Koch O, Nijnik A, Diakite M, Herbert M, Kwiatkowski D. An investigation of transmission ratio distortion in the central region of the human MHC. Genes Immun. 7: 51-58 (2006). *

• Hancock R, Koren G. Celiac disease during pregnancy. Can. Fam. Physician 50: 1361-1363 (2004).

• Handley M, Collins A. Delicate threads: autoimmune complications in a high-risk pregnancy. Nurs. Womens Health 12: 139-145 (2008).

• Hanebutt FL, Demmelmair H, Schiessl B, Larque E, Koletzko B. Long-chain polyunsaturated fatty acid (LC-PUFA) transfer across the placenta. Clin. Nutr. 27: 685-693 (2008).

• Hao L, Noguchi S, Kamada Y, Sasaki A, Matsuda M, Shimizu K, Hiramatsu Y, Nakatsuka M. Adverse effects of advanced glycation end products on embryonal development. Acta Med. Okayama 62: 93-99 (2008).

• Haq AI, Sahai A, Hallwoth S, Rampton DS, Dorudi S. Synchronous colectomy and caesarean section for fulminant ulcerative colitis: case report and review of the literature. Int. J. Colorectal Dis. 21: 465-469 (2006). *

• Haram K, Gjelland K. Foetal growth restriction. Tidsskr. Nor. Laegeforen. 127: 2665-2669 (2007).

• Hardikar W, Kansal S, Oude Elferink RP, Angus P. Intrahepatic cholestasis of pregnancy: when should you look further? World J. Gastroenterol. 15: 1126-1129 (2009). *

• Harding G, McKenna R, Minuk G. The immune response to alkaline phosphatase and other immunogens in patients with primary biliary cirrhosis. Hepatogastroenterology 48: 66-70 (2001).

• Hari Kumar KV, Pushkaraj SG, Krishnaleela BL, Modi KD. Peripartum cardiomyopathy in type II autoimmune polyendocrine syndrome. Int. J. Cardiol. Mar 19 [Epub ahead of print] (2009).

• Harirchian MH, Sahraian MA, Shirani A. Serum prolactin level in patients with multiple sclerosis: a case control study. Med. Sci. Monit. 12: CR177-CR180 (2006). *

• Harnish DC. Estrogen receptor ligands in the control of pathogenic inflammation. Curr. Opin. Investig. Drugs 7: 997-1001 (2006).

• Hasler WL. The irritable bowel syndrome during pregnancy. Gastroenterol. Clin. North Am. 32: 385-406, viii (2003). *

• Haugen HF, Skrede S. Nucleotide pyrophosphatase and phosphodiesterase I. Demonstration of activity in normal serum, and an increase in cholestatic liver disease. Scand. J. Gastroenterol. 11: 121-127 (1976).

• Haugen M, Brantsaeter AL, Alexander J, Meltzer HM. Dietary supplements contribute substantially to the total nutrient intake in pregnant Norwegian women. Ann. Nutr. Metab. 52: 272-280 (2008).

• Hautekeete ML. Hepatotoxicity of antibiotics. Acta Gastroenterol. Belg. 58: 290-296 (1995).

• Hawes SK, Ahmad A. Fecal incontinence: a woman's view. Am. J. Gastroenterol. 101 Suppl. 3: S610-S617 (2006). *

• Hay JE. Liver disease in pregnancy. Hepatology 47: 1067-1076 (2008). *

• Heazell AE, Sinha A, Bhatti NR. A case of gestational diabetes arising following treatment with glucocorticosteroids for pemphigoid gestationis. J. Matern. Fetal Neonatal Med. 18: 353-355 (2005).

• Hecht Y. Hepatic and biliary repercussions of estrogens: dose or duration of treatment effect. Contracept. Fertil. Sex (Paris) 19: 403-408 (1991).

• Heetun ZS, Byrnes C, Neary P, O'Morain C. Review article: reproduction in the patient with inflammatory bowel disease. Aliment. Pharmacol. Ther. 26: 513-533 (2007). *

• Heikkinen J. Effect of a standard test meal on serum bile acid levels in healthy nonpregnant and pregnant women and in patients with intrahepatic cholestasis of pregnancy. Ann. Clin. Res. 15: 183-188 (1983).

• Heikkinen J, Maentausta O, Ylostalo P, Janne O. Changes in serum bile acid concentrations during normal pregnancy, in patients with intrahepatic cholestasis of pregnancy and in pregnant women with itching. Br. J. Obstet. Gynaecol. 88: 240-245 (1981).

• Heikkinen J, Maentausta O, Ylostalo P, Janne O. Serum bile acid levels in intrahepatic cholestasis of pregnancy during treatment with phenobarbital or cholestyramine. Eur. J. Obstet. Gynecol. Reprod. Biol. 14: 153-162 (1982).

• Heine RG, Tang ML. Dietary approaches to the prevention of food allergy. Curr. Opin. Clin. Nutr. Metab. Care 11: 320-328 (2008).

• Heleniak Z, Zdrojewski Z, Rutkowski B. What the nephrologist should know about antiphospholipid syndrome? Pol. Merkur. Lekarski. 26: 215-219 (2009).

• Helland IB, Saugstad OD, Saarem K, Van Houwelingen AC, Nylander G, Drevon CA. Supplementation of n-3 fatty acids during pregnancy and lactation reduces maternal plasma lipid levels and provides DHA to the infants. J. Matern. Fetal Neonatal Med. 19: 397-406 (2006).

• Helland IB, Smith L, Blomen B, Saarem K, Saugstad OD, Drevon CA. Effect of supplementing pregnant and lactating mothers with n-3 very-long-chain fatty acids on children's IQ and body mass index at 7 years of age. Pediatrics 122: e472-e479 (2008). *

• Hendrickx AG, Makori N, Peterson P. Nonhuman primates: their role in assessing developmental effects of immunomodulatory agents. Hum. Exp. Toxicol. 19: 219-225 (2000).

• Heneghan MA, Norris SM, O'Grady JG, Harrison PM, McFarlane IG. Management and outcome of pregnancy in autoimmune hepatitis. Gut 48: 97-102 (2001). *

• Hennes EM, Oo YH, Schramm C, Denzer U, Buggisch P, Wiegard C, Kanzler S, Schuchmann M, Boecher W, Galle PR, Adams DH, Lohse AW. Mycophenolate mofetil as second line therapy in autoimmune hepatitis? Am. J. Gastroenterol. 103: 3063-3070 (2008). *

• Henriquez-Hernandez LA, Flores-Morales A, Santana-Farre R, Axelson M, Nilsson P, Norstedt G, Fernandez-Perez L. Role of pituitary hormones on 17alpha-ethinylestradiol-induced cholestasis in rat. J. Pharmacol. Exp. Ther. 320: 695-705 (2007). *

• Hepburn IS. Pregnancy-associated liver disorders. Dig. Dis. Sci. 53: 2334-2358 (2008). *

• Hermans D, Talbotec C, Lacaille F, Goulet O, Ricour C, Colomb V. Early central catheter infections may contribute to hepatic fibrosis in children receiving long-term parenteral nutrition. J. Pediatr. Gastroenterol. Nutr. 44: 459-463 (2007). *

• Herraiz I, Lopez-Jimenez EA, García-Burguillo A, Nieto O, Villar OP, Escribano D, Galindo A. Role of uterine artery Doppler in interpreting low PAPP-A values in first-trimester screening for Down syndrome in pregnancies at high risk of impaired placentation. Ultrasound Obstet. Gynecol. 33: 518-523 (2009).

• Herrera E, Lopez-Soldado I, Limones M, Amusquivar E, Ramos MP. Lipid metabolism during the perinatal phase, and its implications on postnatal development. Int. J. Vitam. Nutr. Res. 76: 216-224 (2006).

• Herter U, Petney T, Pipitgool V, Sithithaworn P, Vivatpatanakul K, Hinz E, Andrews R. The influence of pregnancy on intestinal parasite infection in Thai women. Acta Trop. 101: 200-206 (2007).

• Hibbeln JR. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J. Affect. Disord. 69: 15-29 (2002).

• Hibbeln JR, Davis JM, Steer C, Emmett P, Rogers I, Williams C, Golding J. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet 369: 578-585 (2007). *

• Hierro L, Jara P. Childhood cholestasis and bile transporters. Gastroenterol. Hepatol. 28: 388-395 (2005).

• Hills FA, Abrahams VM, Gonzalez-Timon B, Francis J, Cloke B, Hinkson L, Rai R, Mor G, Regan L, Sullivan M, Lam EW, Brosens JJ. Heparin prevents programmed cell death in human trophoblast. Mol. Hum. Reprod. 12: 237-243 (2006).

• Hirano S, Furutama D, Hanafusa T. Physiologically high concentrations of 17-beta-estradiol enhance NF-kappaB activity in human T cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292: R1465-R1471 (2007). *

• Hoentjen F, van Bodegraven AA. Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease. World J. Gastroenterol. 15: 2067-2073 (2009). *

• Holness MJ, Greenwood GK, Smith ND, Sugden MC. Peroxisome proliferator-activated receptor-alpha and glucocorticoids interactively regulate insulin secretion during pregnancy. Diabetes 55: 3501-3508 (2006). *

• Holub M, Bodamer OA, Item C, Muhl A, Pollak A, Stockler-Ipsiroglu S. Lack of correlation between fatty acid oxidation disorders and haemolysis, elevated liver enzymes, low platelets (HELLP) syndrome? Acta Paediatr. 94: 48-52 (2005).

• Homar V, Grosek S, Battelino T. High-dose methylprednisolone in a pregnant woman with Crohn's disease and adrenal suppression in her newborn. Neonatology 94: 306-309 (2008).

• Honein MA, Lindstrom JA, Kweder SL. Can we ensure the safe use of known human teratogens?: the iPLEDGE test case. Drug Saf. 30: 5-15 (2007).

• Hook LM, Jude BA, Ter-Grigorov VS, Hartley JW, Morse HC 3rd, Trainin Z, Toder V, Chervonsky AV, Golovkina TV. Characterization of a novel murine retrovirus mixture that facilitates hematopoiesis. J. Virol. 76: 12112-12122 (2002). *

• Hosli I, Zanetti-Daellenbach R, Holzgreve W, Lapaire O. Role of omega 3-fatty acids and multivitamins in gestation. J. Perinat. Med. 35 Suppl. 1: S19-S24 (2007).

• House SH. Schoolchildren, maternal nutrition and generating healthy brains: the importance of lifecycle education for fertility, health and peace. Nutr. Health 20: 51-76 (2009).

• Houtchens KA, Nichols RJ, Ladner MB, Boal HE, Sollars C, Geraghty DE, Davis LM, Parham P, Trachtenberg EA. High-throughput killer cell immunoglobulin-like receptor genotyping by MALDI-TOF mass spectrometry with discovery of novel alleles. Immunogenetics 59: 525-537 (2007). *

• Houtchens MK. Pregnancy and multiple sclerosis. Semin. Neurol. 27: 434-441 (2007).

• Hovdenak N, Schlichting E. Inflammatory bowel disease and pregnancy. Tidsskr. Nor. Laegeforen. 118: 1201-1203 (1998).

• Hovinga IC, Koopmans M, Baelde HJ, Wal AM, Sijpkens YW, Heer ED, Bruijn JA, Bajema IM. Chimerism occurs twice as often in lupus nephritis as in normal kidneys. Arthritis Rheum. 54: 2944-2950 (2006). *

• Howard PJ, Murphy GM. Bile acid stress in the mother and baby unit. Eur. J. Gastroenterol. Hepatol. 15: 317-321 (2003).

• Howel D, Fischbacher CM, Bhopal RS, Gray J, Metcalf JV, James OF. An exploratory population-based case-control study of primary biliary cirrhosis. Hepatology 31: 1055-1060 (2000). *

• Hruby E, Sassi L, Gorbe E, Hupuczi P, Papp Z. The maternal and fetal outcome of 122 triplet pregnancies. Orv. Hetil. 148: 2315-2328 (2007).

• Hsieh AT, Anthony JC, Diersen-Schade DA, Rumsey SC, Lawrence P, Li C, Nathanielsz PW, Brenna JT. The influence of moderate and high dietary long chain polyunsaturated fatty acids (LCPUFA) on baboon neonate tissue fatty acids. Pediatr. Res. 61: 537-545 (2007). *

• Hu YY, Wang XD, Liu SY. Expression of HIF-1alpha mRNA and HIF-2alpha mRNA in placentas of pregnant women with intrahepatic cholestasis of pregnancy. Sichuan Da Xue Xue Bao Yi Xue Ban 38: 641-643 (2007).

• Huang JY, Liu H. Analysis on therapeutic effect of Western and Chinese drug in treating intrahepatic cholestasis pregnancy. Zhongguo Zhong Xi Yi Jie He Za Zhi 24: 309-311 (2004).

• Huang WM, Gowda M, Donnelly JG. Bile acid ratio in diagnosis of intrahepatic cholestasis of pregnancy. Am. J. Perinatol. 26: 291-294 (2009).

• Huang WM, Seubert DE, Donnelly JG, Liu M, Javitt NB. Intrahepatic cholestasis of pregnancy: detection with urinary bile acid assays. J. Perinat. Med. 35: 486-491 (2007).

• Huemer M, Simma B, Fowler B, Suormala T, Bodamer OA, Sass JO. Prenatal and postnatal treatment in cobalamin C defect. J. Pediatr. 147: 469-472 (2005). *

• Hughes G. Hughes syndrome: the antiphospholipid syndrome-a clinical overview. Clin. Rev. Allergy Immunol. 32: 3-12 (2007).

• Hukkanen J, Jacob P 3rd, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol. Rev. 57: 79-115 (2005). *

• Hulstein JJ, Lenting PJ, de Laat B, Derksen RH, Fijnheer R, de Groot P. Beta2-Glycoprotein I inhibits von Willebrand factor-dependent platelet adhesion and aggregation. Blood 110: 1483-1491 (2007). *

• Hunt JS. Stranger in a strange land. Immunol. Rev. 213: 36-47 (2006). *

• Hutchins H. Omega-3 fatty acids: recommendations for therapeutics and prevention. MedGenMed. 7: 18 (2005). *

• Huurre A, Laitinen K, Rautava S, Korkeamaki M, Isolauri E. Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controlled study. Clin. Exp. Allergy 38: 1342-1348 (2008). *

• Hviid TV. HLA-G in human reproduction: aspects of genetics, function and pregnancy complications. Hum. Reprod. Update 12: 209-232 (2006).

• Hviid TV. Non-classical HLA genes: from implantation to transplantation. Ugeskr. Laeger. 168: 461-466 (2006).

• Hviid TV, Christiansen OB. Linkage disequilibrium between human leukocyte antigen (HLA) class II and HLA-G - possible implications for human reproduction and autoimmune disease. Hum. Immunol. 66: 688-699 (2005).

• Hviid TV, Rizzo R, Melchiorri L, Stignani M, Baricordi OR. Polymorphism in the 5' upstream regulatory and 3' untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression. Hum. Immunol. 67: 53-62 (2006).

• Ibebuogu UN, Thornton JW, Reed GL. An unusual case of peripartum cardiomyopathy manifesting with multiple thrombo-embolic phenomena. Thromb. J. 5: 18 (2007).

• Ichinohe T, Teshima T, Matsuoka KI, Maruya E, Saji H. Fetal-maternal microchimerism: impact on hematopoietic stem cell transplantation. Curr. Opin. Immunol. 17: 546-552 (2005).

• Iciek R, Wender-Ozegowska E, Seremak-Mrozikiewicz A, Drews K, Brazert J, Pietryga M. Leptin gene, leptin gene receptor polymorphisms and body weight in pregnant women with type 1 diabetes mellitus. Ginekol. Pol. 79: 592-601 (2008).

• Ieko M, Nakabayashi T, Tarumi T, Yoshida M, Naito S, Atsumi T, Koike T. Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome. Rinsho Byori 54: 256-262 (2006).

• Ilnyckyj A. Surgical treatment of inflammatory bowel diseases and pregnancy. Best Pract. Res. Clin. Gastroenterol. 21: 819-834 (2007).

• Imagawa A, Hanafusa T, Iwahashi H, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Maruyama T, Makino H. Uniformity in clinical and HLA-DR status regardless of age and gender within fulminant type 1 diabetes. Diabetes Res. Clin. Pract. 82: 233-237 (2008).

• Imazio M, Trinchero R. Treatment of acute and recurrent pericarditis. What the clinical cardiologist should know. G. Ital. Cardiol. (Rome) 9: 826-834 (2008).

• Inagaki J, Kondo A, Lopez LR, Shoenfeld Y, Matsuura E. Pregnancy loss and endometriosis: pathogenic role of anti-laminin-1 autoantibodies. Ann. N. Y. Acad. Sci. 1051: 174-184 (2005). *

• Innis SM. Fatty acids and early human development. Early Hum. Dev. 83: 761-766 (2007).

• Invernizzi P, De Andreis C, Sirchia SM, Battezzati PM, Zuin M, Rossella F, Perego F, Bignotto M, Simoni G, Podda M. Blood fetal microchimerism in primary biliary cirrhosis. Clin. Exp. Immunol. 122: 418-422 (2000). *

• Irony-Tur-Sinai M, Grigoriadis N, Lourbopoulos A, Pinto-Maaravi F, Abramsky O, Brenner T. Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein. Exp. Neurol. 198: 136-144 (2006).

• Iser JH, Sali A. Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use. Drugs 21: 90-119 (1981).

• Ishaq S, Green JR. Tolerability of aminosalicylates in inflammatory bowel disease. BioDrugs 15: 339-349 (2001).

• Jaaskelainen E, Keski-Nisula L, Toivonen S, Paattiniemi EL, Helisalmi S, Punnonen K, Heinonen S. Polymorphism of the interleukin 1 receptor antagonist (IL1Ra) gene and placental abruption. J. Reprod. Immunol. 79: 58-62 (2008).

• Jacquemin E. Role of multidrug resistance 3 deficiency in pediatric and adult liver disease: one gene for three diseases. Semin. Liver Dis. 21: 551-562 (2001). *

• Jacquemin E, Cresteil D, Manouvrier S, Boute O, Hadchouel M. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 353: 210-211 (1999).

• Jacquemin E, De Vree JM, Cresteil D, Sokal EM, Sturm E, Dumont M, Scheffer GL, Paul M, Burdelski M, Bosma PJ, Bernard O, Hadchouel M, Oude Elferink RP. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 120: 1448-1458 (2001). *

• Jain P. Recurrent intrahepatic cholestasis of pregnancy: ursodeoxycholic acid should be the first line of treatment. J. Gastrointestin. Liver Dis. 17: 479-480 (2008). *

• Jalili RB, Forouzandeh F, Bahar MA, Ghahary A. The immunoregulatory function of indoleamine 2, 3 dioxygenase and its application in allotransplantation. Iran J. Allergy Asthma Immunol. 6: 167-179 (2007).

• Jamjute P, Ahmad A, Ghosh T, Banfield P. Liver function test and pregnancy. J. Matern. Fetal Neonatal Med. 22: 274-283 (2009).

• Janczewska I, Olsson R, Hultcrantz R, Broome U. Pregnancy in patients with primary sclerosing cholangitis. Liver 16: 326-330 (1996).

• Jankowska I, Oldakowska-Jedynak U, Jabiry-Zieniewicz Z, Cyganek A, Pawlowska J, Teisseyre M, Kalicinski P, Markiewicz M, Paczek L, Socha J. Absence of teratogenicity of sirolimus used during early pregnancy in a liver transplant recipient. Transplant. Proc. 36: 3232-3233 (2004). *

• Jansen AG, Vossen JM, Roelen DL, ten Cate R, Bredius GM. The possible role of microchimerism in the aetiology of autoimmune diseases. Ned. Tijdschr. Geneeskd. 149: 1556-1560 (2005).

• Jansen PL, Muller M. Genetic cholestasis: lessons from the molecular physiology of bile formation. Can. J. Gastroenterol. 14: 233-238 (2000).

• Jansen PL, Muller M, Kuipers F. Bile formation and cholestasis. Ned. Tijdschr. Geneeskd. 144: 2384-2391 (2000).

• Javitt NB. Cholestasis of pregnancy: ursodeoxycholic acid therapy. J. Hepatol. 29: 827-828 (1998).

• Jayaprakash A, Gould S, Lim AG, Shehata HA. Use of cyclosporin in pregnancy. Gut 53: 1386-1387 (2004). *

• Jenkins JK, Boothby LA. Treatment of itching associated with intrahepatic cholestasis of pregnancy. Ann. Pharmacother. 36: 1462-1465 (2002).

• Jensen CL. Effects of n-3 fatty acids during pregnancy and lactation. Am. J. Clin. Nutr. 83: 1452S-1457S (2006). *

• Jeong H, Choi S, Song JW, Chen H, Fischer JH. Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination. Xenobiotica 38: 62-75 (2008). *

• Jia Y, Qi C, Zhang Z, Zhu YT, Rao SM, Zhu YJ. Peroxisome proliferator-activated receptor-binding protein null mutation results in defective mammary gland development. J. Biol. Chem. 280: 10766-10773 (2005). *

• Johansson A, Hermansson G, Ludvigsson J; ABIS Study Group. Tobacco exposure and diabetes-related autoantibodies in children: results from the ABIS study. Ann. N. Y. Acad. Sci. 1150: 197-199 (2008). *

• Johnson WG, Buyske S, Mars AE, Sreenath M, Stenroos ES, Williams TA, Stein R, Lambert GH. HLA-DR4 as a risk allele for autism acting in mothers of probands possibly during pregnancy. Arch. Pediatr. Adolesc. Med. 163: 542-546 (2009).

• Jonas MM. Hepatitis B and pregnancy: an underestimated issue. Liver Int. 29 Suppl. 1: 133-139 (2009).

• Jones DEJ. Is microchimaerism an etiological factor of PBC? Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 21-22. October 15-16 (2003). *

• Joossens M, Joossens S, Van Steen K, Pierik M, Vermeire S, Rutgeerts P, Van Ranst M. Crohn's disease and month of birth. Inflamm. Bowel Dis. 11: 597-599 (2005). *

• Jordan MA, Haywood T. Evaluation of internet websites marketing herbal weight-loss supplements to consumers. J. Altern. Complement. Med. 13: 1035-1043 (2007).

• Jorge A, Fay O, Palazzi J, Sanchez D, Tanno H, Diaz M. Determination of cholic and sulfolithocholic acids in various hepatopathies. Acta Gastroenterol. Latinoam. 12: 143-147 (1982).

• Jorge O, Jorge A, Camus G. Celiac disease associated with antiphospholipid syndrome. Rev. Esp. Enferm. Dig. 100: 102-103 (2008).

• Joutsiniemi T, Leino R, Timonen S, Pulkki K, Ekblad U. Hepatocellular enzyme glutathione S-transferase alpha and intrahepatic cholestasis of pregnancy. Acta Obstet. Gynecol. Scand. 87: 1280-1284 (2008).

• Jozwik M, Jozwik M, Bartnicki J, Jozwik M. Intrahepatic cholestasis of pregnancy: a disorder with increased fetal risks. Part II: fetal condition and medical management. Ginekol. Pol. 78: 405-410 (2007).

• Jozwik M, Jozwik M, Bartnicki J, Jozwik M.. Intrahepatic cholestasis of pregnancy: a disorder of increased fetal risks. Part I. Maternal condition. Ginekol. Pol. 78: 312-316 (2007).

• Juang CM, Hung CF, Yeh JY, Horng HC, Twu NF, Cheng MH, Wen KC, Yuan CC, Chao KC, Wu TC, Yen MS. Regulatory T cells: potential target in anticancer immunotherapy. Taiwan J. Obstet. Gynecol. 46: 215-221 (2007).

• Jung C, Driancourt C, Baussan C, Zater M, Hadchouel M, Meunier-Rotival M, Guiochon-Mantel A, Jacquemin E. Prenatal molecular diagnosis of inherited cholestatic diseases. J. Pediatr. Gastroenterol. Nutr. 44: 453-458 (2007). *

• Kaaja R. Predictors and risk factors of pre-eclampsia. Minerva Ginecol. 60: 421-429 (2008).

• Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. JAMA 294: 2751-2757 (2005). *

• Kaaja RJ, Kontula KK, Raiha A, Laatikainen T. Treatment of cholestasis of pregnancy with peroral activated charcoal. A preliminary study. Scand. J. Gastroenterol. 29: 178-181 (1994).

• Kabyemela ER, Muehlenbachs A, Fried M, Kurtis JD, Mutabingwa TK, Duffy PE. Maternal peripheral blood level of IL-10 as a marker for inflammatory placental malaria. Malar. J. 7: 26 (2008).

• Kallen B, Nilsson E, Otterblad Olausson P. Maternal use of loperamide in early pregnancy and delivery outcome. Acta Paediatr. 97: 541-545 (2008).

• Kallikourdis M, Andersen KG, Welch KA, Betz AG. Alloantigen-enhanced accumulation of CCR5+ ‘effector’ regulatory T cells in the gravid uterus. Proc. Natl. Acad. Sci. U.S.A. 104: 594-599 (2007). *

• Kallikourdis M, Betz AG. Periodic accumulation of regulatory T cells in the uterus: preparation for the implantation of a semi-allogeneic fetus? PLoS ONE 2: e382 (2007). *

• Kamen B, Karwal MA, Yankowitz J. Hemolysis and elevated transaminases imitating severe preeclampsia. Obstet. Gynecol. 113: 545-547 (2009).

• Kane MA, Folias AE, Wang C, Napoli JL. Quantitative profiling of endogenous retinoic acid in vivo and in vitro by tandem mass spectrometry. Anal. Chem. 80: 1702-1708 (2008). *

• Kane S. Inflammatory bowel disease in pregnancy. Gastroenterol. Clin. North Am. 32: 323-340 (2003). *

• Kane S, Ford J, Cohen R, Wagner C. Absence of infliximab in infant sera and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery. J. Clin. Gastroenterol. Jan 12 [Epub ahead of print] (2009).

• Kane S, Kisiel J, Shih L, Hanauer S. HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease. Am. J. Gastroenterol. 99: 1523-1526 (2004). *

• Kane S, Lemieux N. The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am. J. Gastroenterol. 100: 102-105 (2005). *

• Kane SV, Acquah LA. Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. Am. J. Gastroenterol. 104: 228-233 (2009). *

• Kaplan C. Foetal and neonatal alloimmune thrombocytopaenia. Orphanet J. Rare Dis. 1: 39 (2006). *

• Kaplan MM, Bianchi DW. Primary biliary cirrhosis: for want of an X chromosome? Lancet 363: 505-506 (2004). *

• Karger S, Fuhrer-Sakel D. Thyroid diseases and pregnancy. Med. Klin. (Munich) 104: 450-456 (2009).

• Karnik SK, Chen H, McLean GW, Heit JJ, Gu X, Zhang AY, Fontaine M, Yen MH, Kim SK. Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus. Science 318: 806-809 (2007). *

• Karoui S, Sellami MK, Laatar AB, Zitouni M, Matri S, Laadhar L, Fekih M, Boubaker J, Makni S, Filali A. Prevalence of anticardiolipin and anti-beta(2)-glycoprotein I antibodies in celiac disease. Dig. Dis. Sci. 52: 1096-1100 (2007). *

• Kartheuser A, Stangherlin P, Brandt D, Remue C, Sempoux C. Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited. Fam. Cancer 5: 241-260 (2006). *

• Kashef S, Ghaedian MM, Rajaee A, Ghaderi A. Dyslipoproteinemia during the active course of systemic lupus erythematosus in association with anti-double-stranded DNA (anti-dsDNA) antibodies. Rheumatol. Int. 27: 235-241 (2007). *

• Kasper S, Huhulescu S, Auer B, Heller I, Karner F, Wurzner R, Wagner M, Allerberger F. Epidemiology of listeriosis in Austria. Wien. Klin. Wochenschr. 121: 113-119 (2009).

• Kasperska-Zajac A, Brzoza Z, Rogala B. Sex hormones and urticaria. J. Dermatol. Sci. 52: 79-86 (2008).

• Kastrinos F. Maybe a baby? Revisiting the effect of IBD on conception, pregnancy, and newborn outcomes. Inflamm. Bowel Dis. 15: 475-477 (2009).

• Kastrinos F, Stoffel EM, Balmana J, Syngal S. Attitudes toward prenatal genetic testing in patients with familial adenomatous polyposis. Am. J. Gastroenterol. 102: 1284-1290 (2007). *

• Katz HI, Waalen J, Leach EE. Acitretin in psoriasis: an overview of adverse effects. J. Am. Acad. Dermatol. 41: S7-S12 (1999).

• Katz J, Tielsch JM, Thulasiraj RD, Coles C, Sheeladevi S, Yanik EL, Rahmathullah L. Risk factors for maternal night blindness in rural South India. Ophthalmic Epidemiol. 16: 193-97 (2009).

• Katz JA. Pregnancy and inflammatory bowel disease. Curr. Opin. Gastroenterol. 20: 328-332 (2004).

• Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am. J. Gastroenterol. 99: 2385-2392 (2004). *

• Katz JA, Pore G. Inflammatory bowel disease and pregnancy. Inflamm. Bowel Dis. 7: 146-157 (2001). *

• Kawaguchi R, Ozawa-Kondo M, Ohta-Misaki I, Suzuki-Karasaki M, Hayakawa S, Yamamoto T, Tanaka T. Prolactin (PRL) up-regulates indoleamine 2,3-dioxygenase (IDO) expression in CD14+ cells. Nihon Rinsho Meneki Gakkai Kaishi 28: 407-12 (2005).

• Kawaguchi R, Shimokawa T, Umehara N, Nunomura S, Tanaka T, Ra C. Priming of peripheral monocytes with prolactin (PRL) sensitizes IFN-gamma-mediated indoleamine 2,3-dioxygenase (IDO) expression without affecting IFN-gamma signaling. J. Reprod. Immunol. 77: 117-125 (2008).

• Keeffe EB, Davis GL. Advances in liver disease: highlights from the 54th Annual Meeting of the American Association for the Study of Liver Diseases, October 24-28, 2003. Rev. Gastroenterol. Disord. 4: 36-42 (2004). *

• Keitel V, Vogt C, Haussinger D, Kubitz R. Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy. Gastroenterology 131: 624-629 (2006). *

• Keller J, Frederking D, Layer P. The spectrum and treatment of gastrointestinal disorders during pregnancy. Nat. Clin. Pract. Gastroenterol. Hepatol. 5: 430-443 (2008).

• Kelly TL, Neaga OR, Schwahn BC, Rozen R, Trasler JM. Infertility in 5,10-methylenetetrahydrofolate reductase (MTHFR)-deficient male mice is partially alleviated by lifetime dietary betaine supplementation. Biol. Reprod. 72: 667-677 (2005). *

• Kendall-Tackett KA. A new paradigm for depression in new mothers: the central role of inflammation and how breastfeeding and anti-inflammatory treatments protect maternal mental health. Int. Breastfeed. J. 2: 6 (2007). *

• Kenngott S, Lohse P, Beuers U. Intrahepatic cholestasis in pregnancy. What to consider in jaundice and pruritus. MMW Fortschr. Med. 144: 41-44 (2002).

• Kern F Jr, Everson GT, DeMark B, McKinley C, Showalter R, Erfling W, Braverman DZ, Szczepanik-van Leeuwen P, Klein PD. Biliary lipids, bile acids, and gallbladder function in the human female. Effects of pregnancy and the ovulatory cycle. J. Clin. Invest. 68: 1229-1242 (1981). *

• Keymolen K, Goossens V, De Rycke M, Sermon K, Boelaert K, Bonduelle M, Van Steirteghem A, Liebaers I. Clinical outcome of preimplantation genetic diagnosis for cystic fibrosis: the Brussels' experience. Eur. J. Hum. Genet. 15: 752-758 (2007). *

• Khamashta MA. Systemic lupus erythematosus and pregnancy. Best Pract. Res. Clin. Rheumatol. 20: 685-694 (2006).

• Khan HA. Cyclosporin-A augments respiratory burst of whole blood phagocytes in pregnant rats. Immunopharmacol. Immunotoxicol. 29: 367-374 (2007).

• Khanna D, McMahon M, Furst DE. Safety of tumour necrosis factor-alpha antagonists. Drug Saf. 27: 307-324 (2004).

• Khosrotehrani K, Leduc M, Bachy V, Nguyen Huu S, Oster M, Abbas A, Uzan S, Aractingi S. Pregnancy allows the transfer and differentiation of fetal lymphoid progenitors into functional T and B cells in mothers. J. Immunol. 180: 889-897 (2008). *

• Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 8: 223-246 (2003). *

• Kilari AS, Mehendale SS, Dangat KD, Yadav HR, Kulakarni AV, Dhobale MV, Taralekar VS, Joshi SR. Long chain polyunsaturated fatty acids in mothers and term babies. J. Perinat. Med. Jun 3 [Epub ahead of print] (2009).

• Killie MK, Husebekk A, Kjeldsen-Kragh J, Skogen B. A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn. Haematologica 93: 870-877 (2008). *

• Kim MS, Kilgore PE, Kang JS, Kim SY, Lee DY, Kim JS, Hwang PH. Transient acquired hemophilia associated with Mycoplasma pneumoniae pneumonia. J. Korean Med. Sci. 23: 138-141 (2008). *

• Kim YK, Wassef L, Hamberger L, Piantedosi R, Palczewski K, Blaner WS, Quadro L. Retinyl ester formation by lecithin: retinol acyltransferase (LRAT) is a key regulator of retinoid homeostasis in mouse embryogenesis. J. Biol. Chem. 283: 5611-5621 (2008). *

• Kimball S, Fuleihan Gel-H, Vieth R. Vitamin D: a growing perspective. Crit. Rev. Clin. Lab. Sci. 45: 339-414 (2008).

• King AL, Ciclitira PJ. Celiac disease. Curr. Opin. Gastroenterol. 16: 102-106 (2000).

• Kirkinen P, Ylostalo P, Heikkinen J, Maentausta O. Gallbladder function and maternal bile acids in intrahepatic cholestasis of pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 18: 29-34 (1984).

• Kiss E, Tarr T, Soltesz P, Szegedi G. Critical situations in systemic lupus erythematosus. Orv. Hetil. 147: 2469-2473 (2006).

• Kitayama T, Funayama Y, Fukushima K, Shibata C, Takahashi K, Ogawa H, Ueno T, Hashimoto A, Sasaki I. Anal function during pregnancy and postpartum after ileal pouch anal anastomosis for ulcerative colitis. Surg. Today 35: 211-215 (2005).

• Klaamas K, Kodar K, Kurtenkov O. An increased level of the concanavalin A-positive IgG in the serum of patients with gastric cancer as evaluated by a lectin enzyme-linked immunosorbent assay (LELISA). Neoplasma 55: 143-150 (2008).

• Klecha AJ, Barreiro Arcos ML, Frick L, Genaro AM, Cremaschi G. Immune-endocrine interactions in autoimmune thyroid diseases. Neuroimmunomodulation 15: 68-75 (2008).

• Kling C, Steinmann J, Westphal E, Magez J, Kabelitz D. Adverse effects of intradermal allogeneic lymphocyte immunotherapy: acute reactions and role of autoimmunity. Hum. Reprod. 21: 429-435 (2006).

• Klingler M, Blaschitz A, Campoy C, Cano A, Molloy AM, Scott JM, Dohr G, Demmelmair H, Koletzko B, Desoye G. The effect of docosahexaenoic acid and folic acid supplementation on placental apoptosis and proliferation. Br. J. Nutr. 96: 182-190 (2006). *

• Klinnert MD, Nelson HS, Price MR, Adinoff AD, Leung DY, Mrazek DA. Onset and persistence of childhood asthma: predictors from infancy. Pediatrics 108: e69 (2001). *

• Klintschar M, Immel UD, Kehlen A, Schwaiger P, Mustafa T, Mannweiler S, Regauer S, Kleiber M, Hoang-Vu C. Fetal microchimerism in Hashimoto's thyroiditis: a quantitative approach. Eur. J. Endocrinol. 154: 237-241 (2006). *

• Klumb EM, de Andrade MC, Jesus NR, Campani C, Campos CF, Levy RA, Albuquerque E, Cervantes V. Primary antiphospholipid nephropathy beginning during pregnancy. Rheumatol. Int. 27: 289-293 (2007). *

• Knox TA, Olans LB. Liver disease in pregnancy. N. Engl. J. Med. 335: 569-576 (1996). *

• Knudsen VK, Hansen HS, Osterdal ML, Mikkelsen TB, Mu H, Olsen SF. Fish oil in various doses or flax oil in pregnancy and timing of spontaneous delivery: a randomised controlled trial. BJOG 113: 536-543 (2006). *

• Kobashi G, Hata A, Shido K, Ohta K, Yamada H, Kato EH, Minakami H, Tamashiro H, Fujimoto S, Kondo K. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene and preeclampsia in Japanese patients. Semin. Thromb. Hemost. 31: 346-350 (2005).

• Kobayashi S, Momohara S, Kamatani N, Okamoto H. Molecular aspects of rheumatoid arthritis: role of environmental factors. FEBS J. 275: 4456-4462 (2008). *

• Koch KL, Frissora CL. Nausea and vomiting during pregnancy. Gastroenterol. Clin. North Am. 32: 201-234, vi (2003). *

• Koike T, Bohgaki M, Amengual O, Atsumi T. Antiphospholipid antibodies: lessons from the bench. J. Autoimmun. 28: 129-133 (2007).

• Kokrdova Z. Intrahepatic cholestasis of pregnancy - four case reports. Ceska. Gynekol. 71: 184-189 (2006).

• Koletzko B, Larque E, Demmelmair H. Placental transfer of long-chain polyunsaturated fatty acids (LC-PUFA). J. Perinat. Med. 35 Suppl. 1: S5-S11 (2007).

• Koletzko B, Lien E, Agostoni C, Bohles H, Campoy C, Cetin I, Decsi T, Dudenhausen JW, Dupont C, Forsyth S, Hoesli I, Holzgreve W, Lapillonne A, Putet G, Secher NJ, Symonds M, Szajewska H, Willatts P, Uauy R. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J. Perinat. Med. 36: 5-14 (2008).

• Komlos L, Klein T, Korostishevsky M. HLA-A2 class I antigens in couples with recurrent spontaneous abortions. Int. J. Immunogenet. 34: 241-246 (2007). *

• Kondrackiene J, Beuers U, Kupcinskas L. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology 129: 894-901 (2005). *

• Kondrackiene J, Beuers U, Zalinkevicius R, Tauschel HD, Gintautas V, Kupcinskas L. Predictors of premature delivery in patients with intrahepatic cholestasis of pregnancy. World J. Gastroenterol. 13: 6226-6230 (2007). *

• Kondrackiene J, Kupcinskas L. Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems. World J. Gastroenterol. 14: 5781-5788 (2008). *

• Kondrackiene J, Kupcinskas L. Liver diseases unique to pregnancy. Medicina (Kaunas.) 44: 337-345 (2008). *

• Kongnyuy EJ, Wiysonge CS, Shey MS. A systematic review of randomized controlled trials of prenatal and postnatal vitamin A supplementation of HIV-infected women. Int. J. Gynaecol. Obstet. 104: 5-8 (2009).

• Konialis CP, Hagnefelt B, Kazamia C, Karapanou S, Pangalos C. CFTR DeltaF508 mutation detection from dried blood samples in the first trimester of pregnancy: a possible routine prenatal screening strategy for cystic fibrosis? Fetal Diagn. Ther. 22: 41-44 (2006).

• Koopmans M, Kremer Hovinga IC, Baelde HJ, Harvey MS, de Heer E, Bruijn JA, Bajema IM. Chimerism occurs in thyroid, lung, skin and lymph nodes of women with sons. J. Reprod. Immunol. 78: 68-75 (2008).

• Kopcow HD, Rosetti F, Leung Y, Allan DS, Kutok JL, Strominger JL. T cell apoptosis at the maternal-fetal interface in early human pregnancy, involvement of galectin-1. Proc. Natl. Acad. Sci. U.S.A. 105: 18472-18477 (2008). *

• Korelitz BI. Inflammatory bowel disease and pregnancy. Gastroenterol. Clin. North Am. 27: 213-224 (1998).

• Koretz RL, Avenell A, Lipman TO, Braunschweig CL, Milne AC. Does enteral nutrition affect clinical outcome? A systematic review of the randomized trials. Am. J. Gastroenterol. 102: 412-429 (2007). *

• Koretz RL, Rotblatt M. Complementary and alternative medicine in gastroenterology: the good, the bad, and the ugly. Clin. Gastroenterol. Hepatol. 2: 957-967 (2004).

• Korkut E, Kisacik B, Akcan Y, Belenli O, Bicik Z, Yucel OG. Two successive pregnancies after ursodeoxycholic acid therapy in a previously infertile woman with antimitochondrial antibody-negative primary biliary cirrhosis. Fertil. Steril. 83: 761-763 (2005). *

• Kotler DP. Human immunodeficiency virus and pregnancy. Gastroenterol. Clin. North Am. 32: 437-448, ix (2003). *

• Koutroubakis IE, Sfiridaki A, Mouzas IA, Maladaki A, Kapsoritakis A, Roussomoustakaki M, Kouroumalis EA, Manousos ON. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease. Am. J. Gastroenterol. 95: 190-194 (2000). *

• Kowalczyk AE, Kaczmarek MM, Schams D, Ziecik AJ. Effect of prostaglandin E(2) and tumor necrosis factor alpha on the VEGF-receptor system expression in cultured porcine luteal cells. Mol. Reprod. Dev. 75: 1558-1566 (2008).

• Kowdley KV. Ursodeoxycholic acid therapy in hepatobiliary disease. Am. J. Med. 108: 481-486 (2000). *

• Krauss-Etschmann S, Hartl D, Rzehak P, Heinrich J, Shadid R, Ramírez-Tortosa MD, Campoy C, Pardillo S, Schendel DJ, Decsi T, Demmelmair H, Koletzko BV; Nutraceuticals for Healthier Life Study Group. Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women. J. Allergy Clin. Immunol. 121: 464-470.e6 (2008). *

• Krediet TG, Wiertsema SP, Vossers MJ, Hoeks SB, Fleer A, Ruven HJ, Rijkers GT. Toll-like receptor 2 polymorphism is associated with preterm birth. Pediatr. Res. 62: 474-476 (2007). *

• Krikun G, Lockwood CJ, Abrahams VM, Mor G, Paidas M, Guller S. Expression of Toll-like receptors in the human decidua. Histol. Histopathol. 22: 847-854 (2007). *

• Kristof K, Madach K, Czaller I, Bajtay Z, Erdei A. Mathematical analysis of clinical data reveals a homunculus of bacterial mimotopes protecting from autoimmunity via oral tolerance in human. Mol. Immunol. 46: 1673-1678 (2009). *

• Kroser J, Srinivasan R. Drug therapy of inflammatory bowel disease in fertile women. Am. J. Gastroenterol. 101: S633-S639 (2006). *

• Kruchkovich J, Blickstein I. Autoimmune hepatitis during pregnancy. Harefuah. 142: 503-507, 567 (2003).

• Krysiak R, Marek B, Okopien B. Postpartum thyroiditis - current views on unappreciated disease. Endokrynol. Pol. 59: 180-190 (2008).

• Krysiak R, Okopien B, Herman ZS. Hypophysitis. Przegl. Lek. 64: 515-520 (2007).

• Kubicka-Trzaska A, Karska-Basta I, Kobylarz J, Romanowska-Dixon B. Pregnancy and the eye. Klin. Oczna. 110: 401-404 (2008).

• Kubitz R, Keitel V, Burdelski M, Haussinger D. Regulation of hepatobiliary transporters in chronic cholestasis. Falk Symposium 155. XIII FALK LIVER WEEK (Part I) XIX International Bile Acid Meeting. Bile Acids: Biological Actions and Clinical Relevance, October 6 - 7, 2006 Freiburg (Germany), p. 33-35 (2006). *

• Kubitz R, Keitel V, Scheuring S, Kohrer K, Haussinger D. Benign recurrent intrahepatic cholestasis associated with mutations of the bile salt export pump. J. Clin. Gastroenterol. 40: 171-175 (2006).

• Kulczycka L, Sysa-Jedrzejowska A, Robak E. Quality of life in systemic lupus erythematosus patients, with a particular description of methodology. Postepy. Hig. Med. Dosw. (Online) 61: 472-477 (2007).

• Kumar D, Tandon RK. Use of ursodeoxycholic acid in liver diseases. J. Gastroenterol. Hepatol. 16: 3-14 (2001). *

• Kurtovic J, Riordan S. Clinical aspects of primary biliary cirrhosis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 31-32. October 15-16 (2003). *

• Kus E, Kazimierak W, Swierczewski A, Kowalska-Koprek U, Karowicz-Bilinska A. The Lesniowski-Crohn disease and pregnancy: case report. Ginekol. Pol. 79: 212-217 (2008).

• Kuscu NK, Koyuncu F. Hyperemesis gravidarum: current concepts and management. Postgrad. Med. J. 78: 76-79 (2002). *

• Kyewski B, Klein L. A central role for central tolerance. Annu. Rev. Immunol. 24: 571-606 (2006). *

• Kyurkchiev D, Ivanova-Todorova E, Hayrabedyan S, Altankova I, Kyurkchiev S. Female sex steroid hormones modify some regulatory properties of monocyte-derived dendritic cells. Am. J. Reprod. Immunol. 58: 425-433 (2007). *

• Lack G. Epidemiologic risks for food allergy. J. Allergy Clin. Immunol. 121: 1331-1336 (2008).

• Lacroix-Desmazes S, Wootla B, Delignat S, Dasgupta S, Nagaraja V, Kazatchkine MD, Kaveri SV. Pathophysiology of catalytic antibodies. Immunol. Lett. 103: 3-7 (2006).

• Laifer SA, Stiller RJ, Siddiqui DS, Dunston-Boone G, Whetham JC. Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy. J. Matern. Fetal. Med. 10: 131-135 (2001).

• Lakeman P, Plass AM, Henneman L, Bezemer PD, Cornel MC, Ten Kate LP. Preconceptional ancestry-based carrier couple screening for cystic fibrosis and haemoglobinopathies: what determines the intention to participate or not and actual participation? Eur. J. Hum. Genet. Feb 18 [Epub ahead of print] (2009).

• Lam J, Polifka JE, Dohil MA. Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases. J. Am. Acad. Dermatol. 59: 295-315 (2008).

• Lam P, Pearson CL, Soroka C, Xu S, Mennone A, Boyer JL. The level of plasma membrane expression in progressive and benign mutations of the bile salt export pump (BSEP/ABCB11) correlate with severity of cholestatic diseases. Am. J. Physiol. Cell. Physiol. 293: C1709-C1716 (2007). *

• Lambert N, Nelson JL. Microchimerism in autoimmune disease: more questions than answers? Autoimmun. Rev. 2: 133-139 (2003).

• Lambert NC, Evans PC, Hashizumi TL, Maloney S, Gooley T, Furst DE, Nelson JL. Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity. J. Immunol. 164: 5545-5548 (2000). *

• Lambert NC, Pang JM, Erickson TD, Stevens AM, Yan Z, Furst DE, Nelson JL. Male microchimerism in women with systemic sclerosis and healthy women who never gave birth to a son. Ann. Rheum. Dis. 64: 845-848 (2005). *

• Lamers CB, Griffioen G, van Hogezand RA, Veenendaal RA. Azathioprine: an update on clinical efficacy and safety in inflammatory bowel disease. Scand. J. Gastroenterol. Suppl. 230: 111-115 (1999). *

• Lammert F, Marschall HU, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J. Hepatol. 33: 1012-1021 (2000). *

• Lammert F, Marschall HU, Matern S. Intrahepatic cholestasis of pregnancy. Curr. Treat. Options Gastroenterol. 6: 123-132 (2003).

• Lammert F, Reichel C. Intrahepatic cholestasis of pregnancy: new molecular mechanisms and clinical pathways. Dtsch. Med. Wochenschr. 132: 2378-2382 (2007).

• Lan Y, Liu J, Cheng H, Zou SL, Gan XL. Expressions of SHP and CYP7A1 in pregnant rats with intrahepatic cholestasis. Zhonghua Gan Zang Bing Za Zhi 16: 453-456 (2008).

• Landon MB, Soloway RD, Freedman LJ, Gabbe SG. Primary sclerosing cholangitis and pregnancy. Obstet. Gynecol. 69: 457-460 (1987).

• Lapaire O, Hosli I, Zanetti-Daellenbach R, Huang D, Jaeggi C, Gatfield-Mergenthaler S, Hahn S, Holzgreve W. Impact of fetal-maternal microchimerism on women's health - a review. J. Matern. Fetal Neonatal Med. 20: 1-5 (2007).

• Lappalainen M, Hedman K. Serodiagnosis of toxoplasmosis. The impact of measurement of IgG avidity. Ann. Ist. Super Sanita. 40: 81-88 (2004).

• Lappas M, Rice GE. Transcriptional regulation of the processes of human labour and delivery. Placenta 30 Suppl. A: S90-S95 (2009).

• Lappas M, Rice GE. Transcriptional regulation of the processes of human labour and delivery. Placenta Nov 14 [Epub ahead of print] (2008).

• Lara LF, Levy MJ. Idiopathic recurrent acute pancreatitis. MedGenMed. 6: 10 (2004). *

• Larkin TC, Fingleton TA, Mccusker M, Cassidy M, Gunzer G, Lepp CA, Gamboa E. A new Olympus assay for the determination of ceruloplasmin. Clin. Lab. 50: 193-203 (2004).

• Larocca L, Ramhorst R, Roca V, Calafat M, Aisemberg J, Franchi A, Perez Leiros C. Neuroimmune-endocrine interactions during early pregnancy in an autoimmune context: focus on macrophage activation. Neuroimmunomodulation 15: 84-90 (2008).

• Larque E, Krauss-Etschmann S, Campoy C, Hartl D, Linde J, Klingler M, Demmelmair H, Cano A, Gil A, Bondy B, Koletzko B. Docosahexaenoic acid supply in pregnancy affects placental expression of fatty acid transport proteins. Am. J. Clin. Nutr. 84: 853-861 (2006). *

• Larraín de la CD, Abarzua CF, de Jourdan HF, Merino OP, Belmar JC, García CP. Listeria monocytogenes infection in pregnancy: experience of Pontificia Universidad Católica de Chile University Hospital. Rev. Chilena Infectol. 25: 336-341 (2008).

• Larson DW, Pemberton JH. Current concepts and controversies in surgery for IBD. Gastroenterology 126: 1611-1619 (2004). *

• Lartey A. Maternal and child nutrition in Sub-Saharan Africa: challenges and interventions. Proc. Nutr. Soc. 67: 105-108 (2008). *

• Lashner BA. Use with caution: 6MP in pregnancy. Inflamm. Bowel Dis. 9: 277 (2003). *

• Latini G, Del Vecchio A, Massaro M, Verrotti A, DE Felice C. In utero exposure to phthalates and fetal development. Curr. Med. Chem. 13: 2527-2534 (2006).

• Laurberg P, Bournaud C, Karmisholt J, Orgiazzi J. Management of Graves hyperthyroidism in pregnancy. Focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Eur. J. Endocrinol. 160: 1-8 (2009).

• Lausman AY, Al-Yaseen E, Sam D, Nitsch R, Barrett JF, Chan WS. Intrahepatic cholestasis of pregnancy in women with a multiple pregnancy: an analysis of risks and pregnancy outcomes. J. Obstet. Gynaecol. Can. 30: 1008-1013 (2008).

• Lawrance AK, Deng L, Rozen R. Methylenetetrahydrofolate reductase deficiency and low dietary folate reduce tumorigenesis in Apcmin/+ mice. Gut 58: 805-811 (2009).

• Lazarus JH, Premawardhana LD. BEST PRACTICE NO 184. Screening for thyroid disease in pregnancy. J. Clin. Pathol. 58: 449-452 (2005). *

• Le AV, Broide DH. Indoleamine-2,3-dioxygenase modulation of allergic immune responses. Curr. Allergy Asthma Rep. 6: 27-31 (2006).

• Le Guern V, Pannier E, Goffinet F. Systemic lupus erythematosus and pregnancy. Presse. Med. 37: 1627-1635 (2008).

• Le NT, Xue M, Castelnoble LA, Jackson CJ. The dual personalities of matrix metalloproteinases in inflammation. Front. Biosci. 12: 1475-1487 (2007).

• Le Rond S, Gonzalez A, Gonzalez AS, Carosella ED, Rouas-Freiss N. Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways. Immunology 116: 297-307 (2005). *

• Le Thi Huong D, Wechsler B, Piette JC. Pregnancy and systemic lupus erythematosus. Rev. Med. Interne. 29: 725-730 (2008).

• Leanos-Miranda A, Cardenas-Mondragon G, Ulloa-Aguirre A, Isordia-Salas I, Parra A, Ramírez-Peredo J. Anti-prolactin autoantibodies in pregnant women with systemic lupus erythematosus: maternal and fetal outcome. Lupus 16: 342-349 (2007).

• Lee LA. The clinical spectrum of neonatal lupus. Arch. Dermatol. Res. 301: 107-110 (2009). *

• Lee NM, Brady CW. Liver disease in pregnancy. World J. Gastroenterol. 15: 897-906 (2009). *

• Lee RH, Goodwin TM, Greenspoon J, Incerpi M. The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. J. Perinatol. 26: 527-532 (2006).

• Lee RH, Incerpi MH, Miller DA, Pathak B, Goodwin TM. Sudden fetal death in intrahepatic cholestasis of pregnancy. Obstet. Gynecol. 113: 528-531 (2009).

• Lee RH, Kwok KM, Ingles S, Wilson ML, Mullin P, Incerpi M, Pathak B, Goodwin TM. Pregnancy outcomes during an era of aggressive management for intrahepatic cholestasis of pregnancy. Am. J. Perinatol. 25: 341-345 (2008).

• Lee V, Ahmed F, Wada S, Ahmed T, Ahmed AS, Parvin Banu C, Akhter N. Extent of vitamin A deficiency among rural pregnant women in Bangladesh. Public Health Nutr. 11: 1326-1331 (2008).

• Lee YL, Ng HP, Lau KS, Liu WM, O WS, Yeung WS, Kung AW. Increased fetal abortion rate in autoimmune thyroid disease is related to circulating TPO autoantibodies in an autoimmune thyroiditis animal model. Fertil. Steril. 91: S2104-S2109 (2009).

• Leevy CB, Koneru B, Klein KM. Recurrent familial prolonged intrahepatic cholestasis of pregnancy associated with chronic liver disease. Gastroenterology 113: 966-972 (1997). *

• Lefkowitch JH. Hepatobiliary pathology. Curr. Opin. Gastroenterol. 23: 221-231 (2007).

• Leinders-Zufall T, Brennan P, Widmayer P, S PC, Maul-Pavicic A, Jager M, Li XH, Breer H, Zufall F, Boehm T. MHC class I peptides as chemosensory signals in the vomeronasal organ. Science 306: 1033-1037 (2004). *

• Lemann M. Which immunomodulator for Crohn's disease? Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 74. May 7-8 (2004). *

• Lemoine M, Revaux A, Francoz C, Ducarme G, Brechignac S, Jacquemin E, Uzan M, Ganne-Carrie N. Albumin liver dialysis as pregnancy-saving procedure in cholestatic liver disease and intractable pruritus. World J. Gastroenterol. 14: 6572-6574 (2008). *

• Lengyel G, Feher J. Intrahepatic cholestasis of pregnancy. Orv. Hetil. 145: 2103-2105 (2004).

• Lengyel G, Feher R, Gardo S, Feher J. Ursodeoxycholic acid treatment in intrahepatic cholestasis of pregnancy. A case report. Orv. Hetil. 143: 2885-2888 (2002).

• Lepisto A, Sarna S, Tiitinen A, Jarvinen HJ. Female fertility and childbirth after ileal pouch-anal anastomosis for ulcerative colitis. Br. J. Surg. 94: 478-482 (2007). *

• Lernmark B, Lynch K, Lernmark AK. Cord blood islet autoantibodies are related to stress in the mother during pregnancy. Ann. N. Y. Acad. Sci. 1079: 345-349 (2006). *

• Leslie KK, Reznikov L, Simon FR, Fennessey PV, Reyes H, Ribalta J. Estrogens in intrahepatic cholestasis of pregnancy. Obstet. Gynecol. 95: 372-376 (2000).

• Leuschner U. Combination therapy in primary biliary cirrhosis and overlap syndromes. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 52-53. October 15-16 (2003). *

• Leuschner U. Novel approach to the treatment of primary biliary cirrhosis (PBC). Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 79-80 (2004). *

• Levant B, Ozias MK, Carlson SE. Specific brain regions of female rats are differentially depleted of docosahexaenoic acid by reproductive activity and an (n-3) fatty acid-deficient diet. J. Nutr. 137: 130-134 (2007). *

• Levine AM, Vigen C, Gravink J, Mack W, Watts CH, Liebman HA. Progressive prothrombotic state in women with advancing HIV disease. J. Acquir. Immune Defic. Syndr. 42: 572-577 (2006).

• Levy Y, Almog O, Gorshtein A, Shoenfeld Y. The environment and antiphospholipid syndrome. Lupus 15: 784-790 (2006).

• Li LQ, Qi HB. Expression of aquaporin-8 in the hepatocytes of pregnant rats with intrahepatic cholestasis. Zhonghua Fu Chan Ke Za Zhi 43: 128-131 (2008).

• Li N, Shigihara T, Tzioufas AG, Notkins AL, Yoon JW, Jun HS. Human chorionic gonadotropin prevents Sjogren's syndrome-like exocrinopathy in mice. Arthritis Rheum. 56: 2211-2215 (2007). *

• Liaskos C, Rigopoulou E, Zachou K, Georgiadou S, Gatselis N, Papamihali R, Dalekos GN. Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis. J. Autoimmun. 24: 251-260 (2005).

• Liberek A, Gora-Gebka M, Bako W, Sikorska-Wisniewska G, Szlagatys-Sidorkiewicz A, Krolak M, Marek A, Jankowska A, Korzon M, Czauderna P. Congenital extrahepatic biliary atresia as a cause of cholestasis in newborns and infants. Med. Wieku. Rozwoj. X: 395-406 (2006).

• Lieberman DA, Keeffe EB, Stenzel P. Severe and prolonged oral contraceptive jaundice. J. Clin. Gastroenterol. 6: 145-148 (1984).

• Ligumsky M, Badaan S, Lewis H, Meirow D. Effects of 6-mercaptopurine treatment on sperm production and reproductive performance: a study in male mice. Scand. J. Gastroenterol. 40: 444-449 (2005). *

• Liljander M, Sallstrom MA, Andersson S, Andersson A, Holmdahl R, Mattsson R. Identification of collagen-induced arthritis loci in aged multiparous female mice. Arthritis Res. Ther. 8: R45 (2006). *

• Lillycrop KA, Phillips ES, Jackson AA, Hanson MA, Burdge GC. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J. Nutr. 135: 1382-1386 (2005). *

• Lim S, Elston MS, Swarbrick MJ, Conaglen JV. Lymphocytic hypophysitis with associated thyroiditis in a man with aseptic meningitis. Pituitary Apr 10 [Epub ahead of print] (2008).

• Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid antibody syndrome: a systematic review. JAMA 295: 1050-1057 (2006). *

• Lin L, Zhang LJ. Role of CD4(+) CD25(high) regulatory T cells in the pathogenesis of intrahepatic cholestasis of pregnancy. Zhonghua Fu Chan Ke Za Zhi 43: 900-903 (2008).

• Lin YL, Liang YC, Chiang BL. Placental growth factor down-regulates type 1 T helper immune response by modulating the function of dendritic cells. J. Leukoc. Biol. 82: 1473-1480 (2007). *

• Lindberg MC. Hepatobiliary complications of oral contraceptives. J. Gen. Intern. Med. 7: 199-209 (1992).

• Ling B, Yao FQ, Zhou Y, Chen ZZ, Shen GD, Zhu YY. Cell-mediated immunity imbalance in patients with intrahepatic cholestasis of pregnancy. Cell. Mol. Immunol. 4: 71-75 (2007). *

• Link J. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis. Acta Neurol. Scand. Suppl. 158: 1-58 (1994).

• Litou H, Anastasiou E, Thalassinou L, Sarika HL, Philippou G, Alevizaki M. Increased prevalence of VNTR III of the insulin gene in women with gestational diabetes mellitus (GDM). Diabetes Res. Clin. Pract. 76: 223-228 (2007).

• Liu J, Lan Y, Zou SL. Advances in diagnosis and treatment of intrahepatic cholestasis of pregnancy. Zhonghua Gan Zang Bing Za Zhi 16: 580-581 (2008).

• Liu Y, Qiao F, Liu H, Liu D. Ursodeoxycholic acid in the treatment of intraheptic cholestasis of pregnancy. J. Huazhong Univ. Sci. Technolog. Med. Sci. 26: 350-352 (2006).

• Liu YE, Pu W, Wang J, Kang JX, Shi YE. Activation of Stat5 and induction of a pregnancy-like mammary gland differentiation by eicosapentaenoic and docosapentaenoic omega-3 fatty acids. FEBS J. 274: 3351-3362 (2007). *

• Liu YS, Zhao SY, Ji JJ, Zhai ZM, Tong XH, Luo LH, Luan HB. The measurement of proportion and function of regulatory T cells in unexplained recurrent spontaneous abortion. Zhonghua Fu Chan Ke Za Zhi 42: 176-179 (2007).

• Lob S, Ebner S, Wagner S, Weinreich J, Schafer R, Konigsrainer A. Are indoleamine-2,3-dioxygenase producing human dendritic cells a tool for suppression of allogeneic T-cell responses? Transplantation 83: 468-473 (2007).

• Locatelli M, Buzzetti R, Galgani A, Montemari AL, Khazrai M, Petrone A, Visalli N, Meschi F, Minicucci L, Lorini R, Cristaldi A, Valorani MG, Bottazzo GF, Pozzilli P; on behalf of the DIABFIN Study Group. Length of gestation and gender are associated with HLA genotypes at risk for type 1 diabetes (Italian DIABFIN 3). Diabet. Med. 24: 916-919 (2007). *

• Lockshin MD. Sex differences in autoimmune disease. Lupus 15: 753-756 (2006).

• Lok CA, Van Der Post JA, Sargent IL, Hau CM, Sturk A, Boer K, Nieuwland R. Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia. Hypertens. Pregnancy 27: 344-360 (2008).

• Lopez C, Comabella M, Tintore M, Sastre-Garriga J, Montalban X. Variations in chemokine receptor and cytokine expression during pregnancy in multiple sclerosis patients. Mult. Scler. 12: 421-427 (2006).

• Lopez D, McLean MP. Estrogen regulation of the scavenger receptor class B gene: anti-atherogenic or steroidogenic, is there a priority? Mol. Cell. Endocrinol. 247: 22-33 (2006).

• Lopez-Mendez E, Avila-Escobedo L. Pregnancy and portal hypertension a pathology view of physiologic changes. Ann. Hepatol. 5: 219-223 (2006). *

• Lorente S, Montoro MA. Cholestasis of pregnancy. Gastroenterol. Hepatol. 30: 541-548 (2007).

• Lovisetto P, Raviolo P. Intrahepatic cholestasis due to biochemical errors of bile acids. II. Clinical and therapeutic aspects. Minerva Med. 85: 639-646 (1994).

• Lucangioli SE, Castano G, Contin MD, Tripodi VP. Lithocholic acid as a biomarker of intrahepatic cholestasis of pregnancy during ursodeoxycholic acid treatment. Ann. Clin. Biochem. 46: 44-49 (2009).

• Lucas RM, Ponsonby AL, Pasco JA, Morley R. Future health implications of prenatal and early-life vitamin D status. Nutr. Rev. 66: 710-720 (2008).

• Lucena JF, Herrero JI, Quiroga J, Sangro B, Garcia-Foncillas J, Zabalegui N, Sola J, Herraiz M, Medina JF, Prieto J. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis. Gastroenterology 124: 1037-1042 (2003). *

• Ludvigsson JF, Ludvigsson J. Parental smoking and risk of coeliac disease in offspring. Scand. J. Gastroenterol. 40: 336-342 (2005). *

• Ludvigsson JF, Ludvigsson J. Coeliac disease in the father affects the newborn. Gut 49: 169-175 (2001). *

• Ludvigsson JF, Montgomery SM, Ekbom A. Coeliac disease in the father and risk of adverse pregnancy outcome: a population-based cohort study. Scand. J. Gastroenterol. 41: 178-185 (2006). *

• Ludvigsson JF, Montgomery SM, Ekbom A. Smoking and celiac disease: a population-based cohort study. Clin. Gastroenterol. Hepatol. 3: 869-874 (2005).

• Ludvigsson JF, Wahlstrom J, Grunewald J, Ekbom A, Montgomery S. Coeliac disease and risk of tuberculosis: a population-based cohort study. Thorax 62: 23-28 (2007). *

• Lynch KF, Lernmark B, Merlo J, Cilio CM, Ivarsson SA, Lernmark A. Cord blood islet autoantibodies and seasonal association with the type 1 diabetes high-risk genotype. J. Perinatol. 28: 211-217 (2008).

• Macias RI, Jimenez S, Serrano MA, Monte MJ, Marin JJ. Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver. Life Sci. 79: 1014-1019 (2006). *

• Macias RI, Serrano MA, Monte MJ, Jimenez S, Hernandez B, Marin JJ. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis. J. Pharmacol. Exp. Ther. 312: 751-758 (2005). *

• Magee TR, Han G, Cherian B, Khorram O, Ross MG, Desai M. Down-regulation of transcription factor peroxisome proliferator-activated receptor in programmed hepatic lipid dysregulation and inflammation in intrauterine growth-restricted offspring. Am. J. Obstet. Gynecol. 199: 271.e1-e5 (2008).

• Magnusardottir AR, Steingrimsdottir L, Thorgeirsdottir H, Hauksson A, Skuladottir GV. Red blood cell n-3 polyunsaturated fatty acids in first trimester of pregnancy are inversely associated with placental weight. Acta Obstet. Gynecol. Scand. 88: 91-97 (2009).

• Mahadevan U. Fertility and pregnancy in the patient with inflammatory bowel disease. Gut 55: 1198-1206 (2006). *

• Mahadevan U, Kane S. American Gastroenterological Association Institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology 131: 283-311 (2006). *

• Mahadevan U, Kane S. American Gastroenterological Association Institute medical position statement on the use of gastrointestinal medications in pregnancy. Gastroenterology 131: 278-282 (2006). *

• Mahadevan U, Kane S, Sandborn WJ, Cohen RD, Hanson K, Terdiman JP, Binion DG. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment. Pharmacol. Ther. 21: 733-738 (2005). *

• Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology 133: 1106-1112 (2007). *

• Majorczyk E, Luszczek W, Nowak I, Pawlik A, Wisniewski A, Jasek M, Kusnierczyk P. Distribution of killer cell immunoglobulin-like receptor genes in Poles. Int. J. Immunogenet. 35: 405-407 (2008). *

• Makrides M. Is there a dietary requirement for DHA in pregnancy? Prostaglandins Leukot. Essent. Fatty Acids Jun 3 [Epub ahead of print] (2009).

• Malangoni MA. Gastrointestinal surgery and pregnancy. Gastroenterol. Clin. North Am. 32: 181-200 (2003). *

• Malgarinos G, Gikas A, Delicha E, Stamataki A, Georgopoulos F, Papadimitriou A, Stanciu C, Triantafillidis JK. Pregnancy and inflammatory bowel disease: a prospective case-control study. Rev. Med. Chir. Soc. Med. Nat. Iasi. 111: 613-619 (2007).

• Maloney S, Smith A, Furst DE, Myerson D, Rupert K, Evans PC, Nelson JL. Microchimerism of maternal origin persists into adult life. J. Clin. Invest. 104: 41-47 (1999). *

• Malouf M, Grimley EJ, Areosa SA. Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst. Rev. 4: CD004514 (2003). *

• Mameli G, Astone V, Khalili K, Serra C, Sawaya BE, Dolei A. Regulation of the syncytin-1 promoter in human astrocytes by multiple sclerosis-related cytokines. Virology 362: 120-130 (2007).

• Manconi M, Hutchins W, Feroah TR, Zucconi M, Ferini-Strambi L. On the pathway of an animal model for restless legs syndrome. Neurol. Sci. 28 Suppl. 1: S53-S60 (2007). *

• Manthorpe R, Svensson A, Wirestrand LE. Late neonatal lupus erythematosus onset in a child born of a mother with primary Sjogren's syndrome. Ann. Rheum. Dis. 63: 1496-1497 (2004). *

• Mao CT, Li TY, Qu P, Zhao Y, Wang R, Liu YX. Effects of early intervention on learning and memory in young rats of marginal vitamin A deficiency and it's mechanism. Zhonghua Er Ke Za Zhi 44: 15-20 (2006).

• Marai I, Zandman-Goddard G, Shoenfeld Y. The systemic nature of the antiphospholipid syndrome. Scand. J. Rheumatol. 33: 365-372 (2004). *

• Marangell LB, Martinez JM, Zboyan HA, Chong H, Puryear LJ. Omega-3 fatty acids for the prevention of postpartum depression: negative data from a preliminary, open-label pilot study. Depress. Anxiety 19: 20-23 (2004).

• Marin JJ, Macias RI, Briz O, Perez MJ, Serrano MA. Molecular bases of the excretion of fetal bile acids and pigments through the fetal liver-placenta-maternal liver pathway. Ann. Hepatol. 4: 70-76 (2005).

• Marinaccio M, Pinto V, Sambati GS, Papandrea D, De Veteris M. Uncomplicated pregnancy in patients with unrecognized primary biliary cirrhosis. Minerva Ginecol. 44: 273-276 (1992).

• Marker-Hermann E, Bauer H, Gromnica-Ihle E. Rheumatic diseases in pregnancy. Dtsch. Med. Wochenschr. 133: 2410-2414 (2008).

• Markowitz JF. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease. Rev. Gastroenterol. Disord. 3 Suppl. 1: S23-S29 (2003). *

• Marpeau L, Benifla JL, Chazouilleres O, Larue L, Pigne A, Poupon R, Barrat J. Primary biliary cirrhosis and pregnancy. Apropos of a clinical case. Review of the literature. J. Gynecol. Obstet. Biol. Reprod. (Paris) 20: 805-807 (1991).

• Marri SR, Ahn C, Buchman AL. Voluntary childlessness is increased in women with inflammatory bowel disease. Inflamm. Bowel Dis. 13: 591-599 (2007). *

• Marshall AL, Chetwynd A, Morris JA, Placzek M, Smith C, Olabi A, Thistlethwaite D. Type 1 diabetes mellitus in childhood: a matched case control study in Lancashire and Cumbria, UK. Diabet. Med. 21: 1035-1040 (2004).

• Marteau P. IBD and pregnancy. Inflamm. Bowel Dis. 14: S43-S44 (2008).

• Marteau P, Seksik P, Couve S, Jian R. Safety of high doses of mesalazine during pregnancy. Am. J. Gastroenterol. 100: 1897-1898 (2005). *

• Martí-Carvajal AJ, Pena-Marti GE, Comunian-Carrasco G, Marti-Pena AJ. Interventions for treating painful sickle cell crisis during pregnancy. Cochrane Database Syst. Rev. 1: CD006786 (2009).

• Martinelli I. Thromboembolism in women. Semin. Thromb. Hemost. 32: 709-715 (2006).

• Martinelli P, Troncone R, Paparo F, Torre P, Trapanese E, Fasano C, Lamberti A, Budillon G, Nardone G, Greco L. Coeliac disease and unfavourable outcome of pregnancy. Gut 46: 332-335 (2000). *

• Martinez-Frias ML, Perez B, Desviat LR, Castro M, Leal F, Rodriguez L, Mansilla E, Martinez-Fernandez ML, Bermejo E, Rodriguez-Pinilla E, Prieto D, Ugarte M. Maternal polymorphisms 677C-T and 1298A-C of MTHFR, and 66A-G MTRR genes: is there any relationship between polymorphisms of the folate pathway, maternal homocysteine levels, and the risk for having a child with Down syndrome? Am. J. Med. Genet. A. 140: 987-997 (2006).

• Mas AE, Petitbarat M, Dubanchet S, Fay S, Ledee N, Chaouat G. Immune regulation at the interface during early steps of murine implantation: involvement of two new cytokines of the IL-12 family (IL-23 and IL-27) and of TWEAK. Am. J. Reprod. Immunol. 59: 323-38 (2008). *

• Masilamani M, Rajasekaran N, Singh A, Low HZ, Albus K, Anders S, Behne F, Eiermann P, Konig K, Mindnich C, Ribarska T, Illges H. Systemic reduction of soluble complement receptor II/CD21 during pregnancy to levels reminiscent of autoimmune disease. Rheumatol. Int. 28: 1137-1141 (2008). *

• Masmoudi A, Abdelmaksoud W, Ghorbel S, Amouri H, Mseddi M, Bouassida S, Zahaf A, Guermazi M, Boudaya S, Turki H. Impetigo herpetiformis (two cases). J. Gynecol. Obstet. Biol. Reprod. (Paris) 37: 804-807 (2008).

• Massie J, Forbes R, Dusart D, Bankier A, Delatycki MB. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis. J. Paediatr. Child. Health 43: 721-723 (2007).

• Masuyama H, Hiramatsu Y, Mizutani Y, Inoshita H, Kudo T. The expression of pregnane X receptor and its target gene, cytochrome P450 3A1, in perinatal mouse. Mol. Cell. Endocrinol. 172: 47-56 (2001).

• Matalka KZ, Ali DA. Stress-induced versus preovulatory and pregnancy hormonal levels in modulating cytokine production following whole blood stimulation. Neuroimmunomodulation 12: 366-374 (2005).

• Matejuk A, Afentoulis M. Association of CD45(dim)VLA-4 (+) cells with the NKT cell lineage and their selective expression of IL-13, IP-15, and CCR3 transcripts. Arch. Immunol. Ther. Exp. (Warsz.) 54: 183-191 (2006).

• Mathias A, Wax JR, Pinette MG, Cartin A, Blackstone J. Progressive familial intrahepatic cholestasis complicating pregnancy. J. Matern. Fetal Neonatal Med. Jun 1 [Epub ahead of print] (2009).

• Mathieu C, Badenhoop K. Vitamin D and type 1 diabetes mellitus: state of the art. Trends Endocrinol. Metab. 16: 261-266 (2005). *

• Matsubara K, Uchida N, Matsubara Y, Hyodo S, Ito M. Detection of fetal cells in the maternal kidney during gestation in the mouse. Tohoku J. Exp. Med. 218: 107-113 (2009). *

• Mattes E, McCarthy S, Gong G, van Eekelen JA, Dunstan J, Foster J, Prescott SL. Maternal mood scores in mid-pregnancy are related to aspects of neonatal immune function. Brain Behav. Immun. 23: 380-388 (2009).

• Mawson AR. On the association between low resting heart rate and chronic aggression: retinoid toxicity hypothesis. Prog. Neuropsychopharmacol. Biol. Psychiatry 33: 205-213 (2009).

• Mawson AR. Are rheumatoid arthritis and systemic lupus erythematosus inversely related diseases? Med. Hypotheses 18: 377-386 (1985).

• Mazhar SB, Rahim F, Furukh T. Fetomaternal outcome in triplet pregnancy. J. Coll. Physicians Surg. Pak. 18: 217-221 (2008).

• Mazzella G, Rizzo N, Azzaroli F, Simoni P, Bovicelli L, Miracolo A, Simonazzi G, Colecchia A, Nigro G, Mwangemi C, Festi D, Roda E. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers. Hepatology 33: 504-508 (2001). *

• McClain MA, Gatson NN, Powell ND, Papenfuss TL, Gienapp IE, Song F, Shawler TM, Kithcart A, Whitacre CC. Pregnancy suppresses experimental autoimmune encephalomyelitis through immunoregulatory cytokine production. J. Immunol. 179: 8146-8152 (2007). *

• McClure SL, Valentine J, Gordon KB. Comparative tolerability of systemic treatments for plaque-type psoriasis. Drug Saf. 25: 913-927 (2002).

• McCombe PA. Recombinant EPF/chaperonin 10 promotes the survival of O4-positive pro-oligodendrocytes prepared from neonatal rat brain. Cell Stress Chaperones 13: 467-474 (2008).

• McDonald JA. Cholestasis of pregnancy. J. Gastroenterol. Hepatol. 14: 515-518 (1999). *

• McLean M, Chipps D, Cheung NW. Mother to child transmission of diabetes mellitus: does gestational diabetes program type 2 diabetes in the next generation? Diabet. Med. 23: 1213-1215 (2006). *

• McLeod RS. Ileal pouch anal anastomosis: pregnancy-before, during and after. J. Gastrointest. Surg. 12: 2150-2152 (2008).

• McMahon MA, Keogan M, O'Connell P, Kearns G. The prevalence of antiphospholipid antibody syndrome among systemic lupus erythematosus patients. Ir. Med. J. 100: 296-298 (2006).

• Mecacci F, Pieralli A, Bianchi B, Paidas MJ. The impact of autoimmune disorders and adverse pregnancy outcome. Semin. Perinatol. 31: 223-226 (2007).

• Medenica L, Vesic S, Sretenovic-Vukicevic J. Specific dermatoses of pregnancy - new classification and differential diagnosis. Med. Pregl. 61: 586-590 (2008).

• Megia A, Gallart L, Fernandez-Real JM, Vendrell J, Simon I, Gutierrez C, Richart C. Mannose-binding lectin gene polymorphisms are associated with gestational diabetes mellitus. J. Clin. Endocrinol. Metab. 89: 5081-5087 (2004). *

• Meier Y, Zodan T, Lang C, Zimmermann R, Kullak-Ublick GA, Meier PJ, Stieger B, Pauli-Magnus C. Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump. World J. Gastroenterol. 14: 38-45 (2008). *

• Mejia-Romero R, Garcia-Carrasco M, Galarza-Maldonado C, Santos P, Mendoza-Pinto C, Escarcega RO, Salinas-Saldivar S, Soto-Vega E, Lopez-Colombo A, Cervera R. Primary antiphospholipid syndrome in Latin American mestizo patients: clinical and immunologic characteristics and comparison with European patients. Clin. Rheumatol. 27: 891-897 (2008). *

• Mela M, Mancuso A, Burroughs AK. Review article: pruritus in cholestatic and other liver diseases. Aliment. Pharmacol. Ther. 17: 857-870 (2003). *

• Melanitou E. Functional genomics in early autoimmunity. Ann. N. Y. Acad. Sci. 1050: 64-72 (2005). *

• Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4: 762-774 (2004). *

• Melnik BC. Milk - the promoter of chronic Western diseases. Med. Hypotheses 72: 631-639 (2009).

• Melo BC, Amorim MM, Katz L, Coutinho I, Veríssimo G. Epidemiological profile and postpartum outcome in severe preeclampsia. Rev. Assoc. Med. Bras. 55: 175-180 (2009).

• Mendez-Sanchez N, Chavez-Tapia NC, Uribe M. Pregnancy and gallbladder disease. Ann. Hepatol. 5: 227-230 (2006). *

• Menees S, Elta G. Endoscopic retrograde cholangiopancreatography during pregnancy. Gastrointest. Endosc. Clin. N. Am. 16: 41-57 (2006).

• Meneses F, Ney JG, Torres AG, Trugo NM. Erythrocyte membrane and plasma non-esterified n-3 and n-6 polyunsaturated fatty acids of pregnant and non-pregnant Brazilian adolescents. Prostaglandins Leukot. Essent. Fatty Acids 80: 137-142 (2009). *

• Menezes EV, Yakoob MY, Soomro T, Haws RA, Darmstadt GL, Bhutta ZA. Reducing stillbirths: prevention and management of medical disorders and infections during pregnancy. BMC Pregnancy Childbirth 9 Suppl. 1: S4 (2009). *

• Meng LJ, Reyes H, Axelson M, Palma J, Hernandez I, Ribalta J, Sjovall J. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy. Hepatology 26: 1573-1579 (1997). *

• Meng LJ, Reyes H, Palma J, Hernandez I, Ribalta J, Sjovall J. Effects of ursodeoxycholic acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancy. J. Hepatol. 27: 1029-1040 (1997). *

• Meng LJ, Reyes H, Palma J, Hernandez I, Ribalta J, Sjovall J. Profiles of bile acids and progesterone metabolites in the urine and serum of women with intrahepatic cholestasis of pregnancy. J. Hepatol. 27: 346-357 (1997). *

• Merabishvili N, Kamladze S, Sulaberidze G. Peculiarities of lipid metabolism during pregnancy. Georgian Med. News 138: 86-89 (2006).

• Merabishvili N, Kamladze S, Sulaberidze G. Peculiarities of lipid metabolism in pregnant patients with chronic cholecystitis. Georgian Med. News 141: 14-17 (2006).

• Merlino G, Valente M, Serafini A, Gigli GL. Restless legs syndrome: diagnosis, epidemiology, classification and consequences. Neurol. Sci. 28 Suppl. 1: S37-S46 (2007).

• Merrill JT, Asherson RA. Catastrophic antiphospholipid syndrome. Nat. Clin. Pract. Rheumatol. 2: 81-89 (2006). *

• Mert A, Kumbasar H, Ozaras R, Erten S, Tasli L, Tabak F, Ozturk R. Erythema nodosum: an evaluation of 100 cases. Clin. Exp. Rheumatol. 25: 563-570 (2007).

• Meurer M. Pemphigus diseases in children and adolescents. Hautarzt. 60: 208-216 (2009).

• Mezzesimi A, Florio P, Reis FM, D'Aniello G, Sabatini L, Razzi S, Fineschi D, Petraglia F. The detection of anti-beta2-glycoprotein I antibodies is associated with increased risk of pregnancy loss in women with threatened abortion in the first trimester. Eur. J. Obstet. Gynecol. Reprod. Biol. 133: 164-168 (2007).

• Mialdea M, Sangle SR, D'Cruz DP. Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis. J. Autoimmune Dis. 6: 3 (2009). *

• Michaels A, Levy C. The medical management of primary sclerosing cholangitis. Medscape J. Med. 10: 61 (2008). *

• Middleton D, Curran M, Maxwell L. Natural killer cells and their receptors. Transpl. Immunol. 10: 147-164 (2002).

• Miesbach W, Scharrer I. The antiphospholipid syndrome. Dtsch. Med. Wochenschr. 129: 2547-2552 (2004).

• Mighty HE, Atkins D. Pregnancy and inflammatory bowel disease: current management. J. Assoc. Acad. Minor Phys. 11: 38-43 (2000).

• Mikhail MA, M'hamdi H, Welsh J, Levicar N, Marley SB, Nicholls JP, Habib NA, Louis LS, Fisk NM, Gordon MY. High frequency of fetal cells within a primitive stem cell population in maternal blood. Hum. Reprod. 23: 928-933 (2008).

• Milkiewicz P, Gallagher R, Chambers J, Eggington E, Weaver J, Elias E. Obstetric cholestasis with elevated gamma glutamyl transpeptidase: incidence, presentation and treatment. J. Gastroenterol. Hepatol. 18: 1283-1286 (2003). *

• Milkiewicz P, Mendoza A, Cardenas T, Keogh A, Hubscher SG, Elias E. Recurrent autoimmune LKM hepatitis with multiple relapses. Med. Sci. Monit. 6: 586-591 (2000). *

• Milla CE, Billings J, Moran A. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 28: 2141-2144 (2005). *

• Millard KN, Frazer DM, Wilkins SJ, Anderson GJ. Changes in the expression of intestinal iron transport and hepatic regulatory molecules explain the enhanced iron absorption associated with pregnancy in the rat. Gut 53: 655-660 (2004). *

• Mills JP, Terasawa E, Tanumihardjo SA. Ingestion of excessive preformed vitamin A by mothers amplifies storage of retinyl esters in early fetal livers of captive Old World monkeys. Comp. Med. 57: 505-511 (2007).

• Mishkin DS, Van Deinse W, Becker JM, Farraye FA. Successful use of Adalimumab (Humira) for Crohn's disease in pregnancy. Inflamm. Bowel Dis. 12: 827-828 (2006). *

• Misra A, Khurana L, Isharwal S, Bhardwaj S. South Asian diets and insulin resistance. Br. J. Nutr. 101: 457-465 (2009). *

• Mitchell Phd RJ, Osborne Dmd Med PB, Haubenreich Dds JE. Dental amalgam restorations: daily mercury dose and biocompatibility. J. Long Term Eff. Med. Implants 15: 709-721 (2005).

• Miwa N, Hayakawa S, Miyazaki S, Myojo S, Sasaki Y, Sakai M, Takikawa O, Saito S. IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-gamma increase in normal pregnancy but decrease in spontaneous abortion. Mol. Hum. Reprod. 11: 865-870 (2005). *

• Miyake Y, Sasaki S, Tanaka K, Ohfuji S, Hirota Y. Maternal fat consumption during pregnancy and risk of wheeze and eczema in Japanese infants aged 16-24 months: The Osaka Maternal and Child Health Study. Thorax Jun 3 [Epub ahead of print] (2009).

• Miyazaki Y, Yamamoto K. Detection of antigen specific T cell clonality in autoimmune diseases and epitope analysis of autoantigen-reactive T cells. Nippon Rinsho 55: 1403-1409 (1997).

• Mjosberg J, Svensson J, Johansson E, Hellstrom L, Casas R, Jenmalm MC, Boij R, Matthiesen L, Jonsson JI, Ernerudh J. Systemic reduction of functionally suppressive CD4dimCD25high Foxp3+ Tregs in human second trimester pregnancy is induced by progesterone and 17beta-estradiol. J. Immunol. Jun 17 [Epub ahead of print] (2009).

• Mockenhaupt FP, Hamann L, von Gaertner C, Bedu-Addo G, von Kleinsorgen C, Schumann RR, Bienzle U. Common polymorphisms of Toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy. J. Infect. Dis. 194: 184-188 (2006). *

• Moffatt DC, Bernstein CN. Drug therapy for inflammatory bowel disease in pregnancy and the puerperium. Best Pract. Res. Clin. Gastroenterol. 21: 835-847 (2007).

• Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat. Rev. Immunol. 6: 584-594 (2006). *

• Moffett-King A. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2: 656-663 (2002). *

• Mogadam M, Dobbins WO 3rd, Korelitz BI, Ahmed SW. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology 80: 72-76 (1981).

• Molad Y. Systemic lupus erythematosus and pregnancy. Curr. Opin. Obstet. Gynecol. 18: 613-617 (2006).

• Montagnana M, Lippi G, Guidi GC. New strategies for noninvasive screening and prenatal diagnosis: the cell-free fetal DNA in maternal blood. Minerva Ginecol. 59: 331-341 (2007).

• Monte MJ, Marin JJ, Antelo A, Vazquez-Tato J. Bile acids: chemistry, physiology, and pathophysiology. World J. Gastroenterol. 15: 804-816 (2009). *

• Montgomery SM, Wakefield AJ, Ekbom A. Sex-specific risks for pediatric onset among patients with Crohn's disease. Clin. Gastroenterol. Hepatol. 1: 303-309 (2003). *

• Moodie S, Ciclitira P. Recent developments in celiac disease. Curr. Opin. Gastroenterol. 18: 182-186 (2002).

• Mook-Kanamori DO, Steegers EA, Uitterlinden AG, Moll HA, van Duijn CM, Hofman A, Jaddoe VW. Breastfeeding modifies the association of PPARgamma-2 polymorphism Pro12Ala with growth in early life. Diabetes 58: 992-998 (2009).

• Moreau P, Flajollet S, Carosella ED. Nonclassical transcriptional regulation of HLA-G: an update. J. Cell. Mol. Med. Jun 5 [Epub ahead of print] (2009).

• Mortier PE, Gambiez L, Karoui M, Cortot A, Paris JC, Quandalle P, Colombel JF. Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis. Gastroenterol. Clin. Biol. 30: 594-597 (2006). *

• Mosca M, Baldini C, Bombardieri S. Undifferentiated connective tissue diseases in 2004. Clin. Exp. Rheumatol. 22: S14-S18 (2004).

• Mosconi G, Baraldi O, Fantinati C, Cappuccilli M, Corsini S, Zanelli P, Bassi A, Buscaroli B, Feliciangeli G, Stefoni S. Anti-HLA antibodies after bone graft and their impact on kidney transplant programs. G. Ital. Nefrol. 26: 58-63 (2009).

• Moseley RH. Liver and biliary tract disorders. Curr. Opin. Gastroenterol. 23: 217-220 (2007).

• Moser MA, Okun NB, Mayes DC, Bailey RJ. Crohn's disease, pregnancy, and birth weight. Am. J. Gastroenterol. 95: 1021-1026 (2000). *

• Moskovitz DN, Bodian C, Chapman ML, Marion JF, Rubin PH, Scherl E, Present DH. The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am. J. Gastroenterol. 99: 656-661 (2004). *

• Mossong J, Hens N, Friederichs V, Davidkin I, Broman M, Litwinska B, Siennicka J, Trzcinska A, Damme PV, Beutels P, Vyse A, Shkedy Z, Aerts M, Massari M, Gabutti G. Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection. Epidemiol. Infect. 136: 1059-1068 (2008).

• Mostafavi B, Akyuz S, Jacobsson ME, Nilsen LV, Theander E, Jacobsson LH. Perinatal characteristics and risk of developing primary Sjogren's syndrome: a case-control study. J. Rheumatol. 32: 665-668 (2005).

• Motta M, Ciardelli L, Marconi M, Tincani A, Gasparoni A, Lojacono A, Chirico G. Immune system development in infants born to mothers with autoimmune disease, exposed in utero to immunosuppressive agents. Am. J. Perinatol. 24: 441-447 (2007).

• Motta M, Tincani A, Lojacono A, Faden D, Gorla R, Airo P, Neri F, Gasparoni A, Ciardelli L, de Silvestri A, Marconi M, Chirico G. Neonatal outcome in patients with rheumatic disease. Lupus 13: 718-723 (2004).

• Motta M, Tincani A, Meroni PL, Cimaz R. Follow-up of children exposed antenatally to immunosuppressive drugs. Rheumatology (Oxford) 47 Suppl. 3: iii32-iii34 (2008). *

• Mottet C, Juillerat P, Gonvers JJ, Froehlich F, Burnand B, Vader JP, Michetti P, Felley C. Pregnancy and Crohn's disease. Digestion 71: 54-61 (2005).

• Mottet C, Juillerat P, Pittet V, Gonvers JJ, Froehlich F, Vader JP, Michetti P, Felley C. Pregnancy and breastfeeding in patients with Crohn's disease. Digestion 76: 149-160 (2007). *

• Moum B. Chronic inflammatory bowel disease and pregnancy. Scand. J. Gastroenterol. 35: 673-678 (2000). *

• Mountifield R, Bampton P, Prosser R, Muller K, Andrews JM. Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions. Inflamm. Bowel Dis. 15: 720-725 (2009).

• Mozurkewich E, Chilimigras J, Koepke E, Keeton K, King V. Indications for induction of labour: a best-evidence review. BJOG 116: 626-636 (2009).

• Mtiraoui N, Zammiti W, Ghazouani L, Braham NJ, Saidi S, Finan RR, Almawi WY, Mahjoub T. Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and changes in homocysteine concentrations in women with idiopathic recurrent pregnancy losses. Reproduction 131: 395-401 (2006). *

• Muehlenberg K, Wiedmann K, Keppeler H, Sauerbruch T, Lammert F. Recurrent intrahepatic cholestasis of pregnancy and chain-like choledocholitiasis in a female patient with stop codon in the ABCB4-gene of the hepatobiliary phospholipid transporter. Z. Gastroenterol. 46: 48-53 (2008).

• Muetze S, Leeners B, Ortlepp JR, Kuse S, Tag CG, Weiskirchen R, Gressner AM, Rudnik-Schoeneborn S, Zerres K, Rath W. Maternal factor V Leiden mutation is associated with HELLP syndrome in Caucasian women. Acta Obstet. Gynecol. Scand. 87: 635-642 (2008).

• Mukherjee AB, Zhang Z, Chilton BS. Uteroglobin: a steroid-inducible immunomodulatory protein that founded the secretoglobin superfamily. Endocr. Rev. 28: 707-725 (2007).

• Mulder CJ, Tytgat GN, Weterman IT, Dekker W, Blok P, Schrijver M, van der Heide H. Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis. Gastroenterology 95: 1449-1453 (1988).

• Mullally BA, Hansen WF. Intrahepatic cholestasis of pregnancy: review of the literature. Obstet. Gynecol. Surv. 57: 47-52 (2002).

• Mullenbach R, Bennett A, Tetlow N, Patel N, Hamilton G, Cheng F, Chambers J, Howard R, Taylor-Robinson SD, Williamson C. ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy. Gut 54: 829-834 (2005). *

• Mullenbach R, Linton KJ, Wiltshire S, Weerasekera N, Chambers J, Elias E, Higgins CF, Johnston DG, McCarthy MI, Williamson C. ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy. J. Med. Genet. 40: e70 (2003). *

• Muller F, Simon-Bouy B, Girodon E, Monnier N, Malinge MC, Serre JL; French Collaborative Group. Predicting the risk of cystic fibrosis with abnormal ultrasound signs of fetal bowel: results of a French molecular collaborative study based on 641 prospective cases. Am. J. Med. Genet. 110: 109-115 (2002).

• Muller-Lissner SA, Kamm MA, Scarpignato C, Wald A. Myths and misconceptions about chronic constipation. Am. J. Gastroenterol. 100: 232-242 (2005). *

• Murakami K, Miyake Y, Sasaki S, Tanaka K, Ohya Y, Hirota Y; Osaka Maternal and Child Health Study Group. Education, but not occupation or household income, is positively related to favorable dietary intake patterns in pregnant Japanese women: the Osaka Maternal and Child Health Study. Nutr. Res. 29: 164-172 (2009). *

• Muresan D, Ona D, Cruciat G, Rotar I, Stamatian F. Recurrent intrahepatic cholestasis of pregnancy. A case report. J. Gastrointestin. Liver Dis. 17: 323-325 (2008). *

• Muscal E, Brey RL. Neurologic manifestations of the antiphospholipid syndrome: integrating molecular and clinical lessons. Curr. Rheumatol. Rep. 10: 67-73 (2008).

• Muskiet FA, Kemperman RF. Folate and long-chain polyunsaturated fatty acids in psychiatric disease. J. Nutr. Biochem. 17: 717-727 (2006). *

• Muskiet FA, van Goor SA, Kuipers RS, Velzing-Aarts FV, Smit EN, Bouwstra H, Janneke Dijck-Brouwer DA, Rudy Boersma E, Hadders-Algra M. Long-chain polyunsaturated fatty acids in maternal and infant nutrition. Prostaglandins Leukot. Essent. Fatty Acids 75: 135-144 (2006). *

• Muthayya S, Dwarkanath P, Thomas T, Ramprakash S, Mehra R, Mhaskar A, Mhaskar R, Thomas A, Bhat S, Vaz M, Kurpad AV. The effect of fish and omega-3 LCPUFA intake on low birth weight in Indian pregnant women. Eur. J. Clin. Nutr. 63: 340-346 (2009).

• Mutter J, Naumann J, Schneider R, Walach H, Haley B. Mercury and autism: accelerating evidence? Neuro. Endocrinol. Lett. 26: 439-446 (2005).

• Nadashkevich ON. Autoimmune theory of pathogenesis of systemic scleroderma. Lik. Sprava. 2001: 15-17 (2001).

• Nagaraja D, Noone ML, Bharatkumar VP, Christopher R. Homocysteine, folate and vitamin B(12) in puerperal cerebral venous thrombosis. J. Neurol. Sci. 272: 43-47 (2008).

• Nahmias AJ, Nahmias SB, Danielsson D. The possible role of transplacentally-acquired antibodies to infectious agents, with molecular mimicry to nervous system sialic acid epitopes, as causes of neuromental disorders: prevention and vaccine implications. Clin. Dev. Immunol. 13: 167-183 (2006). *

• Naliwaiko K, Araujo RL, da Fonseca RV, Castilho JC, Andreatini R, Bellissimo MI, Oliveira BH, Martins EF, Curi R, Fernandes LC, Ferraz AC. Effects of fish oil on the central nervous system: a new potential antidepressant? Nutr. Neurosci. 7: 91-99 (2004).

• Nardiello S, Pizzella T, Ariviello R. Risks of antibacterial agents in pregnancy. Infez. Med. 10: 8-15 (2002).

• Nava-Ocampo AA, Koren G. Human teratogens and evidence-based teratogen risk counseling: the Motherisk approach. Clin. Obstet. Gynecol. 50: 123-131 (2007).

• Navarro F, Hanauer SB. Treatment of inflammatory bowel disease: safety and tolerability issues. Am. J. Gastroenterol. 98: S18-S23 (2003). *

• Ndakotsu MA, Salawu L, Durosinmi MA. Lupus anticoagulant in Nigerian patients living with human immunodeficiency virus/acquired immunodeficiency syndrome. J. Microbiol. Immunol. Infect. 42: 69-73 (2009).

• Negro R, Formoso G, Coppola L, Presicce G, Mangieri T, Pezzarossa A, Dazzi D. Euthyroid women with autoimmune disease undergoing assisted reproduction technologies: the role of autoimmunity and thyroid function. J. Endocrinol. Invest. 30: 3-8 (2007).

• Nejatizadeh A, Stobdan T, Malhotra N, Pasha MA. The genetic aspects of pre-eclampsia: achievements and limitations. Biochem. Genet. 46: 451-479 (2008). *

• Nelson JL. Microchimerism: incidental byproduct of pregnancy or active participant in human health? Trends Mol. Med. 8: 109-113 (2002). *

• Nelson JL. Microchimerism and the pathogenesis of systemic sclerosis. Curr. Opin. Rheumatol. 10: 564-571 (1998).

• Nelson JL. Microchimerism: implications for autoimmune disease. Lupus 8: 370-374 (1999).

• Nelson JL. HLA relationships of pregnancy, microchimerism and autoimmune disease. J. Reprod. Immunol. 52: 77-84 (2001).

• Nelson JL. Microchimerism and human autoimmune diseases. Lupus 11: 651-654 (2002).

• Nguyen DP, Genc M, Vardhana S, Babula O, Onderdonk A, Witkin SS. Ethnic differences of polymorphisms in cytokine and innate immune system genes in pregnant women. Obstet. Gynecol. 104: 293-300 (2004).

• Nguyen GC, Harris ML, Dassopoulos T. Insights in immunomodulatory therapies for ulcerative colitis and Crohn's disease. Curr. Gastroenterol. Rep. 8: 499-505 (2006).

• Nguyen GC, Ross H, Harris ML, Maxwell CV. Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States. Clin. Gastroenterol. Hepatol. 7: 329-334 (2009).

• Nicastri PL, Diaferia A, Tartagni M, Loizzi P, Fanelli M. A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy. Br. J. Obstet. Gynaecol. 105: 1205-1207 (1998).

• Nichols AA. Cholestasis of pregnancy: a review of the evidence. J. Perinat. Neonatal Nurs. 19: 217-225 (2005).

• Niebyl JR. Antibiotics and other anti-infective agents in pregnancy and lactation. Am. J. Perinatol. 20: 405-414 (2003).

• Nielsen OH, Andreasson B, Bondesen S, Jacobsen O, Jarnum S. Pregnancy in Crohn's disease. Scand. J. Gastroenterol. 19: 724-732 (1984).

• Nikbin B, Bonab MM, Talebian F. Microchimerism and stem cell transplantation in multiple sclerosis. Int. Rev. Neurobiol. 79C: 173-202 (2007).

• Nir A, Sorokin Y, Abramovici H, Theodor E. Pregnancy and primary biliary cirrhosis. Int. J. Gynaecol. Obstet. 28: 279-282 (1989).

• Niva S, Weill P, Loewenbach R. Egg fortification with n-3 polyunsaturated fatty acids (PUFA): nutritional benefits versus high n-6 PUFA western diets, and consumer acceptance. Isr. Med. Assoc. J. 10: 262-265 (2008). *

• No authors listed. Autoimmune disease: pre-eclampsia IgG produces a murine model of maternal morbidity. Dis. Model. Mech. 1: 71 (2008).

• No authors listed. In this issue. Eur. J. Immunol. 38: 321-322 (2008). *

• Noakes PS, Hale J, Thomas R, Lane C, Devadason SG, Prescott SL. Maternal smoking is associated with impaired neonatal Toll-like receptor (TLR) mediated immune responses. Eur. Respir. J. 28: 721-729 (2006).

• Nolan DG, Martin LS, Natarajan S, Hume RF Jr. Fetal compromise associated with extreme fetal bile acidemia and maternal primary sclerosing cholangitis. Obstet. Gynecol. 84: 695-696 (1994).

• Norgard B, Fonager K, Sorensen HT, Olsen J. Birth outcomes of women with ulcerative colitis: a nationwide Danish cohort study. Am. J. Gastroenterol. 95: 3165-3170 (2000). *

• Norgard B, Hundborg HH, Jacobsen BA, Nielsen GL, Fonager K. Disease activity in pregnant women with Crohn's disease and birth outcomes: a regional Danish cohort study. Am. J. Gastroenterol. 102: 1947-1954 (2007). *

• Norgard B, Pedersen L, Christensen LA, Sorensen HT. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study. Am. J. Gastroenterol. 102: 1406-1413 (2007). *

• Novakovic B, Sibson M, Ng HK, Manuelpillai U, Rakyan VK, Down TA, Beck S, Fournier T, Evain-Brion D, Dimitriadis E, Craig JM, Morley R, Saffery R. Placenta specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. J. Biol. Chem. 284: 14838-14848 (2009). *

• Nugent DJ. Immune thrombocytopenic purpura of childhood. Hematology Am. Soc. Hematol. Educ. Program 2006: 97-103 (2006). *

• Nurk E, Tell GS, Refsum H, Ueland PM, Vollset SE. Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study. QJM 99: 289-298 (2006). *

• O'Donnell S, O'Morain C. Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conception. Aliment. Pharmacol. Ther. 27: 885-894 (2008). *

• O'Donoghue K, Chan J, De La Fuente J, Kennea N, Sandison A, Anderson JR, Roberts PI, Fisk PN. Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet 364: 179-182 (2004). *

• O'Donoghue K, Sultan HA, Al-Allaf FA, Anderson JR, Wyatt-Ashmead J, Fisk NM. Microchimeric fetal cells cluster at sites of tissue injury in lung decades after pregnancy. Reprod. Biomed. Online 16: 382-390 (2008).

• O'Leary JG, Pratt DS. Cholestasis and cholestatic syndromes. Curr. Opin. Gastroenterol. 23: 232-236 (2007).

• Odegaard I, Stray-Pedersen B, Hallberg K, Haanaes OC, Storrosten OT, Johannesson M. Maternal and fetal morbidity in pregnancies of Norwegian and Swedish women with cystic fibrosis. Acta Obstet. Gynecol. Scand. 81: 698-705 (2002).

• Oefferlbauer-Ernst A, Reinisch W, Miehsler W, Vogelsang H, Dejaco C. Healthy offspring in parents both receiving thiopurines. Gastroenterology 126: 628 (2004). *

• Offner H. Neuroimmunoprotective effects of estrogen and derivatives in experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis. J. Neurosci. Res. 78: 603-624 (2004). *

• Offner H, Polanczyk M. A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis. Ann. N. Y. Acad. Sci. 1089: 343-372 (2006). *

• Ofori B, Rey E, Berard A. Risk of congenital anomalies in pregnant users of statin drugs. Br. J. Clin. Pharmacol. 64: 496-509 (2007). *

• Ojeda-Uribe M, Gilliot C, Jung G, Drenou B, Brunot A. Administration of rituximab during the first trimester of pregnancy without consequences for the newborn. J. Perinatol. 26: 252-255 (2006).

• Okada H, Makidono C, Takenaka R, Hiraoka S, Fujiwara A, Kato J, Kawahara Y, Kawamoto H, Mizuno M, Shiratori Y. Therapeutic efficacy of leukocytapheresis in a pregnant woman with severe active ulcerative colitis. Digestion 74: 15-18 (2006). *

• Okoro NI, Kane SV. Gender-related issues in the female inflammatory bowel disease patient. Expert Rev. Gastroenterol. Hepatol. 3: 145-154 (2009).

• Okun ML, Hall M, Coussons-Read ME. Sleep disturbances increase interleukin-6 production during pregnancy: implications for pregnancy complications. Reprod. Sci. 14: 560-567 (2007).

• Olen O, Montgomery SM, Ekbom A, Bollgren I, Ludvigsson JF. Urinary tract infections in pregnant women with coeliac disease. Scand. J. Gastroenterol. 42: 186-193 (2007). *

• Olsen NJ, Kovacs WJ. Hormones, pregnancy, and rheumatoid arthritis. J. Gend. Specif. Med. 5: 28-37 (2002).

• Olsen SF, Osterdal ML, Salvig JD, Mortensen LM, Rytter D, Secher NJ, Henriksen TB. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry-based follow-up from a randomized controlled trial. Am. J. Clin. Nutr. 88: 167-175 (2008). *

• Olsen SF, Osterdal ML, Salvig JD, Weber T, Tabor A, Secher NJ. Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. Eur. J. Clin. Nutr. 61: 976-985 (2007). *

• Olsson R, Loof L, Wallerstedt S. Pregnancy in patients with primary biliary cirrhosis - a case for dissuasion? The Swedish Internal Medicine Liver Club. Liver 13: 316-318 (1993).

• Ooi CJ, Sands BE. Treatment of ulcerative colitis. Curr. Opin. Gastroenterol. 15: 298 (1999).

• Ortega-Hernandez OD, Bassi N, Shoenfeld Y, Anaya JM. The long pentraxin 3 and its role in autoimmunity. Semin. Arthritis Rheum. Jul 8 [Epub ahead of print] (2008). *

• Orvis AK, Wesson SK, Breza TS Jr, Church AA, Mitchell CL, Watkins SW. Mycophenolate mofetil in dermatology. J. Am. Acad. Dermatol. 60: 183-199 (2009).

• Ostensen M. Therapy: are TNF inhibitors safe in pregnancy? Nat. Rev. Rheumatol. 5: 184-185 (2009). *

• Ostensen M, Foerger F, Nelson JL, Schumacher A, Hebisch G, Villiger PM. Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post partum. Ann. Rheum. Dis. 64: 839-844 (2005). *

• Ostensen M, Forger F, Villiger PM. Cytokines and pregnancy in rheumatic disease. Ann. N. Y. Acad. Sci. 1069: 353-363 (2006). *

• Ostensen M, Villiger PM. The remission of rheumatoid arthritis during pregnancy. Semin. Immunopathol. 29: 185-191 (2007). *

• Otto SJ, de Groot RH, Hornstra G. Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status. Prostaglandins Leukot. Essent. Fatty Acids 69: 237-243 (2003). *

• Oumeish OY, Parish JL. Impetigo herpetiformis. Clin. Dermatol. 24: 101-104 (2006).

• Oussalah A, Bigard MA, Peyrin-Biroulet L. Certolizumab use in pregnancy. Gut 58: 608 (2009).

• Ouwendijk RJ, Koster JC, Wilson JH, Stibbe J, Lameris JS, Visser W, Benhamou JP. Budd-Chiari syndrome in a young patient with anticardiolipin antibodies: need for prolonged anticoagulant treatment. Gut 35: 1004-1006 (1994). *

• Owen BM, Van Mil SW, Boudjelal M, McLay I, Cairns W, Elias E, White R, Williamson C, Dixon PH. Sequencing and functional assessment of hPXR (NR1I2) variants in intrahepatic cholestasis of pregnancy. Xenobiotica 38: 1289-1297 (2008). *

• Oyama K, Sugimura Y, Murase T, Uchida A, Hayasaka S, Oiso Y, Murata Y. Folic acid prevents congenital malformations in the offspring of diabetic mice. Endocr. J. 56: 29-37 (2009). *

• Ozdemir D, Korkmaz U, Sahin I, Sencan I, Kavak A, Kucukbayrak A, Cakir S. Ofloxacin induced Sweet's syndrome in a patient with Crohn's disease. J. Infect. 52: e155-e157 (2006).

• Ozdemir OM, Ergin H, Ince T. A newborn with positive antiglobulin test whose mother took methyldopa in pregnancy. Turk. J. Pediatr. 50: 592-594 (2008).

• Oztekin D, Aydal I, Oztekin O, Okcu S, Borekci R, Tinar S. Predicting fetal asphyxia in intrahepatic cholestasis of pregnancy. Arch. Gynecol. Obstet. Mar 26 [Epub ahead of print] (2009).

• Pacchiarotti A, Sbracia M, Mohamed MA, Frega A, Pacchiarotti A, Espinola SM, Aragona C. Autoimmune response to Chlamydia trachomatis infection and in vitro fertilization outcome. Fertil. Steril. 91: 946-948 (2009).

• Pache I, Rogler G, Felley C. TNF-alpha blockers in inflammatory bowel diseases: practical consensus recommendations and a user's guide. Swiss Med. Wkly. 139: 278-287 (2009). *

• Pagnoux C. Pregnancy and vasculitides. Presse. Med. 37: 1657-1665 (2008).

• Painter JN, Savander M, Ropponen A, Nupponen N, Riikonen S, Ylikorkala O, Lehesjoki AE, Aittomaki K. Sequence variation in the ATP8B1 gene and intrahepatic cholestasis of pregnancy. Eur. J. Hum. Genet. 13: 435-439 (2005). *

• Painter JN, Savander M, Sistonen P, Lehesjoki AE, Aittomaki K. A known polymorphism in the bile salt export pump gene is not a risk allele for intrahepatic cholestasis of pregnancy. Scand. J. Gastroenterol. 39: 694-695 (2004). *

• Pajares Villarroya R, Castillo Grau P, Mancenido Marcos N, Navajas Leon FJ, Hervias Cruz D, Erdozain Sosa JC, Segura Cabral JM. Primary biliary cirrhosis and pregnancy: benefit of ursodeoxycholic acid therapy. Gastroenterol. Hepatol. 26: 615 (2003).

• Palma J, Reyes H, Ribalta J, Hernandez I, Sandoval L, Almuna R, Liepins J, Lira F, Sedano M, Silva O, Toha D, Silva JJ. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J. Hepatol. 27: 1022-1028 (1997). *

• Palma J, Reyes H, Ribalta J, Iglesias J, Gonzalez M, Hernandez I, Alvarez C, Molina C, Danitz AM. Effects of ursodeoxycholic acid in patients with cholestasis of pregnancy. Rev. Med. Chil. 119: 169-171 (1991).

• Palmer DG. Peripartum cardiomyopathy. J. Perinat. Neonatal Nurs. 20: 324-332 (2006).

• Palmer DG, Eads J. Intrahepatic cholestasis of pregnancy: a critical review. J. Perinat. Neonatal. Nurs. 14: 39-51 (2000).

• Pan H, Zhu L, Deng Y, Pollard JW. Microarray analysis of uterine epithelial gene expression during the implantation window in the mouse. Endocrinology 147: 4904-4916 (2006). *

• Panayotidis C, Triantafyllidis S. Acute abdomen in Crohn's disease mimicking concealed placental abruption in pregnancy. J. Obstet. Gynaecol. 26: 166-167 (2006).

• Pangalos CG, Hagnefelt B, Kokkali G, Pantos K, Konialis CP. Birth of a healthy histocompatible sibling following preimplantation genetic diagnosis for chronic granulomatous disease at the blastocyst stage coupled to HLA typing. Fetal Diagn. Ther. 24: 334-339 (2008).

• Panko J, Florell SR, Hadley J, Zone J, Leiferman K, Vanderhooft S. Neonatal pemphigus in an infant born to a mother with serologic evidence of both pemphigus vulgaris and gestational pemphigoid. J. Am. Acad. Dermatol. 60: 1057-1062 (2009).

• Panther E, Blum HE. Liver diseases in pregnancy. Dtsch. Med. Wochenschr. 133: 2283-2287 (2008).

• Panther E, Thimme R, Blum HE. Jaundice in an HIV-positive pregnant woman. Dtsch. Med. Wochenschr. 133: 1560-1562 (2008).

• Papa A, Mocci G, Bonizzi M, Felice C, Andrisani G, De Vitis I, Guidi L, Gasbarrini A. Use of infliximab in particular clinical settings: management based on current evidence. Am. J. Gastroenterol. 104: 1575-1586 (2009). *

• Papacleovoulou G, Edmondson RJ, Critchley HO, Hillier SG, Mason JI. 3beta-Hydroxysteroid dehydrogenases and pre-receptor steroid metabolism in the human ovarian surface epithelium. Mol. Cell. Endocrinol. 301: 65-73 (2009).

• Papadopoulou A, Lynch KF, Shaat N, Nilsson A, Lernmark B, Berntorp K, Ivarsson SA, Agardh CD, Lernmark A; on behalf of the DiPiS Study Group. The type 1 diabetes protective HLA DQB1*0602 allele is less frequent in gestational diabetes mellitus. Diabetologia 52: 1339-1342 (2009). *

• Papi G, Uberti ED, Betterle C, Carani C, Pearce EN, Braverman LE, Roti E. Subclinical hypothyroidism. Curr. Opin. Endocrinol. Diabetes Obes. 14: 197-208 (2007).

• Parant O, Khosrotehrani K, Aractingi S. Gestational microchimerism in human diseases. Presse. Med. 38: 584-590 (2009).

• Parham P. MHC class I molecules and KIRS in human history, health and survival. Nat. Rev. Immunol. 5: 201-214 (2005). *

• Parikh-Patel A, Gold E, Utts J, Gershwin ME. The association between gravidity and primary biliary cirrhosis. Ann. Epidemiol. 12: 264-272 (2002). *

• Park TS, Lee ST, Kim JS, Song J, Lee KA, Kim SJ, Seok YM, Lee HJ, Han JH, Kim JK, Lee EY, Choi JR. Acute promyelocytic leukemia in early pregnancy with translocation t(15;17) and variant PML/RARA fusion transcripts. Cancer Genet. Cytogenet. 188: 48-51 (2009).

• Parke A. Drug exposure, pregnancy outcome and fetal and childhood development occurring in the offspring of mothers with systemic lupus erythematosus and other chronic autoimmune diseases. Lupus 15: 808-813 (2006).

• Parra-Cabrera S, Moreno-Macias H, Mendez-Ramirez I, Schnaas L, Romieu I. Maternal dietary omega fatty acid intake and auditory brainstem-evoked potentials in Mexican infants born at term: cluster analysis. Early Hum. Dev. 84: 51-57 (2008).

• Parveen F, Tripathi G, Singh B, Agrawal S. Association of chemokines receptor (CCR5 Delta32) in idiopathic recurrent miscarriages among north Indians. Arch. Gynecol. Obstet. Dec 31 [Epub ahead of print] (2008).

• Pasquali JL, Poindron V, Korganow AS, Martin T. The antiphospholipid syndrome. Best Pract. Res. Clin. Rheumatol. 22: 831-845 (2008).

• Paternoster DM, Bertolino M, Garofalo G, Merati E, Lunghi M, Surico N. Autoimmune thrombocytopenia (ITP) during pregnancy in a woman that underwent a splenectomy during childhood. Minerva Ginecol. 60: 555-556 (2008).

• Patrick L. Iodine: deficiency and therapeutic considerations. Altern. Med. Rev. 13: 116-127 (2008). *

• Patrignani A, Nannicosta MP, Antonini L, D'Aroma A, De Berardinis G, Cicogna S. Myocardial and cerebral infarction as initial presentation of antiphospholipid syndrome. G. Ital. Cardiol. (Rome) 10: 259-262 (2009).

• Patterson D. Folate metabolism and the risk of Down syndrome. Downs Syndr. Res. Pract. 12: 93-97 (2008).

• Patton T, Plunkett RW, Beutner EH, Deng JS, Jukic DM. IgG4 as the predominant IgG subclass in pemphigoides gestationis. J. Cutan. Pathol. 33: 299-302 (2006). *

• Pauli-Magnus C, Lang T, Meier Y, Zodan-Marin T, Jung D, Breymann C, Zimmermann R, Kenngott S, Beuers U, Reichel C, Kerb R, Penger A, Meier PJ, Kullak-Ublick GA. Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics 14: 91-102 (2004).

• Pauli-Magnus C, Meier PJ. Pharmacogenetics of hepatocellular transporters. Pharmacogenetics 13: 189-198 (2003).

• Pauli-Magnus C, Meier PJ. Hepatocellular transporters and cholestasis. J. Clin. Gastroenterol. 39: S103-S110 (2005).

• Pauli-Magnus C, Stieger B, Meier Y, Kullak-Ublick GA, Meier PJ. Enterohepatic transport of bile salts and genetics of cholestasis. J. Hepatol. 43: 342-357 (2005). *

• Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 36: 525-531 (2002). *

• Paus TC, Schneider G, Van De Vondel P, Sauerbruch T, Reichel C. Diagnosis and therapy of intrahepatic cholestasis of pregnancy. Z. Gastroenterol. 42: 623-628 (2004).

• Pavan L, Hermouet A, Tsatsaris V, Therond P, Sawamura T, Evain-Brion D, Fournier T. Lipids from oxidized low-density lipoprotein modulate human trophoblast invasion: involvement of nuclear liver X receptors. Endocrinology 145: 4583-4591 (2004). *

• Pawley N, Bishop NJ. Prenatal and infant predictors of bone health: the influence of vitamin D. Am. J. Clin. Nutr. 80: 1748S-1751S (2004). *

• Pazzi P, Gamberini S, Buldrini P, Gullini S. Biliary sludge: the sluggish gallbladder. Dig. Liver Dis. 35 Suppl. 3: S39-S45 (2003).

• Pedron B, Guerin V, Jacquemard F, Munier A, Daffos F, Thulliez P, Aujard Y, Luton D, Sterkers G. Comparison of CD8+ T cell responses to cytomegalovirus between human fetuses and their transmitter mothers. J. Infect. Dis. 196: 1033-1043 (2007). *

• Pegler S, McElhatton P. Metronidazole is used for antibiotic associated diarrhoea in pregnancy in UK. BMJ 325: 903 (1993). *

• Pelfrey CM, Moldovan IR, Cotleur AC, Zamor N, Rudick RA. Effects of sex hormones on costimulatory molecule expression in multiple sclerosis. J. Neuroimmunol. 167: 190-203 (2005).

• Pellicano R, Astegiano M, Bruno M, Fagoonee S, Rizzetto M. Women and celiac disease: association with unexplained infertility. Minerva Med. 98: 217-219 (2007).

• Peng B, Chen Q, Zhang L, Zou H, Liu S. Association of genetic polymorphisms in human leukocyte antigen-DQA1 with intrahepatic cholestasis of pregnancy in Chengdu district. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23: 555-557 (2006).

• Peng B, Liu SY, Chen Q, Wang XD, Zhang L, Zou H. Expression of human leucocyte antigen G on human placenta and its gene polymorphism in relation to intrahepatic cholestasis of pregnancy. Zhonghua Fu Chan Ke Za Zhi 42: 443-447 (2007).

• Peng B, Liu SY, Wang XD, Wang H, Zhang L, Hu M. Relationship of human leucocyte antigen G, E with intrahepatic cholestasis of pregnancy. Sichuan Da Xue Xue Bao Yi Xue Ban 38: 779-782 (2007).

• Penka M, Bulikova A, Smejkal P, Kissova J, Matyskova M, Gumulec J, Kralova S, Slechtova M, Chlupova G. Preparation of patients with haemostatic disorder for invasive medical interventions. Vnitr. Lek. 54: 632-637 (2008).

• Pennings MT, van Lummel M, Derksen RH, Urbanus RT, Romijn RA, Lenting PJ, de Groot PG. Interaction of beta-glycoprotein I with members of the low density lipoprotein receptor family. J. Thromb. Haemost. 4: 1680-1690 (2006). *

• Pereira MA, Segura ME, Santos AM, Casulari LA. Regression of the fibrous disease of the breast in a non-diabetic woman after pregnancy and breastfeeding. Arq. Bras. Endocrinol. Metabol. 51: 1539-1543 (2007).

• Perez Fernandez T, Lopez Serrano P, Tomas E, Gutierrez M, Lledo J, Cacho G, Santander C, Fernandez Rodriguez C. Diagnostic and therapeutic approach to cholestatic liver disease. Rev. Esp. Enferm. Dig. 96: 60-73 (2004).

• Perez MJ, Castano B, Gonzalez-Buitrago JM, Marin JJ. Multiple protective effects of melatonin against maternal cholestasis-induced oxidative stress and apoptosis in the rat fetal liver-placenta-maternal liver trio. J. Pineal Res. 43: 130-139 (2007).

• Perez MJ, Castano B, Jimenez S, Serrano MA, Gonzalez-Buitrago JM, Marin JJ. Role of vitamin C transporters and biliverdin reductase in the dual pro-oxidant and anti-oxidant effect of biliary compounds on the placenta-fetal unit in cholestasis during pregnancy. Toxicol. Appl. Pharmacol. 232: 327-336 (2008). *

• Perez MJ, Macias RI, Duran C, Monte MJ, Gonzalez-Buitrago JM, Marin JJ. Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid. J. Hepatol. 43: 324-332 (2005). *

• Perez MJ, Macias RI, Marin JJ. Maternal cholestasis induces placental oxidative stress and apoptosis. Protective effect of ursodeoxycholic acid. Placenta 27: 34-41 (2006).

• Perez MJ, Velasco E, Monte MJ, Gonzalez-Buitrago JM, Marin JJ. Maternal ethanol consumption during pregnancy enhances bile acid-induced oxidative stress and apoptosis in fetal rat liver. Toxicology 225: 183-194 (2006). *

• Pertynska Marczewska M, Cedzynski M, Swierzko A, Szala A, Sobczak M, Cypryk K, Wilczynski J. Evaluation of lectin pathway activity and mannan-binding lectin levels in the course of pregnancy complicated by diabetes type 1, based on the genetic background. Arch. Immunol. Ther. Exp. (Warsz.) Jun 11 [Epub ahead of print] (2009).

• Pertynska-Marczewska M, Glowacka E, Sobczak M, Cypryk K, Wilczynski J. Glycation endproducts, soluble receptor for advanced glycation endproducts and cytokines in diabetic and non-diabetic pregnancies. Am. J. Reprod. Immunol. 61: 175-182 (2009).

• Peters MG. Special populations with hepatitis B virus infection. Hepatology 49: S146-S155 (2009).

• Pierangeli SS, Chen PP, Gonzalez EB. Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanisms. Curr. Opin. Hematol. 13: 366-375 (2006).

• Pierangeli SS, Vega-Ostertag ME, Gonzalez EB. New targeted therapies for treatment of thrombosis in antiphospholipid syndrome. Expert Rev. Mol. Med. 9: 1-15 (2007).

• Pinterova Kolesarova M, Pinter M, Rejchrt S, Douda T, Tachecí I, Kopacova M, Bures J. The influence of inflammatory bowel disease on the period of conceiving. Ceska. Gynekol. 73: 109-112 (2008).

• Pisoni CN, D'Cruz DP. The safety of mycophenolate mofetil in pregnancy. Expert Opin. Drug Saf. 7: 219-222 (2008).

• Polanczyk MJ, Carson BD, Subramanian S, Afentoulis M, Vandenbark AA, Ziegler SF, Offner H. Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J. Immunol. 173: 2227-2230 (2004). *

• Polanczyk MJ, Hopke C, Huan J, Vandenbark AA, Offner H. Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J. Neuroimmunol. 170: 85-92 (2005).

• Polanczyk MJ, Hopke C, Vandenbark AA, Offner H. Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway. J. Neurosci. Res. 84: 370-378 (2006).

• Poo JL, Gongora J. Hepatic hematoma and hepatic rupture in pregnancy. Ann. Hepatol. 5: 224-226 (2006). *

• Pope R, Sheiner E. Celiac disease during pregnancy: to screen or not to screen? Arch. Gynecol. Obstet. 279: 1-3 (2009).

• Poupon R. Intrahepatic cholestasis of pregnancy: from bedside to bench to bedside. Liver Int. 25: 467-468 (2005). *

• Poupon R, Chretien Y, Chazouilleres O, Poupon RE. Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis. J. Hepatol. 42: 418-419 (2005). *

• Prajapati DN, Newcomer JR, Emmons J, Abu-Hajir M, Binion DG. Successful treatment of an acute flare of steroid-resistant Crohn's colitis during pregnancy with unfractionated heparin. Inflamm. Bowel Dis. 8: 192-195 (2002). *

• Prandoni P. Acquired risk factors for venous thromboembolism in medical patients. Hematology (Am. Soc. Hematol. Educ. Program) 2005: 458-461 (2005). *

• Praprotnik S, Sodin-Semrl S, Tomsic M, Shoenfeld Y. The curiously suspicious: infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients. J. Autoimmun. 30: 37-41 (2008). *

• Prasad AS. Clinical manifestations of zinc deficiency. Annu. Rev. Nutr. 5: 341-363 (1985). *

• Pratt DS. Cholestasis and cholestatic syndromes. Curr. Opin. Gastroenterol. 21: 270-274 (2005).

• Prescott SL, Calder PC. n-3 Polyunsaturated fatty acids and allergic disease. Curr. Opin. Clin. Nutr. Metab. Care 7: 123-129 (2004).

• Prescott SL, Dunstan JA. Prenatal fatty acid status and immune development: the pathways and the evidence. Lipids 42: 801-810 (2007).

• Prescott SL, Dunstan JA, Barden AE, Mori TA. Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord blood derived neutrophils. Clin. Sci. (Lond.) 113: 409-416 (2007). *

• Presotto F, Fornasini F, Betterle C, Federspil G, Rossato M. Acute adrenal failure as the heralding symptom of primary antiphospholipid syndrome: report of a case and review of the literature. Eur. J. Endocrinol. 153: 507-514 (2005). *

• Prieto GA, Rosenstein Y. Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation. Immunology 118: 58-65 (2006). *

• Priori R, Medda E, Conti F, Cassara EA, Sabbadini MG, Antonioli CM, Gerli R, Danieli MG, Giacomelli R, Pietrogrande M, Valesini G, Stazi MA. Risk factors for Sjogren's syndrome: a case-control study. Clin. Exp. Rheumatol. 25: 378-384 (2007).

• Puccetti P, Grohmann U. IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation. Nat. Rev. Immunol. 7: 817-823 (2007). *

• Pugliese A, Beltramo T, Torre D, Roccatello D. Parvovirus B19 and immune disorders. Cell. Biochem. Funct. 25: 639-641 (2007). *

• Pusl T, Beuers U. Intrahepatic cholestasis of pregnancy. Orphanet J. Rare Dis. 2: 26 (2007). *

• Qian X, Lu Z, Tan M, Liu H, Lu D. A meta-analysis of association between C677T polymorphism in the methylenetetrahydrofolate reductase gene and hypertension. Eur. J. Hum. Genet. 15: 1239-1245 (2007). *

• Qin L, Liu SY, Xing AY, Tan ZJ, Cai MY, Zhao ZR. Study of fetal lymphocyte of intrahepatic cholestasis of pregnancy. Zhonghua Fu Chan Ke Za Zhi 41: 445-448 (2006).

• Quemelo PR, Lourenco CM, Peres LC. Teratogenic effect of retinoic acid in Swiss mice. Acta Cir. Bras. 22: 451-456 (2007).

• Qureshi WA. Intrahepatic cholestatic syndromes: pathogenesis, clinical features and management. Dig. Dis. 17: 49-59 (1999).

• Rabinovitz M, Appasamy R, Finkelstein S. Primary biliary cirrhosis diagnosed during pregnancy. Does it have a different outcome? Dig. Dis. Sci. 40: 571-574 (1995).

• Raddino R, Bonadei I, Teli M, Chieppa F, Caretta G, Robba D, Zanini G, Vizzardi E, Cas LD. Peripartum cardiomyopathy. Monaldi Arch. Chest Dis. 70: 15-23 (2008).

• Rahimi R, Nikfar S, Rezaie A, Abdollahi M. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis. Reprod. Toxicol. 25: 271-275 (2008).

• Raine T, Allen R. MHC-I recognition by receptors on myelomonocytic cells: new tricks for old dogs? Bioessays 27: 542-550 (2005). *

• Rajapakse R, Korelitz BI. Inflammatory bowel disease during pregnancy. Curr. Treat. Options Gastroenterol. 4: 245-251 (2001).

• Rajapakse RO, Korelitz BI, Zlatanic J, Baiocco PJ, Gleim GW. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease. Am. J. Gastroenterol. 95: 684-688 (2000). *

• Rajewski M, Skrzypczak J. Frequency of antiphospholipid antibodies and factor V (G1691A), prothrombin (G20210A) gene polimorphism among women with pregnancy complications. Pol. Arch. Med. Wewn. 115: 417-425 (2006).

• Rak JM, Maestroni L, Balandraud N, Guis S, Boudinet H, Guzian MC, Yan Z, Azzouz D, Auger I, Roudier C, Martin M, Didelot R, Roudier J, Lambert NC. Transfer of the shared epitope through microchimerism in women with rheumatoid arthritis. Arthritis Rheum. 60: 73-80 (2009). *

• Rak JM, Pagni PP, Tiev K, Allanore Y, Farge D, Harle JR, Launay D, Hachulla E, Didelot R, Cabane J, Kahan A, Martin M, Granel B, Roudier J, Lambert NC. Male microchimerism and HLA compatibility in French women with sclerodema: a different profile in limited and diffuse subset. Rheumatology (Oxford) 48: 363-366 (2009).

• Ramakrishnan U, Neufeld LM, Flores R, Rivera J, Martorell R. Multiple micronutrient supplementation during early childhood increases child size at 2 y of age only among high compliers. Am. J. Clin. Nutr. 89: 1125-1131 (2009).

• Ramos-Lopez E, Kahles H, Weber S, Kukic A, Penna-Martinez M, Louwen F, Badenhoop K. Gestational diabetes mellitus and vitamin D deficiency: genetic contribution of CYP27B1 and CYP2R1 polymorphisms. Diabetes Obes. Metab. 10: 683-685 (2008). *

• Rand JH. The antiphospholipid syndrome. Hematology Am. Soc. Hematol. Educ. Program 2007: 136-142 (2007). *

• Raqib R, Hossain MB, Kelleher SL, Stephensen CB, Lonnerdal B. Zinc supplementation of pregnant rats with adequate zinc nutriture suppresses immune functions in their offspring. J. Nutr. 137: 1037-1042 (2007). *

• Ratajska A, Ciszek B, Zajaczkowska A, Jablonska A, Juszynski M. Angioarchitecture of the venous and capillary system in heart defects induced by retinoic acid in mice. Birth Defects Res. A. Clin. Mol. Teratol. Mar 20 [Epub ahead of print] (2009).

• Rautou PE, Angermayr B, Garcia-Pagan JC, Moucari R, Peck-Radosavljevic M, Raffa S, Bernuau J, Condat B, Levardon M, Yver C, Ducarme G, Luton D, Denninger MH, Valla D, Plessier A. Pregnancy in women with known and treated Budd-Chiari syndrome: maternal and fetal outcomes. J. Hepatol. 51: 47-54 (2009).

• Rautou PE, Plessier A, Bernuau J, Denninger MH, Moucari R, Valla D. Pregnancy: a risk factor for Budd-Chiari syndrome? Gut 58: 606-608 (2009).

• Raynard Ortiz M, Jamart V, Cambray C, Borras R, Mailan J. Anesthetic management in a pregnant woman suffering from idiopathic thrombocytopenic purpura. Rev. Esp. Anestesiol. Reanim. 56: 185-188 (2009).

• Raza S, Ullah K, Ahmed P, Khan B. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia. J. Coll. Physicians Surg. Pak. 18: 546-550 (2008).

• Rebar RW. Premature ovarian "failure" in the adolescent. Ann. N. Y. Acad. Sci. 1135: 138-145 (2008). *

• Rebar RW. Premature ovarian failure. Obstet. Gynecol. 113: 1355-1363 (2009).

• Reddy D, Murphy SJ, Kane SV, Present DH, Kornbluth AA. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes. Am. J. Gastroenterol. 103: 1203-1209 (2008). *

• Reddy H, Jamil K. Polymorphisms in the MTHFR gene and their possible association with susceptibility to childhood acute lymphocytic leukemia in an Indian population. Leuk. Lymphoma 47: 1333-1339 (2006).

• Redecha P, Franzke CW, Ruf W, Mackman N, Girardi G. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome. J. Clin. Invest. 118: 3453-3461 (2008). *

• Rees AM, Austin MP, Owen C, Parker G. Omega-3 deficiency associated with perinatal depression: case control study. Psychiatry Res. 166: 254-259 (2009).

• Rees WD, McNeil CJ, Maloney CA. The roles of PPARs in the fetal origins of metabolic health and disease. PPAR Res. 2008: 459030 (2008). *

• Rehan VK, Sakurai R, Wang Y, Santos J, Huynh K, Torday JS. Reversal of nicotine-induced alveolar lipofibroblast-to-myofibroblast transdifferentiation by stimulants of parathyroid hormone-related protein signaling. Lung 185: 151-159 (2007).

• Reichen J. Drug treatment of cholestatic liver diseases. Ther. Umsch. 49: 315-325 (1992).

• Reichenbach J, Van de Velde H, De Rycke M, Staessen C, Platteau P, Baetens P, Gungor T, Ozsahin H, Scherer F, Siler U, Seger RA, Liebaers I. First successful bone marrow transplantation for X-linked chronic granulomatous disease by using preimplantation female gender typing and HLA matching. Pediatrics 122: e778-e782 (2008). *

• Reichrath J, Querings K. Vitamin D deficiency during pregnancy: a risk factor not only for fetal growth and bone metabolism but also for correct development of the fetal immune system? Am. J. Clin. Nutr. 81: 1177 (2005). *

• Reindl W, Schmid RM, Huber W. Cyclosporin A treatment of steroid-refractory ulcerative colitis during pregnancy: report of two cases. Gut 56: 1019 (2007). *

• Reinisch W, Dejaco C, Knoflach P, Petritsch W, Vogelsang H, Tilg H. Immunosuppressive therapy for inflammatory bowel disease: consensus by the Austrian Working Group on IBD. Z. Gastroenterol. 42: 1033-1045 (2004).

• Requena L, Sanchez Yus E. Erythema nodosum. Semin. Cutan. Med. Surg. 26: 114-125 (2007).

• Requena L, Yus ES. Erythema nodosum. Dermatol. Clin. 26: 425-438 (2008).

• Retnakaran R, Connelly PW, Sermer M, Zinman B, Hanley AJ. The impact of family history of diabetes on risk factors for gestational diabetes. Clin. Endocrinol. (Oxf.) 67: 754-760 (2007). *

• Reyes H. Review: intrahepatic cholestasis. A puzzling disorder of pregnancy. J. Gastroenterol. Hepatol. 12: 211-216 (1997).

• Reyes H. Sex hormones and bile acids in intrahepatic cholestasis of pregnancy. Hepatology 47: 376-379 (2008). *

• Reyes H. The spectrum of liver and gastrointestinal disease seen in cholestasis of pregnancy. Gastroenterol. Clin. North Am. 21: 905-921 (1992).

• Reyes H, Palma J, Ribalta J. Recurrent familial cholestasis disclosed by pregnancy. Gastroenterology 114: 1354-1355 (1998). *

• Reyes H, Ribalta J, Hernandez I, Arrese M, Pak N, Wells M, Kirsch RE. Is dietary erucic acid hepatotoxic in pregnancy? An experimental study in rats and hamsters. Hepatology 21: 1373-1379 (1995).

• Reyes H, Simon FR. Intrahepatic cholestasis of pregnancy: an estrogen-related disease. Semin. Liver Dis. 13: 289-301 (1993).

• Reyes H, Sjovall J. Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy. Ann. Med. 32: 94-106 (2000).

• Reyes H, Zapata R, Hernandez I, Gotteland M, Sandoval L, Jiron MI, Palma J, Almuna R, Silva JJ. Is a leaky gut involved in the pathogenesis of intrahepatic cholestasis of pregnancy? Hepatology 43: 715-722 (2006). *

• Reza-Lopez SA, Anderson GH, Szeto IM, Taha AY, Ma DW. High vitamin intake by Wistar rats during pregnancy alters tissue fatty acid concentration in the offspring fed an obesogenic diet. Metabolism 58: 722-730 (2009).

• Ribalta J, Reyes H, Gonzalez MC, Iglesias J, Arrese M, Poniachik J, Molina C, Segovia N. S-Adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results. Hepatology 13: 1084-1089 (1991).

• Ribalta J, Reyes H, Hernandez I, Fuentes O, Baez M, Gonzalez M, Palma J. Can a selenium deficiency affect the pathogenesis of cholestasis in pregnancy? Gastroenterol. Hepatol. 18: 114-120 (1995).

• Richter JE. Gastroesophageal reflux disease during pregnancy. Gastroenterol. Clin. North Am. 32: 235-261 (2003). *

• Riely CA, Bacq Y. Intrahepatic cholestasis of pregnancy. Clin. Liver Dis. 8: 167-176 (2004).

• Riis L, Vind I, Politi P, Wolters F, Vermeire S, Tsianos E, Freitas J, Mouzas I, Ochoa VR, O'Morain C, Odes S, Binder V, Moum B, Stockbrugger R, Langholz E, Munkholm P, on behalf of the European Collaborative study group on Inflammatory Bowel Disease. Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am. J. Gastroenterol. 101: 1539-1545 (2006). *

• Rinaldo P. Fatty acid transport and mitochondrial oxidation disorders. Semin. Liver Dis. 21: 489-500 (2001).

• Rinella ME. Pregnancy after liver transplantation. Ann. Hepatol. 5: 212-215 (2006). *

• Ringel I, Zettl UK. Intravenous immunoglobulin therapy in neurological diseases during pregnancy. J. Neurol. 253 Suppl. 5: v70-v74 (2006).

• Ringseis R, Gutgesell A, Dathe C, Brandsch C, Eder K. Feeding oxidized fat during pregnancy up-regulates expression of PPARalpha-responsive genes in the liver of rat fetuses. Lipids Health Dis. 6: 6 (2007). *

• Rivoire C, Houlle C, Bonnin M, Cotte B, Bolandard F, Nohuz E, Jardon K, Rabischong B, Canis M, Mage G. Autoimmune hepatitis and pregnancy: about a patient's three consecutive pregnancies. Gynecol. Obstet. Fertil. 36: 299-305 (2008).

• Rizzo R, Melchiorri L, Stignani M, Baricordi OR. HLA-G expression is a fundamental prerequisite to pregnancy. Hum. Immunol. 68: 244-250 (2007).

• Rizzo R, Stignani M, Amoudruz P, Nilsson C, Melchiorri L, Baricordi O, Sverremark-Ekstrom E. Allergic women have reduced sHLA-G plasma levels at delivery. Am. J. Reprod. Immunol. 61: 368-376 (2009).

• Roberts SE, Williams JG, Meddings D, Davidson R, Goldacre MJ. Perinatal risk factors and coeliac disease in children and young adults: a record linkage study. Aliment. Pharmacol. Ther. 29: 222-231 (2009). *

• Robertson B, Greaves M. Antiphospholipid syndrome: an evolving story. Blood Rev. 20: 201-212 (2006).

• Robinson NJ, Glazier JD, Greenwood SL, Baker PN, Aplin JD. Tissue transglutaminase expression and activity in placenta. Placenta 27: 148-157 (2006).

• Rodriguez LM, Giraldo MC, Garcia N, Velasquez L, Paris SC, Alvarez CM, Garcia LF. Human leucocyte antigen gene (HLA-A, HLA-B, HLA-DRB1) frequencies in deceased organ donors. Biomedica 27: 537-547 (2007).

• Rodriguez-Garay EA. Cholestasis: human disease and experimental animal models. Ann. Hepatol. 2: 150-158 (2003). *

• Rogers MS, D'Amato RJ. The effect of genetic diversity on angiogenesis. Exp. Cell. Res. 312: 561-574 (2006). *

• Romanowicz L, Bankowski E. Lipid compounds of the umbilical cord artery and their alterations in preeclampsia. Atherosclerosis 204: e44-e51 (2009).

• Romero Arauz JF, Garcia Alonso Lopez A, Gonzalez AL, Rivera Velasquez P, Ayala Mendez JA. Antiphospholipid syndrome and pregnancy. Ginecol. Obstet. Mex. 74: 367-375 (2006).

• Romero-Mate A, Garcia-Donoso C, Cordoba-Guijarro S. Efficacy and safety of etanercept in psoriasis/psoriatic arthritis: an updated review. Am. J. Clin. Dermatol. 8: 143-155 (2007).

• Romieu I, Torrent M, Garcia-Esteban R, Ferrer C, Ribas-Fito N, Anto JM, Sunyer J. Maternal fish intake during pregnancy and atopy and asthma in infancy. Clin. Exp. Allergy 37: 518-525 (2007). *

• Roncaglia N, Locatelli A, Arreghini A, Assi F, Cameroni I, Pezzullo JC, Ghidini A. A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of gestational cholestasis. BJOG 111: 17-21 (2004).

• Ropponen A, Aittomaki K, Vihma V, Tikkanen MJ, Ylikorkala O. Effects of oral and transdermal estradiol administration on levels of sex hormone-binding globulin in postmenopausal women with and without a history of intrahepatic cholestasis of pregnancy. J. Clin. Endocrinol. Metab. 90: 3431-3434 (2005). *

• Ropponen A, Sund R, Riikonen S, Ylikorkala O, Aittomaki K. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology 43: 723-728 (2006). *

• Rose RF, Batchelor RJ, Turner D, Goulden V. Narrowband ultraviolet B phototherapy does not influence serum and red cell folate levels in patients with psoriasis. J. Am. Acad. Dermatol. Jun 1 [Epub ahead of print] (2009).

• Rosenthal P. Digestive disease week 2000. American association for the study of liver diseases. IDrugs 3: 868-871 (2000).

• Rosmorduc O, Hermelin B, Boelle PY, Poupon RE, Poupon R, Chazouilleres O. ABCB4 gene mutations and primary sclerosing cholangitis. Gastroenterology 126: 1220-1222 (2004). *

• Rosner I, Haddad A, Boulman N, Feld J, Avshovich N, Slobodin G, Rozenbaum M. Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy. Rheumatology (Oxford) 46: 1508 (2007). *

• Rotondi M, Cappelli C, Pirali B, Pirola I, Magri F, Fonte R, Castellano M, Agabiti Rosei E, Chiovato L. The effect of pregnancy on subsequent relapse from Graves' disease following a successful course of anti-thyroid drug therapy. J. Clin. Endocrinol. Metab. 93: 3985-3988 (2008). *

• Rouas-Freiss N, Naji A, Durrbach A, Carosella ED. Tolerogenic functions of human leukocyte antigen G: from pregnancy to organ and cell transplantation. Transplantation 84: S21-S25 (2007).

• Roussev RG, Coulam CB. HLA-G and its role in implantation (review). J. Assist. Reprod. Genet. 24: 288-295 (2007).

• Rovere-Querini P, Castiglioni MT, Sabbadini MG, Manfredi AA. Signals of cell death and tissue turnover during physiological pregnancy, pre-eclampsia, and autoimmunity. Autoimmunity 40: 290-294 (2007).

• Rowe AM, Brundage KM, Schafer R, Barnett JB. Immunomodulatory effects of maternal atrazine exposure on male Balb/c mice. Toxicol. Appl. Pharmacol. 214: 69-77 (2006). *

• Rudi J, Schonig T, Stremmel W. Therapy with ursodeoxycholic acid in primary biliary cirrhosis in pregnancy. Z. Gastroenterol. 34: 188-191 (1996).

• Rudolph MC, Neville MC, Anderson SM. Lipid synthesis in lactation: diet and the fatty acid switch. J. Mammary Gland Biol. Neoplasia 12: 269-281 (2007). *

• Rust DW, Bianchi DW. Microchimerism in endocrine pathology. Endocr. Pathol. 20: 11-16 (2009).

• Rutherford AE, Pratt DS. Cholestasis and cholestatic syndromes. Curr. Opin. Gastroenterol. 22: 209-214 (2006). *

• Rutherford ME, Dockerty JD, Jasseh M, Howie SR, Herbison P, Jeffries DJ, Mulholland K, Adegbola RA, Hill PC. Preventive measures in infancy to reduce under-five mortality: a case-control study in The Gambia. Trop. Med. Int. Health 14: 149-155 (2009).

• Saadatnia M, Fatehi F, Basiri K, Mousavi SA, Mehr GK. Cerebral venous sinus thrombosis risk factors. Int. J. Stroke 4: 111-123 (2009).

• Saar P, Hermann W, Muller-Ladner U. Connective tissue diseases and pregnancy. Rheumatology (Oxford) 45 Suppl. 3: iii30-iii32 (2006). *

• Sabel KG, Lundqvist-Persson C, Bona E, Petzold M, Strandvik B. Fatty acid patterns early after premature birth, simultaneously analysed in mothers' food, breast milk and serum phospholipids of mothers and infants. Lipids Health Dis. 8: 20 (2009).

• Sadowska A, Hebanowski M, Trzeciak B, Kliszcz J, Nowicka-Sauer K, Waldman M. Retrospective evaluation of pregnancy in women suffering from systemic lupus erythematosus (SLE). Ginekol. Pol. 76: 955-959 (2005).

• Sakai H, Tanaka Y, Tanaka M, Ban N, Yamada K, Matsumura Y, Watanabe D, Sasaki M, Kita T, Inagaki N. ABCA2 deficiency results in abnormal sphingolipid metabolism in mouse brain. J. Biol. Chem. 282: 19692-19699 (2007). *

• Salam MT, Gauderman WJ, McConnell R, Lin PC, Gilliland FD. Transforming growth factor-beta1 C-509T polymorphism, oxidant stress, and early onset childhood asthma. Am. J. Respir. Crit. Care Med. 176: 1192-1199 (2007). *

• Saldeen P, Saldeen T. Women and omega-3 fatty acids. Obstet. Gynecol. Surv. 59: 722-730 (2004).

• Saldeen P, Saldeen T. Omega-3 fatty acids: structure, function, and relation to the metabolic syndrome, infertility, and pregnancy. Metab. Syndr. Relat. Disord. 4: 138-148 (2006).

• Saleh MM, Abdo KR. Intrahepatic cholestasis of pregnancy: review of the literature and evaluation of current evidence. J. Womens Health (Larchmt.) 16: 833-841 (2007).

• Salleh N, Baines DL, Naftalin RJ, Milligan SR. The hormonal control of uterine luminal fluid secretion and absorption. J. Membr. Biol. 206: 17-28 (2005). *

• Salvatore S, Finazzi S, Radaelli G, Lotzniker M, Zuccotti GV; Premacel Study Group. Prevalence of undiagnosed celiac disease in the parents of preterm and/or small for gestational age infants. Am. J. Gastroenterol. 102: 168-173 (2007). *

• Samsami Dehaghani A, Doroudchi M, Kalantari T, Pezeshki AM, Ghaderi A. Heterozygosity in CTLA-4 gene and severe preeclampsia. Int. J. Gynaecol. Obstet. 88: 19-24 (2005).

• Samuel D, Riordan S, Strasser S, Kurtovic J, Singh-Grewel I, Koorey D. Severe autoimmune hepatitis first presenting in the early post partum period. Clin. Gastroenterol. Hepatol. 2: 622-624 (2004). *

• Samuelsson AM, Matthews PA, Argenton M, Christie MR, McConnell JM, Jansen EH, Piersma AH, Ozanne SE, Twinn DF, Remacle C, Rowlerson A, Poston L, Taylor PD. Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance. A novel murine model of developmental programming. Hypertension 51: 383-392 (2008).

• Sanchez Carazo JL, Mahiques Santos L, Oliver Martinez V. Safety of etanercept in psoriasis: a critical review. Drug Saf. 29: 675-685 (2006).

• Sanchez-Ramon S, Navarro A J, Aristimuno C, Rodriguez-Mahou M, Bellon JM, Fernandez-Cruz E, Andres C. Pregnancy-induced expansion of regulatory T-lymphocytes may mediate protection to multiple sclerosis activity. Immunol. Lett. 96: 195-201 (2005).

• Sandhu BS, Sanyal AJ. Pregnancy and liver disease. Gastroenterol. Clin. North Am. 32: 407-436, ix (2003). *

• Sapin V. Alcohol and pregnancy: diagnostic aspects and abnormalities in the placental vitamin A pathway. Ann. Biol. Clin. (Paris) 66: 509-513 (2008).

• Sapir T, Blank M, Shoenfeld Y. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss. Ann. N. Y. Acad. Sci. 1051: 743-778 (2005). *

• Sapir T, Shoenfeld Y. Facing the enigma of immunomodulatory effects of intravenous immunoglobulin. Clin. Rev. Allergy Immunol. 29: 185-200 (2005).

• Sarafana S, Coelho R, Neves A, Costa Trindade J. Gestational immunology. Acta Med. Port. 20: 355-358 (2008).

• Sarkar K, Miller FW. Possible roles and determinants of microchimerism in autoimmune and other disorders. Autoimmun. Rev. 3: 454-463 (2004).

• Sasaki S, Murase T, Kuno S, Yamamoto T. Changes of complement in recurrent abortion and pregnancy loss with antiphospholipid antibody positive. Nihon Rinsho Meneki Gakkai Kaishi 29: 372-377 (2006).

• Sasaki Y, Darmochwal-Kolarz D, Suzuki D, Sakai M, Ito M, Shima T, Shiozaki A, Rolinski J, Saito S. Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia. Clin. Exp. Immunol. 149: 139-145 (2007). *

• Sathyanarayana G, Saraya A. Ulcerative colitis and pregnancy. Trop. Gastroenterol. 25: 4-8 (2004).

• Sauk J, Kane S. The use of medications for inflammatory bowel disease during pregnancy and nursing. Expert Opin. Pharmacother. 6: 1833-1839 (2005).

• Savander M, Ropponen A, Avela K, Weerasekera N, Cormand B, Hirvioja ML, Riikonen S, Ylikorkala O, Lehesjoki AE, Williamson C, Aittomaki K. Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy. Gut 52: 1025-1029 (2003). *

• Sawyer SM, Cerritelli B, Carter LS, Cooke M, Glazner JA, Massie J. Changing their minds with time: a comparison of hypothetical and actual reproductive behaviors in parents of children with cystic fibrosis. Pediatrics 118: e649-e656 (2006). *

• Schaeffner F. The effect of oral contraceptives on the liver. J. Am. Med. Assoc. 198: 1019-1021 (1966).

• Schaffner F. The history of liver disease at The Mount Sinai Hospital. Mt. Sinai J. Med. 67: 76-83 (2000). *

• Scheinfeld N, Bangalore S. Facial edema induced by isotretinoin use: a case and a review of the side effects of isotretinoin. J. Drugs Dermatol. 5: 467-468 (2006).

• Schenkein HA, Best AM, Brooks CN, Burmeister JA, Arrowood JA, Kontos MC, Tew JG. Anti-cardiolipin and increased serum adhesion nolecule levels in patients with aggressive periodontitis. J. Periodontol. 78: 459-466 (2007).

• Scher MS. Maternal ulcerative colitis and fetal brain injury: long-term neurologic outcome. J. Child. Neurol. 22: 1293-1296 (2007).

• Schirmer BD, Winters KL, Edlich RF. Cholelithiasis and cholecystitis. J. Long. Term Eff. Med. Implants 15: 329-338 (2005).

• Schneider G, Paus TC, Kullak-Ublick GA, Meier PJ, Wienker TF, Lang T, van de Vondel P, Sauerbruch T, Reichel C. Linkage between a new splicing site mutation in the MDR3 alias ABCB4 gene and intrahepatic cholestasis of pregnancy. Hepatology 45: 150-158 (2007). *

• Schoyer KD, Gilbert F, Rosenwaks Z. Infertility and abnormal cervical mucus in two sisters who are compound heterozygotes for the cystic fibrosis (CF) DeltaF508 and R117H/7T mutations. Fertil. Steril. 90: 1201.e19-e22 (2008).

• Schramm C, Herkel J, Beuers U, Kanzler S, Galle PR, Lohse AW. Pregnancy in autoimmune hepatitis: outcome and risk factors. Am. J. Gastroenterol. 101: 556-560 (2006). *

• Schrijver I, Oitmaa E, Metspalu A, Gardner P. Genotyping microarray for the detection of more than 200 CFTR mutations in ethnically diverse populations. J. Mol. Diagn. 7: 375-387 (2005). *

• Schroder O, Mickisch O, Seidler U, de Weerth A, Dignass AU, Herfarth H, Reinshagen M, Schreiber S, Junge U, Schrott M, Stein J. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease - a randomized, controlled, open-label, multicenter study. Am. J. Gastroenterol. 100: 2503-2509 (2005). *

• Schroeder KW. Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications. Scand. J. Gastroenterol. Suppl. 236: 42-47 (2002). *

• Schuchmann S, Dorner T. Antiphospholipid syndrome 2007: current aspects of laboratory diagnostics and their therapeutic consequences. Z. Rheumatol. 66: 198-205 (2007).

• Schulz SW, Bober M, Johnson C, Braverman N, Jimenez SA. Maternal mixed connective tissue disease and offspring with chondrodysplasia punctata. Semin. Arthritis Rheum. Dec 23 [Epub ahead of print] (2008). *

• Schumann R, Hudcova J. Cholestasis of pregnancy, pruritus and 5-hydroxytryptamine 3 receptor antagonists. Acta Obstet. Gynecol. Scand. 83: 861-862 (2004).

• Schunk MK, Macallum GE. Applications and optimization of immunization procedures. ILAR J. 46: 241-257 (2005). *

• Schwahn BC, Laryea MD, Chen Z, Melnyk S, Pogribny I, Garrow T, James SJ, Rozen R. Betaine rescue of an animal model with methylenetetrahydrofolate reductase deficiency. Biochem. J. 382: 831-840 (2004). *

• Schwalfenberg G. Recommend omega-3 fatty acids in pregnancy? Can. Fam. Physician 53: 1299-1300 (2007).

• Schwartz N, Shoenfeld Y, Barzilai O, Cervera R, Font J, Blank M, Yacobi S, Patlas N, Cohen A, Mevorach D, Ornoy A. Reduced placental growth and hCG secretion in vitro induced by antiphospholipid antibodies but not by anti-Ro or anti-La: studies on sera from women with SLE/PAPS. Lupus 16: 110-120 (2007).

• Schwendimann RN, Alekseeva N. Gender issues in multiple sclerosis. Int. Rev. Neurobiol. 79C: 377-392 (2007).

• Scotet V, Dugueperoux I, Audrezet MP, Blayau M, Boisseau P, Journel H, Parent P, Ferec C. Prenatal diagnosis of cystic fibrosis: the 18-year experience of Brittany (western France). Prenat. Diagn. 28: 197-202 (2008).

• Scully MA, Machin SJ. Berend Houwen Memorial Lecture: ISLH Las Vegas May 2009: the pathogenesis and management of thrombotic microangiopathies. Int. J. Lab. Hematol. 31: 268-276 (2009).

• See AW, Kaiser ME, White JC, Clagett-Dame M. A nutritional model of late embryonic vitamin A deficiency produces defects in organogenesis at a high penetrance and reveals new roles for the vitamin in skeletal development. Dev. Biol. 316: 171-190 (2008). *

• Seeger JD, Lanza LL, West WA, Fernandez C, Rivero E. Pregnancy and pregnancy outcome among women with inflammatory skin diseases. Dermatology 214: 32-39 (2007).

• Seeman MV. Secondary effects of antipsychotics: women at greater risk than men. Schizophr. Bull. Apr 9 [Epub ahead of print] (2008).

• Segerer S, Muller N, van den Brandt J, Kapp M, Dietl J, Reichardt H, Rieger L, Kammerer U. Modulation of maturation and function of dendritic cells by female sex steroid hormones. Am. J. Reprod. Immunol. 60: 86 (2008). *

• Sela HY, Rojansky N, Hershko AY. Reproduction and ulcerative colitis: a review. J. Reprod. Med. 50: 361-366 (2005).

• Semkova K, Black M. Pemphigoid gestationis: current insights into pathogenesis and treatment. Eur. J. Obstet. Gynecol. Reprod. Biol. Jun 9 [Epub ahead of print] (2009).

• Semrad CE. Zinc and intestinal function. Curr. Gastroenterol. Rep. 1: 398-403 (1999).

• Sentilhes L, Bacq Y. Intrahepatic cholestasis of pregnancy. J. Gynecol. Obstet. Biol. Reprod. (Paris) 37: 118-126 (2008).

• Sentilhes L, Verspyck E, Pia P, Marpeau L. Fetal death in a patient with intrahepatic cholestasis of pregnancy. Obstet. Gynecol. 107: 458-460 (2006).

• Sentilhes L, Verspyck E, Roman H, Marpeau L. Intrahepatic cholestasis of pregnancy and bile acid levels. Hepatology 42: 737-738 (2005). *

• Serrano MA, Macias RI, Vallejo M, Briz O, Bravo A, Pascual MJ, St-Pierre MV, Stieger B, Meier PJ, Marin JJ. Effect of ursodeoxycholic acid on the impairment induced by maternal cholestasis in the rat placenta-maternal liver tandem excretory pathway. J. Pharmacol. Exp. Ther. 305: 515-524 (2003). *

• Shah SB, Hanauer SB. Treatment of diarrhea in patients with inflammatory bowel disease: concepts and cautions. Rev. Gastroenterol. Disord. 7 Suppl. 3: S3-S10 (2007).

• Shand AW, Dickinson JE, D'Orsogna L. Refractory fetal supraventricular tachycardia and obstetric cholestasis. Fetal Diagn. Ther. 24: 277-281 (2008).

• Shao Y, Yao Z, Lu J, Li H, Wu W, Ding M. Change of heart rate power spectrum and its association with sudden death in the fetuses of rats with intrahepatic cholestasis of pregnancy. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 24: 1215-129 (2007).

• Sheiner E, Peleg R, Levy A. Pregnancy outcome of patients with known celiac disease. Eur. J. Obstet. Gynecol. Reprod. Biol. 129: 41-45 (2006).

• Sherer Y, Blank M, Shoenfeld Y. Antiphospholipid syndrome (APS): where does it come from? Best Pract. Res. Clin. Rheumatol. 21: 1071-1078 (2007).

• Sherlock S. Patterns of hepatocyte injury in man. Lancet 1: 782-786 (1982).

• Shetty S, Ghosh K. Anti-phospholipid antibodies and other immunological causes of recurrent foetal loss - a review of literature of various therapeutic protocols. Am. J. Reprod. Immunol. 62: 9-24 (2009).

• Shi QY, Kong BH, Ma KD, Zhang XL, Jiang S. Effects of ursodeoxycholic acid on the liver plasma membrane fluidity, hepatic glutathione concentration, hepatic estrogen receptors and progesterone receptors in pregnant rats with ethinylestradiol and progesterone induced intrahepatic cholestasis. Zhonghua Fu Chan Ke Za Zhi 38: 680-682 (2003).

• Shigeru S, Akitoshi N, Subaru MH, Shiozaki A. The balance between cytotoxic NK cells and regulatory NK cells in human pregnancy. J. Reprod. Immunol. 77: 14-22 (2008).

• Shoenfeld Y, Carp HJ, Molina V, Blank M, Cervera R, Balasch J, Tincani A, Faden D, Lojacono A, Doria A, Konova E, Meroni PL. Autoantibodies and prediction of reproductive failure. Am. J. Reprod. Immunol. 56: 337-344 (2006).

• Shoenfeld Y, Twig G, Katz U, Sherer Y. Autoantibody explosion in antiphospholipid syndrome. J. Autoimmun. 30: 74-83 (2008).

• Shoji H, Franke C, Demmelmair H, Koletzko B. Effect of docosahexaenoic acid on oxidative stress in placental trophoblast cells. Early Hum. Dev. Mar 25 [Epub ahead of print] (2009).

• Shovman O, Gilburd B, Barzilai O, Langevitz P, Shoenfeld Y. Novel insights into associations of antibodies against cardiolipin and beta2-glycoprotein i with clinical features of antiphospholipid syndrome. Clin. Rev. Allergy Immunol. 32: 145-152 (2007).

• Showkat A, Lo A, Shokouh-Amiri H, Nezakatgoo N, Gaber AO, Mya M, Egidi MF. Are autoimmune diseases or glomerulonephritis affecting the development of panel-reactive antibodies in candidates for renal transplantation? Transplant. Proc. 37: 645-647 (2005). *

• Sidorova IS, Borovkova EI, Martynova IV, Shemanaeva TV, Solonitsyn AN. The role of immune placental inflammation in the genesis of complicated pregnancy. Vestn. Ross. Akad. Med. Nauk. 9: 32-37 (2007).

• Sills ES, Walsh DJ, Shkrobot LV, Palermo GD, Walsh AP. Clinical experience with intravenous immunoglobulin and TNF-alpha inhibitor therapies for recurrent pregnancy loss. Ulster Med. J. 78: 57-58 (2009).

• Silman AJ, Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 4 Suppl. 3: S265-S272 (2002). *

• Simcox AM, Hewison J, Duff AJ, Morton AM, Conway SP. Decision-making about pregnancy for women with cystic fibrosis. Br. J. Health Psychol. 14: 323-342 (2009).

• Simpson E. A historical perspective on immunological privilege. Immunol. Rev. 213: 12-22 (2006). *

• Simpson PW, Melmed GY, Dubinksy M. The impact of medical therapy for inflammatory bowel disease on pregnancy outcome. Am. J. Gastroenterol. 103: 805-806 (2008).

• Singh N, Perfect JR. Immune reconstitution syndrome and exacerbation of infections after pregnancy. Clin. Infect. Dis. 45: 1192-1199 (2007).

• Sinha S, Taly AB, Prashanth LK, Arunodaya GR, Swamy HS. Successful pregnancies and abortions in symptomatic and asymptomatic Wilson's disease. J. Neurol. Sci. 217: 37-40 (2004). *

• Sinikovic DS, Yeatman HR, Cameron D, Meyer BJ. Women's awareness of the importance of long-chain omega-3 polyunsaturated fatty acid consumption during pregnancy: knowledge of risks, benefits and information accessibility. Public Health Nutr. 12: 562-569 (2009).

• Sipak-Szmigiel O, Cybulski C, Lubinski J, Ronin-Walknowska E. HLA-G polymorphism in a Polish population and reproductive failure. Tissue Antigens 71: 67-71 (2008). *

• Sipak-Szmigiel O, Cybulski C, Ronin-Walknowska E, Lubinski J. HLA-G alleles and risk of early pregnancy loss. Ann. Acad. Med. Stetin. 54: 60-64 (2008).

• Sipak-Szmigiel O, Ronin-Walknowska E, Miklaszewicz A, Dolubeczko A, Zejmo M, Giedrys-Kalemba S. Association between HLA-DQA1, HLA-DQB1 alleles and risk of early pregnancy loss. Ginekol. Pol. 78: 792-795 (2007).

• Sjovall J. Fifty years with bile acids and steroids in health and disease. Lipids 39: 703-722 (2004).

• Skomsvoll JF, Wallenius M, Koksvik HS, Rodevand E, Salvesen KA, Spigset O, Kvien TK. Drug insight: anti-tumor necrosis factor therapy for inflammatory arthropathies during reproduction, pregnancy and lactation. Nat. Clin. Pract. Rheumatol. 3: 156-164 (2007). *

• Slostad J, Stein QP, Flanagan JD, Hansen KA. Screening for mutations in the cystic fibrosis transmembrane regulator gene in an infertility clinic. Fertil. Steril. 88: 1687-1688 (2007). *

• Smallridge RC, Glinoer D, Hollowell JG, Brent G. Thyroid function inside and outside of pregnancy: what do we know and what don't we know? Thyroid 15: 54-59 (2005).

• Smith AD, Kim YI, Refsum H. Is folic acid good for everyone? Am. J. Clin. Nutr. 87: 517-533 (2008). *

• Smolarczyk R, Monika G, Jacek S, Krzysztof C. Successful perinatal outcome in an early onset intrahepatic cholestasis of pregnancy with extremely high serum hepatic function tests. Gynecol. Endocrinol. Jun 2 [Epub ahead of print] (2009).

• Sogaard KK, Horvath-Puho E, Gronbaek H, Jepsen P, Vilstrup H, Sorensen HT. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am. J. Gastroenterol. 104: 96-101 (2009). *

• Somm E, Schwitzgebel VM, Vauthay DM, Camm EJ, Chen CY, Giacobino JP, Sizonenko SV, Aubert ML, Huppi PS. Prenatal nicotine exposure alters early pancreatic islet and adipose tissue development with consequences on the control of body weight and glucose metabolism later in life. Endocrinology 149: 6289-6299 (2008). *

• Sommer SS. The importance of immune gene variability (MHC) in evolutionary ecology and conservation. Front. Zool. 2: 16 (2005).

• Song YZ, Li BX, Hao H, Xin RL, Zhang T, Zhang CH, Kobayashi K, Wang ZZ, Zheng XY. Selective screening of inborn errors of metabolism and secondary methylmalonic aciduria in pregnancy at high risk district of neural tube defects: a human metabolome study by GC-MS in China. Clin. Biochem. 41: 616-620 (2008). *

• Sonntag B, Stolze B, Heinecke A, Luegering A, Heidemann J, Lebiedz P, Rijcken E, Kiesel L, Domschke W, Kucharzik T, Maaser C. Preterm birth but not mode of delivery is associated with an increased risk of developing inflammatory bowel disease later in life. Inflamm. Bowel Dis. 13: 1385-1390 (2007). *

• Sontrop J, Avison WR, Evers SE, Speechley KN, Campbell MK. Depressive symptoms during pregnancy in relation to fish consumption and intake of n-3 polyunsaturated fatty acids. Paediatr. Perinat. Epidemiol. 22: 389-399 (2008).

• Sookoian S. Liver disease during pregnancy: acute viral hepatitis. Ann. Hepatol. 5: 231-236 (2006). *

• Sookoian S. Effect of pregnancy on pre-existing liver disease: chronic viral hepatitis. Ann. Hepatol. 5: 190-197 (2006). *

• Sookoian S, Castano G, Burgueno A, Gianotti TF, Pirola CJ. Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy. J. Hepatol. 48: 125-132 (2008). *

• Sookoian S, Castano G, Pirola CJ. Role of ABCC2 common variants in intrahepatic cholestasis of pregnancy. World J. Gastroenterol. 14: 2126-2127 (2008). *

• Soos JM, Johnson HM. Interferon-tau: prospects for clinical use in autoimmune disorders. BioDrugs 11: 125-135 (1999).

• Sorensen HT, Larsen H, Jensen ES, Thulstrup AM, Schonheyder HC, Nielsen GL, Czeizel A. Safety of metronidazole during pregnancy: a cohort study of risk of congenital abnormalities, preterm delivery and low birth weight in 124 women. J. Antimicrob. Chemother. 44: 854-856 (1999). *

• Soska V. Secondary dyslipidemias and their treatment. Vnitr. Lek. 53: 396-400 (2007).

• Soubassi L, Haidopoulos D, Sindos M, Pilalis A, Chaniotis D, Diakomanolis E, Antsaklis A, Zerefos N. Pregnancy outcome in women with pre-existing lupus nephritis. J. Obstet. Gynaecol. 24: 630-634 (2004).

• Soulimane-Mokhtari NA, Guermouche B, Saker M, Merzouk S, Merzouk H, Hichami A, Madani S, Khan NA, Prost J. Serum lipoprotein composition, lecithin cholesterol acyltransferase and tissue lipase activities in pregnant diabetic rats and their offspring receiving enriched n-3 PUFA diet. Gen. Physiol. Biophys. 27: 3-11 (2008).

• Spanos CP, Mamopoulos A, Tsapas A, Syrakos T, Kiskinis D. Female fertility and colorectal cancer. Int. J. Colorectal Dis. 23: 735-743 (2008). *

• Sparbel KJ, Williams JK. Pregnancy as foreground in cystic fibrosis carrier testing decisions in primary care. Genet. Test. Jan 8 [Epub ahead of print] (2009).

• Sparbel KJ, Williams JK. Pregnancy as foreground in cystic fibrosis carrier testing decisions in primary care. Genet. Test. Mol. Biomarkers 13: 133-142 (2009).

• Sperber K, Hom C, Peng Chao C, Shapiro D, Ash J, Aberientos C. Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases. Pediatr. Rheumatol. Online J. 7: 9 (2009). *

• Spinillo A, Beneventi F, Epis OM, Montanari L, Mammoliti D, Ramoni V, Di Silverio E, Alpini C, Caporali R, Montecucco C. Prevalence of undiagnosed autoimmune rheumatic diseases in the first trimester of pregnancy. Results of a two-steps strategy using a self-administered questionnaire and autoantibody testing. BJOG 115: 51-57 (2008). *

• Spong CY. Prediction and prevention of recurrent spontaneous preterm birth. Obstet. Gynecol. 110: 405-15 (2007).

• Stander S, Weisshaar E, Mettang T, Szepietowski JC, Carstens E, Ikoma A, Bergasa NV, Gieler U, Misery L, Wallengren J, Darsow U, Streit M, Metze D, Luger TA, Greaves MW, Schmelz M, Yosipovitch G, Bernhard JD. Clinical classification of itch: a position paper of the international forum for the study of itch. Acta Derm. Venereol. 87: 291-294 (2007). *

• Staroselsky A, Garcia-Bournissen F, Koren G. American Gastroenterological Association Institute medical position statement on the use of gastrointestinal medication in pregnancy. Gastroenterology 132: 824-825 (2007). *

• Stea EA, Routsias JG, Clancy RM, Buyon JP, Moutsopoulos HM, Tzioufas AG. Anti-LA/SSB antiidiotypic antibodies in maternal serum: a marker of low risk for neonatal lupus in an offspring. Arthritis Rheum. 54: 2228-2234 (2006). *

• Steer C, Emmett P, Lewis S, Smith GD, Tobias J. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with spinal BMD in nine-year-old children. J. Bone Miner. Res. 24: 117-124 (2009).

• Steinborn A, Saran G, Schneider A, Fersis N, Sohn C, Schmitt E. The presence of gestational diabetes is associated with increased detection of anti-HLA-class II antibodies in the maternal circulation. Am. J. Reprod. Immunol. 56: 124-134 (2006). *

• Stengel JZ, Arnold HL. Is infliximab safe to use while breastfeeding? World J. Gastroenterol. 14: 3085-3087 (2008). *

• Stevens AM. Do maternal cells trigger or perpetuate autoimmune diseases in children? Pediatr. Rheumatol. Online J. 5: 9 (2007). *

• Stevens AM. Microchimeric cells in systemic lupus erythematosus: targets or innocent bystanders? Lupus 15: 820-826 (2006).

• Stevens AM, Michael McDonnell W, Mullarkey ME, Pang JM, Leisenring W, Lee Nelson J. Liver biopsies from human females contain male hepatocytes in the absence of transplantation. Lab. Invest. 84: 1603-1609 (2004).

• Stevens AM, Tsao BP, Hahn BH, Guthrie K, Lambert NC, Porter AJ, Tylee TS, Nelson JL. Maternal HLA class II compatibility in men with systemic lupus erythematosus. Arthritis Rheum. 52: 2768-2773 (2005). *

• Stiehl A. Bile acids in liver diseases - current indications. Ther. Umsch. 52: 682-686 (1995).

• Stiehl A. Treatment of cholestatic liver diseases with phenobarbital and ursodeoxycholic acid. Z. Gastroenterol. 31 Suppl. 2: 129-130 (1993).

• Stipcevic T, Pivac N, Kozaric-Kovacic D, Muck-Seler D. Thyroid activity in patients with major depression. Coll. Antropol. 32: 973-976 (2008).

• Stojanovic M, Zivkovic I, Inic-Kanada A, Petrusic V, Micic M, Dimitrijevic L. The context of tetanus toxoid application influences the outcome of antigen-specific and self-directed humoral immune response. Microbiol. Immunol. 53: 89-100 (2009). *

• Stonek F, Hafner E, Metzenbauer M, Katharina S, Stumpflen I, Schneeberger C, Zeisler H, Husslein P, Philipp K. Absence of an association of tumor necrosis factor (TNF)-alpha G308A, interleukin-6 (IL-6) G174C and interleukin-10 (IL-10) G1082A polymorphism in women with preeclampsia. J. Reprod. Immunol. 77: 85-90 (2008).

• Stonek F, Hafner E, Philipp K, Hefler LA, Bentz EK, Tempfer CB. Methylenetetrahydrofolate reductase C677T polymorphism and pregnancy complications. Obstet. Gynecol. 110: 363-368 (2007).

• Stonek F, Metzenbauer M, Hafner E, Philipp K, Tempfer C. Interleukin-10 -1082 G/A promoter polymorphism and pregnancy complications: results of a prospective cohort study in 1,616 pregnant women. Acta Obstet. Gynecol. Scand. 87: 430-433 (2008).

• Stonek F, Metzenbauer M, Hafner E, Philipp K, Tempfer C. Interleukin 6 -174 G/C promoter polymorphism and pregnancy complications: results of a prospective cohort study in 1626 pregnant women. Am. J. Reprod. Immunol. 59: 347-351 (2008). *

• Strand S, Strand D, Seufert R, Mann A, Lotz J, Blessing M, Lahn M, Wunsch A, Broering DC, Hahn U, Grischke EM, Rogiers X, Otto G, Gores GJ, Galle PR. Placenta-derived CD95 ligand causes liver damage in hemolysis, elevated liver enzymes, and low platelet count syndrome. Gastroenterology 126: 849-858 (2004). *

• Strassburg CP. Autoimmune liver diseases. Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, pp. 66-70 (2005). *

• Strieder TG, Tijssen JG, Wenzel BE, Endert E, Wiersinga WM. Prediction of progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) Score. Arch. Intern. Med. 168: 1657-1663 (2008). *

• Strom M, Mortensen EL, Halldorson TI, Thorsdottir I, Olsen SF. Fish and long-chain n-3 polyunsaturated fatty acid intakes during pregnancy and risk of postpartum depression: a prospective study based on a large national birth cohort. Am. J. Clin. Nutr. May 27 [Epub ahead of print] (2009). *

• Su GL. Pregnancy and liver disease. Curr. Gastroenterol. Rep. 10: 15-21 (2008).

• Su KP, Huang SY, Chiu TH, Huang KC, Huang CL, Chang HC, Pariante CM. Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial. J. Clin. Psychiatry. 69: 644-651 (2008).

• Sueblinvong V, Whittaker LA. Fertility and pregnancy: common concerns of the aging cystic fibrosis population. Clin. Chest Med. 28: 433-443 (2007).

• Sugden MC, Holness MJ. Role of nuclear receptors in the modulation of insulin secretion in lipid-induced insulin resistance. Biochem. Soc. Trans. 36: 891-900 (2008). *

• Sugiyama M, Arakawa H, Ozawa K, Mizuno T, Mochizuki H, Tokuyama K, Morikawa A. Early-life risk factors for occurrence of atopic dermatitis during the first year. Pediatrics 119: e716-e723 (2007). *

• Suh JR, Herbig AK, Stover PJ. New perspectives on folate catabolism. Annu. Rev. Nutr. 21: 255-282 (2001). *

• Sukenik-Halevy R, Ellis MH, Fejgin MD. Management of immune thrombocytopenic purpura in pregnancy. Obstet. Gynecol. Surv. 63: 182-188 (2008).

• Summerfield JA. Liver failure. ENCYCLOPEDIA OF LIFE SCIENCES Nature Publishing Group www.els.net (2001). *

• Sundaram SS, Sokol RJ. The multiple facets of ABCB4 (MDR3) deficiency. Curr. Treat. Options Gastroenterol. 10: 495-503 (2007).

• Surawicz CM. Treatment of recurrent Clostridium difficile-associated disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 32-38 (2004). *

• Surawicz CM. Clostridium difficile disease: diagnosis and treatment. Gastroenterologist 6: 60-65 (1998).

• Surawicz CM, McFarland LV. Pseudomembranous colitis: causes and cures. Digestion 60: 91-100 (1999).

• Surriga O, Ortega A, Jadeja V, Bellafronte A, Lasala N, Zhou H. Altered hepatic inflammatory response in the offspring following prenatal LPS exposure. Immunol. Lett. 123: 88-95 (2009).

• Sweeney TR, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. Decreased nuclear hormone receptor expression in the livers of mice in late pregnancy. Am. J. Physiol. Endocrinol. Metab. 290: E1313-E1320 (2006). *

• Swift GL, Srivastava ED, Stone R, Pullan RD, Newcombe RG, Rhodes J, Wilkinson S, Rhodes P, Roberts G, Lawrie BW, et al. Controlled trial of anti-tuberculous chemotherapy for two years in Crohn's disease. Gut 35: 363-368 (1994). *

• Symmons DP. Looking back: rheumatoid arthritis - aetiology, occurrence and mortality. Rheumatology (Oxford) 44 Suppl. 4: iv14-iv17 (2005). *

• Szczepaniska M, Muszewska E, Szprynger K, Niwinska-Faryna B. Systemic lupus erythematosus and pregnancy. Wiad. Lek. 61: 161-165 (2008).

• Szepetiuk G, Melotte C, Pierard-Franchimont C, Quatresooz P, Pierard GE. How I explore...pruritus in a pregnant woman. Rev. Med. Liege. 62: 719-724 (2007).

• Sziller I, Hupuczi P, Normand N, Halmos A, Papp Z, Witkin SS. Fas (TNFRSF6) gene polymorphism in pregnant women with hemolysis, elevated liver enzymes, and low platelets and in their neonates. Obstet. Gynecol. 107: 582-587 (2006).

• Tait AS, Butts CL, Sternberg EM. The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease. J. Leukoc. Biol. 84: 924-931 (2008). *

• Takahashi K, Funayama Y, Fukushima K, Shibata C, Ogawa H, Kumagai E, Sasaki I. Pregnancy and delivery in patients with enterostomy due to anorectal complications from Crohn's disease. Int. J. Colorectal Dis. 22: 313-318 (2007). *

• Takaishi K, Miyoshi J, Matsumura T, Honda R, Ohba T, Katabuchi H. Hypertriglyceridemic acute pancreatitis during pregnancy: prevention with diet therapy and omega-3 fatty acids in the following pregnancy. Nutrition Jun 11 [Epub ahead of print] (2009).

• Tan J, Surti B, Saab S. Pregnancy and cirrhosis. Liver Transpl. 14: 1081-1091 (2008).

• Tan LK. Obstetric cholestasis: current opinions and management. Ann. Acad. Med. Singapore 32: 294-298 (2003).

• Tan LK, Kanagalingam D, Tan HK, Choong HL. Obstetric outcomes in women with end-stage renal failure requiring renal dialysis. Int. J. Gynaecol. Obstet. 94: 17-22 (2006).

• Tanaka A, Lindor K, Ansari A, Gershwin ME. Fetal microchimerisms in the mother: immunologic implications. Liver Transpl. 6: 138-143 (2000). *

• Tanaka E. Gender-related differences in pharmacokinetics and their clinical significance. J. Clin. Pharm. Ther. 24: 339-346 (1999). *

• Tanaka H, Umekawa T, Kikukawa T, Toyoda N. Autoimmune hepatitis complicated with antiphospholipid syndrome in pregnancy. Am. J. Reprod. Immunol. 47: 142-145 (2002). *

• Tanda ML, Piantanida E, Lai A, Lombardi V, Dalle Mule I, Liparulo L, Pariani N, Bartalena L. Thyroid autoimmunity and environment. Horm. Metab. Res. 41: 436-442 (2009).

• Tanis AA. Azathioprine in inflammatory bowel disease, a safe alternative? Mediators Inflamm. 7: 141-144 (1998). *

• Tanno H, Fay O, Palazzi J, Pedrana R, Yager E, Roncoroni M. LP-X in cholestasis. Acta Hepatogastroenterol. (Stuttg.) 22: 289-291 (1975).

• Tantisirin O, Puavilai S. Long-term follow-up of erythema nodosum. J. Med. Assoc. Thai. 86: 1095-1100 (2003).

• Tanyuksel M, Guney C, Araz E, Saracli MA, Doganci L. Performance of the immunoglobulin G avidity and enzyme immunoassay IgG/IgM screening tests for differentiation of the clinical spectrum of toxoplasmosis. J. Microbiol. 42: 211-215 (2004). *

• Tata LJ, Card TR, Logan RF, Hubbard RB, Smith CJ, West J. Fertility and pregnancy-related events in women with celiac disease: a population-based cohort study. Gastroenterology 128: 849-855 (2005). *

• Tavian D, Degiorgio D, Roncaglia N, Vergani P, Cameroni I, Colombo R, Coviello DA. A new splicing site mutation of the ABCB4 gene in intrahepatic cholestasis of pregnancy with raised serum gamma-GT. Dig. Liver Dis. Mar 2 [Epub ahead of print] (2009).

• Taylor WJ, Korendowych E, Nash P, Helliwell PS, Choy E, Krueger GG, Soriano ER, McHugh NJ, Rosen CF. Drug use and toxicity in psoriatic disease: focus on methotrexate. J. Rheumatol. 35: 1454-1457 (2008).

• Teml A, Schaeffeler E, Herrlinger KR, Klotz U, Schwab M. Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing. Clin. Pharmacokinet. 46: 187-208 (2007).

• Teng CL, Hwang GY, Lee BJ, Wang RC, Chou MM. Pregnancy-induced hemophagocytic lymphohistiocytosis combined with autoimmune hemolytic anemia. J. Chin. Med. Assoc. 72: 156-159 (2009). *

• Tennenbaum R, Marteau P, Elefant E, Rambaud JC, Modigliani R, Gendre JP, Cosnes J. Pregnancy outcome in inflammatory bowel diseases. Gastroenterol. Clin. Biol. 23: 464-469 (1999).

• ter Borg PC, van Buuren HR, Visser W. Intrahepatic cholestasis of pregnancy. Ned. Tijdschr. Geneeskd. 147: 1056-1059 (2003).

• Terrabuio DR, Abrantes-Lemos CP, Carrilho FJ, Cancado EL. Follow-up of pregnant women with autoimmune hepatitis: the disease behavior along with maternal and fetal outcomes. J. Clin. Gastroenterol. 43: 350-356 (2009).

• Tfayli H, Arslanian S. Pathophysiology of type 2 diabetes mellitus in youth: the evolving chameleon. Arq. Bras. Endocrinol. Metabol. 53: 165-174 (2009). *

• Tham TC, Vandervoort J, Wong RC, Montes H, Roston AD, Slivka A, Ferrari AP, Lichtenstein DR, Van Dam J, Nawfel RD, Soetikno R, Carr-Locke DL. Safety of ERCP during pregnancy. Am. J. Gastroenterol. 98: 308-311 (2003). *

• Thibault L, Beausejour A, de Grandmont MJ, Long A, Goldman M, Chevrier MC. Establishment of an immunoglobulin A-deficient blood donor registry with a simple in-house screening enzyme-linked immunosorbent assay. Transfusion 46: 2115-2121 (2006).

• Thomas B, Ghebremeskel K, Lowy C, Crawford M, Offley-Shore B. Nutrient intake of women with and without gestational diabetes with a specific focus on fatty acids. Nutrition 22: 230-236 (2006). *

• Thomas M, Caroli J. Polycythemia and Budd-Chiari syndrome. Apropos of 17 cases. Ann. Med. Interne (Paris) 122: 1175-1186 (1971).

• Thompson NP, Montgomery SM, Wadsworth ME, Pounder RE, Wakefield AJ. Early determinants of inflammatory bowel disease: use of two national longitudinal birth cohorts. Eur. J. Gastroenterol. Hepatol. 12: 25-30 (2000).

• Thornton CA, Holloway JA, Shute JK, Holloway JW, Diaper ND, Warner JO. Human mid-gestation amniotic fluid contains interleukin-16 bioactivity. Immunology 126: 543-551 (2009). *

• Thukral C, Wolf JL. Therapy insight: drugs for gastrointestinal disorders in pregnant women. Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 256-266 (2006). *

• Thurston A, Grau RH. An update on the dermatoses of pregnancy. J. Okla. State Med. Assoc. 101: 7-11 (2008).

• Tielsch JM, Rahmathullah L, Katz J, Thulasiraj RD, Coles C, Sheeladevi S, Prakash K. Maternal night blindness during pregnancy is associated with low birthweight, morbidity, and poor growth in south India. J. Nutr. 138: 787-792 (2008). *

• Tilburgs T, Scherjon SA, Roelen DL, Claas FH. Decidual CD8+CD28- T cells express CD103 but not perforin. Hum. Immunol. 70: 96-100 (2009).

• Timonen M, Horrobin D, Jokelainen J, Laitinen J, Herva A, Rasanen P. Fish consumption and depression: the Northern Finland 1966 birth cohort study. J. Affect. Disord. 82: 447-452 (2004).

• Tincani A, Bompane D, Danieli E, Doria A. Pregnancy, lupus and antiphospholipid syndrome (Hughes syndrome). Lupus 15: 156-160 (2006).

• Tincani A, Nuzzo M, Motta M, Zatti S, Lojacono A, Faden D. Autoimmunity and pregnancy: autoantibodies and pregnancy in rheumatic diseases. Ann. N. Y. Acad. Sci. 1069: 346-352 (2006). *

• Tincani A, Rebaioli CB, Frassi M, Taglietti M, Gorla R, Cavazzana I, Faden D, Taddei F, Lojacono A, Motta M, Trepidi L, Meroni P, Cimaz R, Ghirardello A, Doria A, Pisoni MP, Muscara M, Brucato A; Pregnancy Study Group of Italian Society of Rheumatology. Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome. Autoimmun. Rev. 4: 423-428 (2005).

• Tincani A, Scarsi M, Franceschini F, Cattaneo R. Intravenous immunoglobulin in pregnancy: a chance for patients with an autoimmune disease. Isr. Med. Assoc. J. 9: 553-554 (2007). *

• Tiribelli C, Rigato I. Liver cirrhosis and pregnancy. Ann. Hepatol. 5: 201 (2006). *

• Todd RD, Neuman RJ. Gene-environment interactions in the development of combined type ADHD: evidence for a synapse-based model. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 144: 971-975 (2007).

• Togni V, Ota CC, Folador A, Junior OT, Aikawa J, Yamazaki RK, Freitas FA, Longo R, Martins EF, Calder PC, Curi R, Fernandes LC. Cancer cachexia and tumor growth reduction in Walker 256 tumor-bearing rats supplemented with n-3 polyunsaturated fatty acids for one generation. Nutr. Cancer 46: 52-58 (2003).

• Toiyama Y, Araki T, Yoshiyama S, Sakamoto N, Miki C, Kusunoki M. Fulminant ulcerative colitis during pregnancy successfully treated by three-stage operation. J. Gastroenterol. 39: 300-301 (2004). *

• Tok EC, Ertunc D, Bilgin O, Erdal EM, Kaplanoglu M, Dilek S. PPAR-gamma2 Pro12Ala polymorphism is associated with weight gain in women with gestational diabetes mellitus. Eur. J. Obstet. Gynecol. Reprod. Biol. 129: 25-30 (2006).

• Toldi G, Svec P, Vasarhelyi B, Meszaros G, Rigo J, Tulassay T, Treszl A. Decreased number of FoxP3+ regulatory T cells in preeclampsia. Acta Obstet. Gynecol. Scand. 87: 1229-1233 (2008).

• Tonelli MR, Aitken ML. Pregnancy in cystic fibrosis. Curr. Opin. Pulm. Med. 13: 537-540 (2007).

• Torn C, Gupta M, Sanjeevi CB, Aberg A, Frid A, Landin-Olsson M. Different HLA-DR-DQ and MHC class I chain-related gene A (MICA) genotypes in autoimmune and nonautoimmune gestational diabetes in a Swedish population. Hum. Immunol. 65: 1443-1450 (2004).

• Torpy JM, Burke AE, Glass RM. JAMA patient page. Thrombophlebitis. JAMA 300: 1718 (2008). *

• Torres AG, Trugo NM. Evidence of inadequate docosahexaenoic acid status in Brazilian pregnant and lactating women. Rev. Saude. Publica 43: 359-368 (2009).

• Toth B, Bastug M, Mylonas I, Scholz C, Makovitzky J, Kunze S, Thaler C, Friese K, Jeschke U. Peroxisome proliferator-activated receptor-gamma in normal human pregnancy and miscarriage. Acta Histochem. 111: 372-378 (2009).

• Toth B, Bastug M, Scholz C, Arck P, Schulze S, Kunze S, Friese K, Jeschke U. Leptin and peroxisome proliferator-activated receptors: impact on normal and disturbed first trimester human pregnancy. Histol. Histopathol. 23: 1465-1475 (2008). *

• Toth B, Hornung D, Scholz C, Djalali S, Friese K, Jeschke U. Peroxisome proliferator-activated receptors: new players in the field of reproduction. Am. J. Reprod. Immunol. 58: 289-310 (2007). *

• Trachter AB, Rogers AI, Leiblum SR. Inflammatory bowel disease in women: impact on relationship and sexual health. Inflamm. Bowel Dis. 8: 413-421 (2002). *

• Trauner M. Molecular mechanisms of cholestasis. Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, pp. 64-65 (2005). *

• Trauner M, Boyer JL. Cholestatic syndromes. Curr. Opin. Gastroenterol. 15: 217-228 (1999).

• Trauner M, Boyer JL. Cholestatic syndromes. Curr. Opin. Gastroenterol. 18: 314-329 (2002).

• Trauner M, Boyer JL. Cholestatic syndromes. Curr. Opin. Gastroenterol. 20: 220-230 (2004).

• Trauner M, Boyer JL. Cholestatic syndromes. Curr. Opin. Gastroenterol. 19: 216-231 (2003).

• Trauner M, Boyer JL. Cholestatic syndromes. Curr. Opin. Gastroenterol. 17: 242-256 (2001).

• Trauner M, Fickert P, Halilbasic E, Moustafa T. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases. Wien. Med. Wochenschr. 158: 542-548 (2008). *

• Trauner M, Fickert P, Lammert F, Marschall HU. ABCB4 gene mutations and primary sclerosing cholangitis. Gastroenterology 126: 1222-1223 (2004). *

• Trauner M, Fickert P, Wagner M. MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes. Semin. Liver Dis. 27: 77-98 (2007). *

• Trauner M, Graziadei IW. Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases. Aliment. Pharmacol. Ther. 13: 979-996 (1999). *

• Traverse W, Tendler B, Galea C, Lakshminarayan S, Parke A. Neuroendocrine manifestations of phospholipid antibody disease identified by long-term follow-up study of patients with phospholipid antibodies. Ann. N. Y. Acad. Sci. 1069: 386-390 (2006). *

• Travis SP, Stange EF, Lemann M, Oresland T, Chowers Y, Forbes A, D'Haens G, Kitis G, Cortot A, Prantera C, Marteau P, Colombel JF, Gionchetti P, Bouhnik Y, Tiret E, Kroesen J, Starlinger M, Mortensen NJ. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 55 Suppl. 1: i16-i35 (2006). *

• Trbojevic B, Djurica S. Diagnosis of autoimmune thyroid disease. Srp. Arh. Celok. Lek. 133 Suppl. 1: 25-33 (2005).

• Trezise AE, Romano PR, Gill DR, Hyde SC, Sepulveda FV, Buchwald M, Higgins CF. The multidrug resistance and cystic fibrosis genes have complementary patterns of epithelial expression. EMBO J. 11: 4291-4303 (1992). *

• Tripathi P, Naik S, Agrawal S. HLA-E and immunobiology of pregnancy. Tissue Antigens 67: 207-213 (2006). *

• Trowsdale J, Moffett A. NK receptor interactions with MHC class I molecules in pregnancy. Semin. Immunol. 20: 317-320 (2008). *

• Tschopp TB, Zucker MB. Platelet function tests in disease. Annu. Rev. Med. 24: 1-18 (1973). *

• Tsuchiya N, Husby G, Williams RC Jr. Studies of humoral and cell-mediated immunity to peptides shared by HLA-27.1 and Klebsiella pneumoniae nitrogenase in ankylosing spondylitis. Clin. Exp. Immunol. 76: 354-360 (1989). *

• Tuomikoski P, Aittomaki K, Mikkola TS, Ropponen A, Ylikorkala O. Effect of oral and transdermal hormone therapy on hyaluronic acid in women with and without a history of intrahepatic cholestasis of pregnancy. Am. J. Obstet. Gynecol. 198: 375.e1-e5 (2008).

• Turco AE, Bambara LM. Pregnancy, microchimerism and autoimmunity: an update. Lupus 13: 659-660 (2004).

• Turner D. The human leucocyte antigen (HLA) system. Vox. Sang. 87 Suppl. 1: 87-90 (2004).

• Tursi A. Effect of intentional infliximab use throughout pregnancy in inducing and maintaining remission in Crohn's disease. Dig. Liver Dis. 38: 439-440 (2006).

• Tursi A, Giorgetti G, Brandimarte G, Elisei W. Effect of gluten-free diet on pregnancy outcome in celiac disease patients with recurrent miscarriages. Dig. Dis. Sci. 53: 2925-2928 (2008). *

• Ubina-Aznar E, De Sola-Earle C, Rivera-Irigoin R, Fernandez-Moreno N, Vera-Rivero F, Fernandez-Perez F, Navarro-Jarabo JM, Garcia-Fernandez G, Moreno-Mejias P, Perez-Aisa A, Perea-Milla E. Crohn's disease and pregnancy. A descriptive and retrospective study. Gastroenterol. Hepatol. 29: 277-281 (2006).

• Ueland PM, Holm PI, Hustad S. Betaine: a key modulator of one-carbon metabolism and homocysteine status. Clin. Chem. Lab. Med. 43: 1069-1075 (2005). *

• Ulander VM, Stefanovic V, Rinta-Kiikka I, Kaaja R. Pregnancy-associated recurrent liver necrosis in patient with antiphospholipid syndrome. Lupus 15: 889-891 (2006).

• Ulbricht C, Basch E, Szapary P, Hammerness P, Axentsev S, Boon H, Kroll D, Garraway L, Vora M, Woods J; Natural Standard Research Collaboration. Guggul for hyperlipidemia: a review by the Natural Standard Research Collaboration. Complement. Ther. Med. 13: 279-290 (2005).

• Ulcova-Gallova Z. Antiphospholipid antibodies and reproductive failure. Chem. Immunol. Allergy 88: 139-149 (2005).

• Umlawska W, Prusek-Dudkiewicz A. Short stature of children suffering from certain chronic diseases. Endokrynol. Diabetol. Chor. Przemiany. Materii. Wieku. Rozw. 13: 135-138 (2007).

• Urbanus R, Derksen R, de Groot P. Platelets and the antiphospholipid syndrome. Lupus 17: 888-894 (2008).

• Urbanus RT, Derksen RH, de Groot PG. Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome. Blood Rev. 22: 93-105 (2008).

• Uribe M, Chavez-Tapia NC, Mendez-Sanchez N. Pregnancy and autoimmune hepatitis. Ann. Hepatol. 5: 187-189 (2006). *

• Uz E, Loubiere LS, Gadi VK, Ozbalkan Z, Stewart J, Nelson JL, Ozcelik T. Skewed X-chromosome inactivation in scleroderma. Clin. Rev. Allergy Immunol. 34: 352-355 (2008). *

• Vader JP, Froehlich F, Juillerat P, Burnand B, Felley C, Gonvers JJ, Mottet C, Pittet V, Dubois RW, Wietlisbach V, Michetti P. Appropriate treatment for Crohn's disease: methodology and summary results of a multidisciplinary international expert panel approach - EPACT. Digestion 73: 237-248 (2006). *

• Vaidya SS, Gerk PM. Lack of interaction between tauroursodeoxycholate and ATP-binding cassette transporter isoform G2 (ABCG2). Mol. Pharm. 3: 303-306 (2006). *

• Vallejo M, Briz O, Serrano MA, Monte MJ, Marin JJ. Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy. J. Hepatol. 44: 1150-1157 (2006). *

• Vambergue A, Fajardy I, Bianchi F, Cazaubiel M, Verier-Mine O, Goeusse P, Fontaine P, Danze PM. Gestational diabetes mellitus and HLA class II (-DQ, -DR) association: The Digest Study. Eur. J. Immunogenet. 24: 385-394 (1997).

• Van Bodegraven AA, Pena AS. Treatment of extraintestinal manifestations in inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 6: 201-212 (2003).

• Van den Branden BJ, Bruggeling WA, Corbeij HM, Dunselman PH. Spontaneous coronary artery dissection in the postpartum period. Neth. Heart J. 16: 412-414 (2008).

• van Goor SA, Dijck-Brouwer DA, Hadders-Algra M, Doornbos B, Erwich JJ, Schaafsma A, Muskiet FA. Human milk arachidonic acid and docosahexaenoic acid contents increase following supplementation during pregnancy and lactation. Prostaglandins Leukot. Essent. Fatty Acids 80: 65-69 (2009). *

• van Mil SW, Milona A, Dixon PH, Mullenbach R, Geenes VL, Chambers J, Shevchuk V, Moore GE, Lammert F, Glantz AG, Mattsson LA, Whittaker J, Parker MG, White R, Williamson C. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology 133: 507-516 (2007). *

• van Runnard Heimel PJ, Kavelaars A, Heijnen CJ, Peters WH, Huisjes AJ, Franx A, Bruinse HW. HELLP syndrome is associated with an increased inflammatory response, which may be inhibited by administration of prednisolone. Hypertens. Pregnancy 27: 253-265 (2008).

• Vannozzi G, Tozzi A, Chibbaro G, Mello G, Ponzalli M. Hepatic and mesenteric sarcoidosis without thoracic involvement: a case of severe noncirrhotic portal hypertension and successful pregnancy. Eur. J. Gastroenterol. Hepatol. 20: 1032-1035 (2008).

• Vanzyl B, Gillespie KM. Microchimerism in type 1 diabetes. Curr. Diab. Rep. 9: 125-129 (2009).

• Vargova V, Mechírova V, Pytliak M. Thyroid gland in the gravidity. Ceska. Gynekol. 74: 12-17 (2009).

• Vasiliauskas EA, Church JA, Silverman N, Barry M, Targan SR, Dubinsky MC. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin. Gastroenterol. Hepatol. 4: 1255-1258 (2006).

• Vasku JA, Vasku A, Dostalova Z, Bienert P. Association of leptin genetic polymorphism -2548 G/A with gestational diabetes mellitus. Genes Nutr. 1: 117-123 (2006).

• Vasoo S, Sangle S, Zain M, D'Cruz D, Hughes G. Orthopaedic manifestations of the antiphospholipid (Hughes) syndrome. Lupus 14: 339-345 (2005).

• Vazquez-Del Mercado M, Martin-Marquez BT, Petri MH, Martinez-Garcia EA, Munoz-Valle JF. Molecular mechanisms in normal pregnancy and rheumatic diseases. Clin. Exp. Rheumatol. 24: 707-712 (2006).

• Vega-Ostertag ME, Pierangeli SS. Mechanisms of aPL-mediated thrombosis: effects of aPL on endothelium and platelets. Curr. Rheumatol. Rep. 9: 190-197 (2007).

• Veit TD, Chies JA. Tolerance versus immune response - microRNAs as important elements in the regulation of the HLA-G gene expression. Transpl. Immunol. 20: 229-231 (2009).

• Vender RJ, Spiro HM. Inflammatory bowel disease and pregnancy. J. Clin. Gastroenterol. 4: 231-249 (1982).

• Veneri D, Franchini M. Autoimmune thrombocytopenia: diagnosis and treatment. Recenti Prog. Med. 96: 250-253 (2005).

• Vercammen M, Verloes A, Haentjens P, Van de Velde H. Can soluble human leucocyte antigen-G predict successful pregnancy in assisted reproductive technology? Curr. Opin. Obstet. Gynecol. 21: 285-290 (2009).

• Verhoef P, de Groot LC. Dietary determinants of plasma homocysteine concentrations. Semin. Vasc. Med. 5: 110-123 (2005).

• Verlinsky Y, Rechitsky S, Sharapova T, Laziuk K, Barsky I, Verlinsky O, Tur-Kaspa I, Kuliev A. Preimplantation diagnosis for immunodeficiencies. Reprod. Biomed. Online 14: 214-223 (2007).

• Verzijl JM, van Bodegraven AA. Mesalazine - still a first-line therapy. European Pharmacotherapy, Business Briefing (http://bbriefings.com/pdf/26/ept032_r_26_verzil.pdf), pp. 1-7 (2003). *

• Vesga L, Terdiman JP, Mahadevan U. Adalimumab use in pregnancy. Gut 54: 890 (2005). *

• Vettriselvi V, Vijayalakshmi K, Paul SF, Venkatachalam P. ACE and MTHFR gene polymorphisms in unexplained recurrent pregnancy loss. J. Obstet. Gynaecol. Res. 34: 301-306 (2008).

• Vianna P, Dalmaz CA, Veit TD, Tedoldi C, Roisenberg I, Chies JA. Immunogenetics of pregnancy: role of a 14-bp deletion in the maternal HLA-G gene in primiparous pre-eclamptic Brazilian women. Hum. Immunol. 68: 668-674 (2007).

• Vidailhet M. Omega 3: is there a situation of deficiency in young children? Arch. Pediatr. 14: 116-123 (2007).

• Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J, Bombardier C, Carmona L, van der Heijde D, Bijlsma JW, Boumpas DT, Canhao H, Edwards CJ, Hamuryudan V, Kvien TK, Leeb BF, Martín-Mola EM, Mielants H, Muller-Ladner U, Murphy G, et al. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in … Ann. Rheum. Dis. 68: 1086-1093 (2009). *

• Vlachoyiannopoulos PG, Samarkos M, Sikara M, Tsiligros P. Antiphospholipid antibodies: laboratory and pathogenetic aspects. Crit. Rev. Clin. Lab. Sci. 44: 271-338 (2007).

• Volpe MD R. The pathogenesis of Graves' disease. Endocr. Pract. 1: 103-115 (1995).

• Vyse AJ, Andrews NJ, Hesketh LM, Pebody R. The burden of parvovirus B19 infection in women of childbearing age in England and Wales. Epidemiol. Infect. 135: 1354-1362 (2007).

• Wagner M, Fickert P, Zollner G, Silbert D, Gumhold J, Fuchsbichler A, Zatloukal K, Marschall HU, Denk H, Trauner M. Gender and pregnancy affect hepatic and renal ABC transporter expression in mice. J. Hepatol. 40 Suppl. 1: 94 (2004).

• Wagner M, Trauner M. Transcriptional regulation of hepatobiliary transport systems in health and disease: implications for a rational approach to the treatment of intrahepatic cholestasis. Ann. Hepatol. 4: 77-99 (2005). *

• Wagner M, Zollner G, Trauner M. New molecular insights into the mechanisms of cholestasis. J. Hepatol. [In Press] (2009).

• Wakim-Fleming J, Zein NN. The liver in pregnancy: disease vs benign changes. Cleve. Clin. J. Med. 72: 713-721 (2005). *

• Wald A. Constipation, diarrhea, and symptomatic hemorrhoids during pregnancy. Gastroenterol. Clin. North Am. 32: 309-322, vii (2003). *

• Waldorf KM, Nelson JL. Autoimmune disease during pregnancy and the microchimerism legacy of pregnancy. Immunol. Invest. 37: 631-644 (2008). *

• Waljee A, Waljee J, Morris A, Higgins PD. Three-fold increased risk of infertility: a meta-analysis of infertility after pouch surgery in ulcerative colitis. Gut 55: 1575-1580 (2006). *

• Walsh MC, Choi Y. Biology of the TRANCE axis. Cytokine Growth Factor Rev. 14: 251-263 (2003).

• Wang C, Dehghani B, Li Y, Kaler LJ, Vandenbark AA, Offner H. Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin-17 production via programmed death 1. Immunology 126: 329-335 (2009). *

• Wang JL, Yang Z, Wang R, Zhu JM. Interaction among abnormal fatty acid oxidation, endothelial function disorder, and oxidative stress in the onset of severe preeclampsia. Zhonghua Yi Xue Za Zhi 88: 1471-1475 (2008).

• Wang X, Lin Q, Ma Z, Hong Y, Zhao A, Di W, Lu P. Association of the A/G polymorphism at position 49 in exon 1 of CTLA-4 with the susceptibility to unexplained recurrent spontaneous abortion in the Chinese population. Am. J. Reprod. Immunol. 53: 100-105 (2005). *

• Wang X, Zhang L, Ou R, Wang J, Liu S, Chen Q, Su P. Association between CYP1A1 gene polymorphism and intrahepatic cholestasis of pregnancy. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 25: 70-72 (2008).

• Wang XD, He MM, Liu ZF, Liu SY. Intrahepatic cholestasis of pregnancy. Zhonghua Gan Zang Bing Za Zhi 16: 634-636 (2008).

• Wang XD, Peng B, Yao Q, Zhang L, Ai Y, Xing AY, Liu XH, Liu SY. Perinatal outcomes of intrahepatic cholestasis of pregnancy: analysis of 1210 cases. Zhonghua Yi Xue Za Zhi 86: 446-449 (2006).

• Wang XD, Yao Q, Peng B, Zhang L, Ai Y, Ying AY, Liu XH, Liu SY. A clinical analysis of intrahepatic cholestasis of pregnancy in 1241 cases. Zhonghua Gan Zang Bing Za Zhi 15: 291-293 (2007).

• Wang XL, Tan X, Zhang L, Ou RG, Yan AH, Chen Q, Zou H. Association of gene polymorphisms of CYP1B1 with intrahepatic cholestasis of pregnancy. Sichuan Da Xue Xue Bao Yi Xue Ban 39: 434-437 (2008).

• Wang XP, Lin QD, Ma ZW, Hong Y, Zhao AM, DI W, Lu PH. A/G polymorphism at position 49 in exon 1 of CTLA-4 gene in Chinese women with unexplained recurrent spontaneous abortion. Zhonghua Fu Chan Ke Za Zhi 41: 155-158 (2006).

• Wani NA, Hamid A, Kaur J. Folate status in various pathophysiological conditions. IUBMB Life 60: 834-842 (2008). *

• Ware Branch D, Eller AG. Antiphospholipid syndrome and thrombosis. Clin. Obstet. Gynecol. 49: 861-874 (2006).

• Warren JB, Silver RM. Autoimmune disease in pregnancy: systemic lupus erythematosus and antiphospholipid syndrome. Obstet. Gynecol. Clin. North Am. 31: 345-372 (2004).

• Warren JE, Blaylock RC, Silver RM. Plasmapheresis for the treatment of intrahepatic cholestasis of pregnancy refractory to medical treatment. Am. J. Obstet. Gynecol. 192: 2088-2089 (2005). *

• Warstedt K, Furuhjelm C, Duchen K, Falth-Magnusson K, Fageras M. The effects of omega-3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine and chemokine secretion. Pediatr. Res. Apr 22 [Epub ahead of print] (2009).

• Wasmuth HE, Glantz A, Keppeler H, Simon E, Bartz C, Rath W, Mattsson LA, Marschall HU, Lammert F. Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter gene ABCB4. Gut 56: 265-270 (2007). *

• Waterman M, Eliakim R. Capsule enteroscopy of the small intestine. Abdom. Imaging Jun 25 [Epub ahead of print] (2008). *

• Weatherhead S, Robson SC, Reynolds NJ. Management of psoriasis in pregnancy. BMJ 334: 1218-1220 (2007). *

• Weiler H. Tracing the molecular pathogenesis of antiphospholipid syndrome. J. Clin. Invest. 118: 3276-3278 (2008). *

• Weiner HL. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. Arch. Neurol. 61: 1613-1615 (2004). *

• Weiss ST, Litonjua AA. Maternal diet vs lack of exposure to sunlight as the cause of the epidemic of asthma, allergies and other autoimmune diseases. Thorax 62: 745-746 (2007). *

• Werner M, Bjornsson E, Prytz H, Lindgren S, Almer S, Broome U, Wallerstedt S, Sandberg-Gertzen H, Hultcrantz R, Sangfeldt P, Nilsson J, Danielsson A. Autoimmune hepatitis among fertile women: strategies during pregnancy and breastfeeding? Scand. J. Gastroenterol. 42: 986-991 (2007). *

• Weseler AR, Dirix CE, Bruins MJ, Hornstra G. Dietary arachidonic acid dose-dependently increases the arachidonic acid concentration in human milk. J. Nutr. 138: 2190-2197 (2008). *

• Weterman IT. Fertility and pregnancy in inflammatory bowel disease. Neth. J. Med. 35 Suppl. 1: S67-S75 (1989).

• Wexler ID, Johannesson M, Edenborough FP, Sufian BS, Kerem E. Pregnancy and chronic progressive pulmonary disease. Am. J. Respir. Crit. Care Med. 175: 300-305 (2007). *

• White B. Ginger: an overview. Am. Fam. Physician 75: 1689-1691 (2007). *

• Whitington PF, Hibbard JU. High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet 364: 1690-1698 (2004). *

• Wichmann I, Aguilera I, Sousa JM, Bernardos A, Garcia Nunez EJ, Vigil E, Magarino R, Magarino I, Torres A, Nunez-Roldan A. Antibodies against glutathione S-transferase T1 in non-solid organ transplanted patients. Transfusion 46: 1505-1509 (2006). *

• Wiedermann CJ, Zagler B. Reduced watery diarrhea during pregnancy in a psoriasis patient with lymphocytic colitis. Z. Gastroenterol. 46: 1275-1277 (2008).

• Wieser F, Waite L, Depoix C, Taylor RN. PPAR action in human placental development and pregnancy and its complications. PPAR Res. 2008: 527048 (2008). *

• Wilczynski JR. Immunological analogy between allograft rejection, recurrent abortion and pre-eclampsia - the same basic mechanism? Hum. Immunol. 67: 492-511 (2006).

• Wilczynski JR, Kalinka J, Radwan M. The role of T-regulatory cells in pregnancy and cancer. Front. Biosci. 13: 2275-2289 (2008).

• Wilczynski JR, Radwan M, Kalinka J. The characterization and role of regulatory T cells in immune reactions. Front. Biosci. 13: 2266-2274 (2008).

• Wilder RL, Elenkov IJ. Hormonal regulation of tumor necrosis factor-alpha, interleukin-12 and interleukin-10 production by activated macrophages. A disease-modifying mechanism in rheumatoid arthritis and systemic lupus erythematosus? Ann. N. Y. Acad. Sci. 876: 14-31 (1999). *

• Willer CJ, Dyment DA, Sadovnick AD, Ebers GC. Maternal - offspring HLA-DRB1 compatibility in multiple sclerosis. Tissue Antigens 66: 44-47 (2005). *

• Willers SM, Devereux G, Craig LC, McNeill G, Wijga AH, Abou El-Magd W, Turner SW, Helms PJ, Seaton A. Maternal food consumption during pregnancy and asthma, respiratory and atopic symptoms in 5-year-old children. Thorax 62: 772-778 (2007). *

• Williams CM, Burdge G. Long-chain n-3 PUFA: plant v. marine sources. Proc. Nutr. Soc. 65: 42-50 (2006). *

• Williams IO, Eka OU, Essien EU. Vitamin A status of pregnant women in Calabar metropolis, Nigeria. Pak. J. Biol. Sci. 11: 1702-1707 (2008).

• Williams MA, Frederick IO, Qiu C, Meryman LJ, King IB, Walsh SW, Sorensen TK. Maternal erythrocyte omega-3 and omega-6 fatty acids, and plasma lipid concentrations, are associated with habitual dietary fish consumption in early pregnancy. Clin. Biochem. 39: 1063-1070 (2006). *

• Wolf JL. Liver disease in pregnancy. Med. Clin. North Am. 80: 1167-1187 (1996).

• Wolf R, Orion E, Matz H, Maitra S, Rowland-Payne C. Smoking can be good for you. J. Cosmet. Dermatol. 3: 107-111 (2004).

• Wolters FL, Russel MG, Sijbrandij J, Schouten LJ, Odes S, Riis L, Munkholm P, Langholz E, Bodini P, O'Morain C, Katsanos K, Tsianos E, Vermeire S, Van Zeijl G, Limonard C, Hoie O, Vatn M, Moum B, et al. Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up study. Scand. J. Gastroenterol. Suppl. 243: 46-54 (2006). *

• Wong KK, Goh KL. Pregnancy in primary biliary cirrhosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 45: 149-151 (1992).

• Wong LF, Shallow H, O'Connell MP. Comparative study on the outcome of obstetric cholestasis. J. Matern. Fetal Neonatal Med. 21: 327-330 (2008).

• Xia Y, Kellems RE. Is preeclampsia an autoimmune disease? Clin. Immunol. Jun 4 [Epub ahead of print] (2009).

• Xia Y, Zhou CC, Ramin SM, Kellems RE. Angiotensin receptors, autoimmunity, and preeclampsia. J. Immunol. 179: 3391-3395 (2007). *

• Xie L, Innis SM. Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation. J. Nutr. 138: 2222-2228 (2008). *

• Xing X, Tao F. Advance of study on vitamin A deficiency and excess associatied with congenital heart disease. Wei Sheng Yan Jiu 37: 754-756 (2008).

• Xu Y, Agrawal S, Cook TJ, Knipp GT. Maternal di-(2-ethylhexyl)-phthalate exposure influences essential fatty acid homeostasis in rat placenta. Placenta 29: 962-969 (2008).

• Xu Z, Ke JC, Xing AY. Study on relationship between expression of familial intrahepatic cholestasis 1 mRNA in placenta and Intrahepatic cholestasis of pregnancy. Sichuan Da Xue Xue Bao Yi Xue Ban 39: 430-433 (2008).

• Yamamoto Y, Moore R, Hess HA, Guo GL, Gonzalez FJ, Korach KS, Maronpot RR, Negishi M. Estrogen receptor alpha mediates 17alpha-ethynylestradiol-causing hepatotoxicity. J. Biol. Chem. 281: 16625-16631 (2006). *

• Yan C, Boyd DD. Regulation of matrix metalloproteinase gene expression. J. Cell. Physiol. 211: 19-26 (2007). *

• Yang CH, Chen JY, Lee SC, Luo SF. Successful preventive treatment of congenital heart block during pregnancy in a woman with systemic lupus erythematosus and anti-Sjogren's syndrome A/Ro antibody. J. Microbiol. Immunol. Infect. 38: 365-369 (2005). *

• Yang J, Chen L, Zhang X, Zhou Y, Zhang D, Huo M, Guan Y. PPARs and female reproduction: evidence from genetically manipulated mice. PPAR Res. 2008: 723243 (2008). *

• Yang L, Li X, Zhao J, Hou Y. Progesterone is involved in the maturation of murine spleen CD11c-positive dendritic cells. Steroids 71: 922-929 (2006).

• Yang Q, Yamada A, Kimura S, Peters JM, Gonzalez FJ. Alterations in skin and stratified epithelia by constitutively activated PPARalpha. J. Invest. Dermatol. 126: 374-385 (2006). *

• Yang X, Ding YL. Relationship of the occurrence of fetal distress and change of umbilical cord and expression of vasoactive substance in umbilical vein in intrahepatic cholestasis of pregnancy. Zhonghua Fu Chan Ke Za Zhi 43: 85-89 (2008).

• Yashodhara BM, Umakanth S, Pappachan JM, Bhat SK, Kamath R, Choo BH. Omega-3 fatty acids: a comprehensive review of their role in health and disease. Postgrad. Med. J. 85: 84-90 (2009).

• Yasuda S, Bohgaki M, Atsumi T, Koike T. Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway. Immunobiology 210: 775-780 (2005).

• Yasuda S, Koike T. New insights into the pathogenicity of antiphospholipid antibodies. Nihon Rinsho Meneki Gakkai Kaishi 29: 311-318 (2006).

• Ye L, Liu S, Wang M, Shao Y, Ding M. High-performance liquid chromatography-tandem mass spectrometry for the analysis of bile acid profiles in serum of women with intrahepatic cholestasis of pregnancy. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 860: 10-17 (2007). *

• Yessoufou A, Hichami A, Besnard P, Moutairou K, Khan NA. Peroxisome proliferator-activated receptor alpha deficiency increases the risk of maternal abortion and neonatal mortality in murine pregnancy with or without diabetes mellitus: modulation of T cell differentiation. Endocrinology 147: 4410-4418 (2006). *

• Yiallourides M, Sebert S, Wilson V, Sharkey D, Rhind S, Symonds M, Budge H. The differential effects of the timing of maternal nutrient restriction in the ovine placenta on glucocorticoid sensitivity, uncoupling protein 2, PPAR-gamma and cell proliferation. Reproduction Jun 12 [Epub ahead of print] (2009).

• Yoong W, Memtsa M, Pun S, West P, Loo C, Okolo S. Pregnancy outcomes of women with pruritus, normal bile salts and liver enzymes: a case control study. Acta Obstet. Gynecol. Scand. 87: 419-422 (2008).

• Yu HY, Yao Q, Wang XD, Liu SY. The preliminary study on cord blood lymphocytes apoptosis in patients with intrahepatic cholestasis of pregnancy. Sichuan Da Xue Xue Bao Yi Xue Ban 38: 257-259 (2007).

• Yu XW, Li X, Ren YH, Li XC. Tumour necrosis factor-alpha receptor 1 polymorphisms and serum soluble TNFR1 in early spontaneous miscarriage. Cell. Biol. Int. 31: 1396-1399 (2007). *

• Yu Y, Wang Y, Feng M. Human leukocyte antigen-G1 inhibits natural killer cytotoxicity through blocking the activating signal transduction pathway and formation of activating immunologic synapse. Hum. Immunol. 69: 16-23 (2008).

• Yunis EJ, Zuniga J, Romero V, Yunis EJ. Chimerism and tetragametic chimerism in humans: implications in autoimmunity, allorecognition and tolerance. Immunol. Res. 38: 213-236 (2007).

• Yuzawa E, Imaizumi T, Matsumiya T, Yoshida H, Fukuhara R, Kimura H, Fukui A, Tanji K, Mori F, Wakabayashi K, Fujii S, Mizunuma H, Satoh K. Retinoic acid-inducible gene-I is induced by interferon-gamma and regulates CXCL11 expression in HeLa cells. Life Sci. 82: 670-675 (2008). *

• Zamah AM, El-Sayed YY, Milki AA. Two cases of cholestasis in the first trimester of pregnancy after ovarian hyperstimulation. Fertil. Steril. 90: 1202.e7-e10 (2008).

• Zammiti W, Mtiraoui N, Finan RR, Almawi WY, Mahjoub T. Tumor necrosis factor alpha and lymphotoxin alpha haplotypes in idiopathic recurrent pregnancy loss. Fertil. Steril. 91: 1903-1908 (2009).

• Zammiti W, Mtiraoui N, Khairi H, Gris JC, Almawi WY, Mahjoub T. Associations between tumor necrosis factor-alpha and lymphotoxin-alpha polymorphisms and idiopathic recurrent miscarriage. Reproduction 135: 397-403 (2008).

• Zammiti W, Mtiraoui N, Mahjoub T. Lack of consistent association between endothelial nitric oxide synthase gene polymorphisms, homocysteine levels and recurrent pregnancy loss in Tunisian women. Am. J. Reprod. Immunol. 59: 139-145 (2008). *

• Zapata R, Sandoval L, Palma J, Hernandez I, Ribalta J, Reyes H, Sedano M, Toha D, Silva JJ. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. Liver Int. 25: 548-554 (2005). *

• Zecca E, De Luca D, Barbato G, Marras M, Tiberi E, Romagnoli C. Predicting respiratory distress syndrome in neonates from mothers with intrahepatic cholestasis of pregnancy. Early Hum. Dev. 84: 337-341 (2008).

• Zecca E, De Luca D, Baroni S, Vento G, Tiberi E, Romagnoli C. Bile acid-induced lung injury in newborn infants: a bronchoalveolar lavage fluid study. Pediatrics 121: e146-e149 (2008). *

• Zecca E, De Luca D, Marras M, Caruso A, Bernardini T, Romagnoli C. Intrahepatic cholestasis of pregnancy and neonatal respiratory distress syndrome. Pediatrics 117: 1669-1672 (2006). *

• Zeisel SH. Is maternal diet supplementation beneficial? Optimal development of baby depends on mother's diet. Am. J. Clin. Nutr. 89: 685S-687S (2009). *

• Zhang J, Sun R, Wei H, Wu D, Tian Z. Toll-like receptor 3 agonist enhances IFN-gamma and TNF-alpha production by murine uterine NK cells. Int. Immunopharmacol. 7: 588-596 (2007).

• Zhang L, Liu S, Chen Q, Yang X, Chen X. Human leucocyte antigen-DPA1 polymorphism distribution in Chengdu Chinese families with intrahepatic cholestasis of pregnancy. Sichuan Da Xue Xue Bao Yi Xue Ban 34: 530-532 (2003).

• Zhang L, Liu S, Chen Q, Zou H, Zuo Y, Xu X, Chen Y. An associated analysis of estrogen receptor 2 gene polymorphism linked with intrahepatic cholestasis of pregnancy. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23: 434-436 (2006).

• Zhang L, Liu SY, Chen Q, Shi QY, Zou H, Wu L. Association between polymorphisms of CYP17 and CYP3A4 genes and intrahepatic cholestasis of pregnancy in Chengdu. Sichuan Da Xue Xue Bao Yi Xue Ban 37: 551-553, 582 (2006).

• Zhang L, Liu SY, Shi QY, Chen Q, Zou H, Xing AY. Study on the association between estrogen receptor alpha gene polymorphism and intrahepatic cholestasis of pregnancy. Zhonghua Fu Chan Ke Za Zhi 41: 307-310 (2006).

• Zhang P, Shi Y, Gao X, Wang S, Wang J, Chen ZJ. Clinical analysis of Chinese infertility women with premature ovarian failure. Neuro. Endocrinol. Lett. 28: 580-584 (2007).

• Zhang Y, Liu D, Ma Q, Dang C, Wei W, Chen W. Factors influencing the prevalence of gallstones in liver cirrhosis. J. Gastroenterol. Hepatol. 21: 1455-1458 (2006). *

• Zhao J, Lei Z, Liu Y, Li B, Zhang L, Fang H, Song C, Wang X, Zhang GM, Feng ZH, Huang B. Human pregnancy up-regulates Tim-3 in innate immune cells for systemic immunity. J. Immunol. 182: 6618-6624 (2009).

• Zhao Y, Xia S, Zou L. The association between polymorphism of TNF-alpha gene and hypertensive disorder complicating pregnancy. J. Huazhong Univ. Sci. Technolog. Med. Sci. 27: 729-732 (2007).

• Zhou CC, Zhang Y, Irani RA, Zhang H, Mi T, Popek EJ, Hicks MJ, Ramin SM, Kellems RE, Xia Y. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat. Med. 14: 855-862 (2008). *

• Zhu H, Zhao ZY, Jiang YJ, Liang L, Wang JY, Mao HQ, Zou CC, Chen LQ, Qu YP. Multifactorial analysis of effects of mothers' autoimmune thyroid disease on their infants' intellectual development. Zhonghua Er Ke Za Zhi 43: 340-344 (2005).

• Zhu WH, Lu CZ, Huang YM, Link H, Xiao BG. A putative mechanism on remission of multiple sclerosis during pregnancy: estrogen-induced indoleamine 2,3-dioxygenase by dendritic cells. Mult. Scler. 13: 33-40 (2007).

• Zimmer V, Mullenbach R, Simon E, Bartz C, Matern S, Lammert F. Combined functional variants of hepatobiliary transporters and FXR aggravate intrahepatic cholestasis of pregnancy. Liver Int. Apr 16 [Epub ahead of print] (2009). *

• Zlatanic J, Korelitz BI, Rajapakse R, Kim PS, Rubin SD, Baiocco PJ, Panagopoulos G. Complications of pregnancy and child development after cessation of treatment with 6-mercaptopurine for inflammatory bowel disease. J. Clin. Gastroenterol. 36: 303-309 (2003).

• Zlotnikova AD. Wegener's granulomatosis. Arkh. Patol. 37: 70-72 (1975).

• Zollner G, Trauner M. Mechanisms of cholestasis. Clin. Liver Dis. 12: 1-26 (2008).

• Zou SH, Yang ZZ, Zhang P, Song DP, Li B, Wu RY, Cong X. Autoimmune disorders affect the in vitro fertilization outcome in infertile women. Zhonghua Nan Ke Xue 14: 343-346 (2008).

• Zou SL, Liu J, Lan Y, Cheng H, Gan XL. Effects of farnesoid X receptor ligand on the metabolism of bile acids in rats with estrogen-induced intrahepatic cholestasis of pregnancy. Zhonghua Gan Zang Bing Za Zhi 16: 383-386 (2008).

• Zutshi M, Hull TL, Hammel J. Crohn's disease: a patient's perspective. Int. J. Colorectal Dis. 22: 1437-1444 (2007). *

• Zylicz M, Bocian K, Korczak-Kowalska G. Regulatory cells: their development, mechanisms and effects of action, and their potential use in transplantation. Postepy. Hig. Med. Dosw. (Online) 59: 160-171 (2005).

Number of references = 1605

www psc-literature.org